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Multidisciplinary teams (MDTs) are considered central to the delivery of 
high quality cancer care. Some evidence suggests that there is poor 
participation and limited contribution from the clinical nurse specialist 
(CNS) whose focus is on patient-centred issues.  
Aim  
The main aims were to: 1) explore the CNS contribution to the 
multidisciplinary team meeting (MDM); and 2) identify the factors that 
enable and inhibit CNSs from contributing patient-centred information. 
Methods 
Using a sequential mixed methods design Phase 1 consisted of non-
participant observation of 16 colorectal MDMs across four colorectal 
teams. Phase 2 consisted of semi-structured interviews with a purposive 
sample of 18 core colorectal MDT members from the four teams. For 
Phase 3 the colorectal CNSs attended a focus group to explore and 
validate proposals to enhance their contributions. The quantitative data 
were analysed using descriptive statistics and framework analysis was 
undertaken for the interview data.  
Findings 
In Phase 1 CNSs were observed contributing patient-centred information 
variably across the four teams with few patient-centred dimensions raised. 
Phase 2 findings showed variations between the CNS and other MDT 
members in their perceptions of the role and contribution of the CNS in the 
MDM. The integrated findings of Phase 1 and 2 showed that there was 
low participation and minimal contribution of the CNSs across all MDTs 
due to the perceived low professional status of the CNSs, role conflict and 
ambiguity and a meeting culture focused on the ‘tumour’ rather than the 
‘person’. 
Phase 3 indicated support for three proposals: 1) agreed clarity on the role 
of the CNS in the MDM; 2) systematising of the CNS opinion in the MDM 




There are problems with CNSs fulfilling their role within the context of the 
cancer MDT meeting. Potential strategies for enhancing their contribution 
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1.1 The research problem 
Cancer clinical nurse specialists (CNSs) are at the front line of cancer 
care; they are the main point of contact for patients and as a result help to 
shape services for each patient according to need and choice 
(Department of Health, 2010). CNSs, therefore, have an important role in 
supporting cancer patients throughout their cancer journey and this 
includes ensuring they communicate relevant patient-centred information 
into the clinical decision-making process of the multidisciplinary team 
meeting (MDM). MDMs remain the standard mechanism in the United 
Kingdom by which decisions about a cancer patient’s treatment is made 
and these decisions should be based on a range of professional opinions 
(Department of Health, 2004). This includes information about the 
patient’s co-morbidities, preferences for treatment, and relevant 
psychological and social issues. All of which should be considered as they 
are likely to have an impact on the decision being implemented (Blazeby 
et al., 2006; Stalfors et al., 2007; Wood et al., 2008). 
CNSs are designated in the Manual of Cancer Services (2004) as the 
professional within the MDM with the responsibility of ensuring that 
patient-centred concerns are factored into the case discussion within the 
MDM. Whilst there is little research into the role and contribution of the 
CNS within the MDM emerging evidence suggests that their participation 
is minimal and contribution limited (Amir et al., 2004; Lanceley et al., 
2008; Kidger et al., 2009; Lamb et al., 2011a). This situation, therefore, 
has important implications for decision-making in terms of decision 
implementation and outcome. 
The purpose of this research was to investigate if the emerging evidence 
with regard to low participation and limited contribution of the CNS within 
the MDM is valid and to explore the perceptions of MDT members of the 
role and contribution of the CNS within the meeting. Critical to this was an 
understanding of the barriers and enablers to their contribution in order to 
develop proposals grounded in practice that could enable the CNSs to 
fulfil their professional role in the meeting and improve decision-making. 
This thesis is divided into six chapters: Chapter 2 reviews the literature on 
the CNS contribution justifying the reasons for this research and the 
chosen methods; Chapter 3 describes the research design and methods 
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in detail; Chapter 4 presents the findings from the study and integrates the 
results from both the quantitative and qualitative data; Chapter 5 provides 
a discussion and interpretation of the findings and; Chapter 6 concludes 
with some final reflections on the future of MDT working in cancer care. 
This chapter sets the context for this research, explores the problem and 
the significance of this to patient care and explains the rationale for this 
study. To accomplish this, the following sections will review the growth of 
cancer MDTs and MDMs in the UK and the challenges of this model of 
team working; the role of CNSs in cancer care; the rationale for 
undertaking the research with colorectal MDTs and colorectal cancer 
CNSs; and the theoretical position I have taken within this study. 
 
1.2 Multidisciplinary teams in cancer care 
An MDT has been defined as; 
 
“A group of different healthcare disciplines, which meets together at 
a given time (MDM), whether physically in one place, or by video or 
teleconference, to discuss a given patient and who are each able to 
contribute independently to the diagnostic and treatment decisions 
about the patient” (Department of Health, Manual for Cancer 
Services, 2004 p2) 
 
MDTs thus aim to ensure that patients receive timely treatment and care 
from appropriately skilled professionals, provide continuity of care and 
ensure that patients receive adequate information and support (Taylor et 
al., 2010). 
MDTs and MDMs are now considered an essential component in the 
treatment and management of cancer patients in the UK.  The introduction 
of routine MDMs into cancer care followed the publication of the Calman-
Hine Report (1995) into the organisation of cancer services, which 
identified a number of shortfalls in the delivery and organization of cancer 
care in the UK.   
The Calman–Hine Report was the first comprehensive cancer strategy to 
be produced for England and Wales, and set out principles for cancer care 
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and the clinical organisation for service delivery. A key concern noted by 
the Expert Advisory Group on Cancer (EAGC) was the apparent variation 
in the recorded mortality outcomes of treatment in the UK. To overcome 
these inequalities in outcome it advocated the development of cancer 
units and cancer centres and a change from a generalist model (e.g., care 
given by general surgeons and physicians) that was supported by 
specialists to a fully specialist service (Haward, 2006). Underpinning this 
was the acknowledgement that there was a positive relationship between 
the volume of cancer cases treated and outcomes for the patient i.e. the 
higher the volume of a certain cancer type treated in a particular centre or 
unit the better the patient outcomes. 
Further impetus to the implementation of MDTs within cancer units and 
centres was the publication of national guidance on improving clinical 
outcomes for specific cancer types. This commenced with the 
development and publication of guidance for the management of patients 
with breast cancer in 1996 with guidance documents subsequently 
developed for twenty three cancer types and updated under the direction 
of the National Institute for Health and Care Excellence (NICE).  
These guidance documents detail the composition of MDTs (defining core 
and extended members, including surgeons, oncologists, radiologists, 
histopathologists, multidisciplinary team coordinators, allied health 
professional and clinical nurse specialists). The guidance also specifies 
the need for a lead clinician and defines the working practices of the team 
such as the requirement to meet regularly to discuss all newly diagnosed 
patients (Taylor et al., 2010). 
This approach to the organisation of cancer services was further 
embedded with the publication of the NHS Cancer Plan in 2000 
(Department of Health, 2000) which provided significant investment in and 
reform of England’s NHS cancer services. The Cancer Plan was 
committed to addressing health inequalities through setting new national 
and local targets for the reduction of smoking rates, new targets for the 
reduction of waiting times, the establishment of national standards for 
cancer services, and in particular the expansion and development of the 
cancer workforce, cancer facilities, and cancer research. 
MDTs and MDMs in cancer care have subsequently become the standard 
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mechanism by which diagnosis and treatment decisions are made for 
patients in the United Kingdom. MDT working in cancer care has also 
expanded globally and two systematic reviews (Wright et al., 2007; 
Prades et al., 2015) have assessed the impact of cancer MDTs on patient 
outcomes with findings to show that MDTs are now the approach 
validated by experts in Europe (Jelenc et al., 2012), adopted as a key 
objective in many European cancer plans (Atun et al., 2009) and with 
variant models of ‘meetings’, ‘conferences’ or ‘clinics’ existing in Australia, 
Canada and the United States. 
There are approximately 1500 cancer MDTs in England and it is estimated 
that multidisciplinary team meetings cost the NHS around £100m a year 
(Taylor et al., 2010). Whilst there is accumulating  evidence that MDTs 
and MDMs are associated with better clinical decision-making, clinical 
outcomes, recruitment to research trials and improved health professional 
satisfaction (McNair et al., 2008; Taylor et al., 2013; Taylor et al., 2010; 
Kesson et al., 2012; and Hong et al., 2010) there is also emerging 
evidence that there are challenges with MDT working.  
These challenges are varied and relate to issues of poor attendance and 
shortages of core MDT members (Department of Health, 2007; Trevatt et 
al., 2008); time pressure, lack of clinical information, lack of nursing input 
and poor leadership (Sidhom and Poulsen, 2008; Lamb et al., 2011a); the 
potential to over treat patients with more aggressive treatment due to 
collective decision making (Eigenmann, 2015); the overwhelming and 
increasing burden of cancer on MDTs and the need to ensure that more 
complex cases are adequately reviewed (Independent Cancer Taskforce, 
2015); and issues relating to team culture, team dynamics and barriers to 
effective team working (Lanceley et al., 2008; Kidger et al., 2009; Devitt et 
al., 2010). 
Some of these challenges will be further explored in Chapter two and 
Chapter six as part of the review of the literature and conclusion. 
 
1.3 The role of CNSs in cancer care 
The concept of specialist clinical nursing was first described by De Witt 
(De Witt, 1900) and later by Francis Reiter in the 1940s who used the 
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term ‘nurse clinician’ to refer to nurses in advanced and specialist roles 
(Reiter, 1966). The specialist nurse role in the UK evolved in the 1970s 
(Castledine, 2003), and though it is often defined as consisting of a 
combination of four elements: clinical, education, research and 
consultation (Hamric and Spross, 1989, Ball, 2005) it has been argued 
that this is an over simplification of a complex role and does not account 
for much of the ‘hidden’ work a CNS undertakes (Leary et al., 2008). 
Within cancer care the activities of the cancer CNS have been nationally 
debated and now considered to fall under the following four functions 
(Department of Health, 2010);  
1. Using and applying technical knowledge of cancer and treatment 
to oversee and personalise the cancer pathway and to meet the 
complex information and support needs of patients and their 
families. 
2. Acting as the key accessible professional for the MDT and 
undertaking proactive case management. 
3. Using empathy, knowledge and experience to assess and alleviate 
the psychosocial suffering of cancer patients including onward 
referral to other agencies. 
4. Using technical knowledge and insight from patient experience to 
lead service redesign and ensure services are responsive to 
patient need. 
CNSs in cancer care can be described as registered nurses, who have 
graduate level nursing preparation and who would be expected to be 
qualified to Masters level in nursing. They are clinical experts within a 
speciality and this may be focused on a population (e.g. paediatrics), type 
of problem (e.g. lymphoedema), type of care (e.g. palliative care), type of 
treatment (e.g. chemotherapy) or type of cancer (e.g. colorectal) as is the 
case within this study (Department of Health, 2010).  
CNSs in cancer care generally work autonomously but within the context 
of either a nursing or multidisciplinary team and integrate their knowledge 
of cancer and its treatment into assessment, diagnosis, and the treatment 
of patients’ problems and concerns. In terms of advanced level practice 
not all CNSs will function at this level and thus the title of CNS does not 
indicate ‘advanced practitioner’ status. 
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Many cancer CNSs work with a particular cancer type as a core member 
of a cancer MDT and will have an important part to play in the clinical 
decision-making process that occurs within the MDM. Whilst there is more 
clarification with regard to the core functions of the CNS role there 
appears less clarity about the role of the CNS within the context of the 
MDM meeting.  
The national cancer peer review programme which aims to assess the 
extent to which cancer services meet agreed clinical guidance has one 
peer review measure relating to the role of the CNS within the MDM and 
states: 
“The MDT should have an agreed list of responsibilities, with each of 
the core nurse members of the team which includes the following: 
x Contributing to the multidisciplinary discussion and patient 
assessment/care planning decision of the team at their regular 
meeting” (Manual for Cancer Services - Colorectal Specific 
Measures (2D: 229), 2004) 
 
Whilst there is an acknowledgement in the literature that the contribution 
of the CNS is crucial and tasked with ensuring that the patents’ 
perspective and psychosocial issues are brought to the MDM discussion 
(Junnola et al., 2002; Kidger et al., 2009; Lanceley et al., 2008) there is 
little guidance that describes and defines their role and responsibilities 
within the MDM. There are also no published studies that explicitly explore 
the role and contribution of the CNS within the MDM.  
 
1.4 The relevance of patient centredness 
One of the underpinning principles of the Calman-Hine Report was that,  
 
“ The development of cancer services should be patient-centred 
and should take account of patients', families' and carers' views 
and preferences as well as those of professionals involved in 
cancer care. Individuals' perceptions of their needs may differ from 
those of the professional. Good communication between 
professionals and patients is especially important. (Calman-Hine, 




The concept of patient-centredness within health care has received 
widespread global interest in the last decade (Gerteis,1993; Institute of 
Medicine, 2001; Goodrich and Cornwell, 2008; Health Foundation, 2014). 
Whilst it is not the intention to explore this complex phenomenon and its 
multiple definitions in full within this thesis it has relevance to this study for 
a number of reasons.  
The first lies in the recognition that patient-centred care is an essential 
dimension of health care systems and is acknowledged as an important 
precondition for ensuring quality in health care (Liberati et al., 2015). It 
follows therefore that for decisions about patients to be patient centred the 
quality of clinical decision making must be dependent on comprehensive 
consideration of information relating to disease as well as information on 
patient preferences, psychosocial issues and comorbidities (Lamb et al., 
2013) and that ensuring that the patients perspective is integrated into this 
process is indicative of a high quality service. 
Secondly, and in the context of clinical decision-making in cancer care, 
MDMs have been shown to make decisions based on biomedical 
information only (Lamb et al., 2011a; Hahlweg et al., 2015) with the 
patients’ perspective often unknown or ignored (Devitt et al., 2010). 
Patients do not attend meetings but recommendations for treatment made 
within the MDM directly impact on the decision-making process between 
the patient and their clinician (Taylor et al., 2014). Failure to take account 
of patient-based information at the MDM can result in recommendations 
that are either unacceptable or inappropriate and may cause delay in 
treatment if decisions have to be reconsidered by the MDM. MDMs 
therefore need to ensure that they develop processes that enable them to 
be patient-centred in their decision-making. 
Cancer CNSs have an important role to play in contributing to the 
development of patient-centred MDMs as they have a key role in 
assessing the holistic needs of patients and advocating for patients (see 
core functions previously discussed). The view that CNSs should be the 
key professional to input patient-centred issues into the MDM has also 
been supported by an analysis of the free text responses from 1, 636 MDT 
members which considered the facilitators and barriers to team working 
and patient centeredness with MDMs (Lamb et al., 2013). The consensus 
from this survey was that the CNS, as the patient’s advocate, should play 
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a central role in contributing patient-centred information to the MDM 
process. It therefore seems appropriate that cancer CNSs should be 
viewed as the primary contributor of patient-centred information and that 
their contribution be acknowledged as such. 
 
1.5 Rationale for colorectal MDTs 
Colorectal cancer is one of the most common cancers in the UK, with 
about 40,000 people newly diagnosed each year. It is more common in 
people aged 65 and over. Around half of people diagnosed with colorectal 
cancer survive for at least 5 years after diagnosis (National Institute for 
Health and Care Excellence, 2011). Colorectal cancer is therefore a 
disease of older persons and as such is likely to be accompanied by a 
range of comorbidities and other chronic conditions. Older people with 
cancer are known to have a more complex cancer trajectory and this 
makes the need for MDTs to consider factors beyond the disease ever 
more important.  
A recent report into cancer and older people undertaken by the National 
Cancer Intelligence Network (NCIN) reported that older people are more 
likely to be frail and have other health and social conditions that may 
impact upon their quality of life and affect their cancer treatment (NCIN, 
2014). 
As a common cancer there will be a colorectal MDT and MDM within 
every acute NHS Trusts in the UK and because of the potential impact on 
patient outcomes it is important to understand if decisions about the 
treatment and care of these patients is informed by the patient-centred 
contributions of CNSs.  
Additionally, a preliminary review of the literature indicated that there were 
very few studies that had explored MDT working in colorectal teams and 
as Munro et al. (2015) have indicated, of the two hundred publications 
assessing the benefits to patients of MDT meetings only six papers have 
studied colorectal teams. Significantly, one of these studies (Wood et al., 
2008) identified that colorectal teams do not always take into account 
patient preferences and wider psychological and social issues and that 
10-15% of treatment recommendations were not implemented for this 
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cohort. This resulted in patients receiving more conservative treatment 
than originally planned because teams had not considered patient 
preferences and other patient based information. 
 
1.6 Philosophical position 
All science is based on paradigmatic thinking that involves distinct 
assumptions on the nature of reality (ontology), how we come to know that 
reality (epistemology) and how we can systematically access what can be 
known about that reality (methodology) (Guba and Lincoln, 1994). 
Traditionally, these assumptions have resulted in researchers adopting an 
approach to building theory that is either methodologically positivist or 
interpretive. The rigidity of this perspective especially when researching 
complex processes, as is the case in this study, have led researchers to 
rethink the possible benefits of a combined approach to exploring 
phenomena – using an approach that combines and integrates both 
quantitative and qualitative data – mixed methods.   
Debates about the philosophical assumptions underpinning mixed 
methods research remain. However, there is a growing view that the 
‘incompatibility thesis’ (Howe, 1988) which posits that qualitative and 
quantitative research paradigms, including their associated methods, 
cannot and should not be mixed, is divisive and that the goal of mixed 
methods research is not to replace these two dominant paradigms but 
rather to draw from the strengths and minimise the weaknesses of both in 
a single research study (Johnson and Onwuegbuzie, 2004).  
Within this study the position I have taken is that of pragmatism – meaning 
that mixed method research attempts to fit together the insights provided 
by qualitative and quantitative research into a workable solution. The 
ultimate aim was that the research approaches used were mixed in a way 
that offered the best opportunity for answering the research questions. 
Pragmatism as a philosophical partner to mixed methods research has 
growing paradigmatic traction within the mixed methods research 
community as it enables the researcher to adopt a pluralistic stance to 
using all types of data to best answer the research question (Creswell and 
Plano Clark, 2011). My research questions called for evidence drawn from 
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both qualitative and quantitative approaches and so justified a more 
pragmatic approach to paradigmatic orientation. 
 
1.7 Summary  
CNSs within cancer care ultimately have an important part to play in 
relation to ensuring that decisions are not only based on clinical 
information but also informed by the personal and social circumstances of 
the patient. As studies examining other aspects of the MDM have 
highlighted problems with the contribution of the CNS within the MDM, this 
study set out to explore the nature of the contribution of the CNS, barriers 
and enablers to their contribution and also to identify changes to practice 
that could improve contribution.  
The need for research into the contribution of the cancer CNS within the 
context of the MDM is therefore indicated for several reasons; the 
requirement for good decision-making by ensuring that the patients’ 
preferences and wishes are incorporated into the discussion; better 
decision implementation; and the need to ensure that the skills and 
expertise of cancer CNSs are effectively and appropriately used for the 
benefit of patient care. 
The following chapter will review the evidence in relation to the 
contribution of CNSs to MDMs and provide further evidence for the 





















In many countries including the United Kingdom, Australia, the United 
States, Canada and Hong Kong the preferred method of making clinical 
decisions in cancer care is by multidisciplinary care teams (MDTs) 
(Department of Health, 2004, McAvoy, 2003, Wright et al., 2007, Chan et 
al., 2006). These teams are comprised of surgeons, medical and clinical 
oncologists, pathologists, radiologists, specialist nurses and other key 
professionals involved in cancer treatment and care. A focal aspect of the 
MDT is the MDT meeting (MDM). The primary task during an MDM is to 
review and bring together information about the patient and make a plan 
with regards to treatment and management. 
The quality of clinical decision-making in MDMs depends on 
comprehensive assessment of a range of information. This includes 
information about the disease as well as patient preferences and 
comorbidities. 
Within the NICE Guidance for Supportive and Palliative Care (NICE, 
2004b) CNSs are identified as the key worker for cancer patients. In order 
to undertake this role, they require a wide variety of skills and expertise, 
and the holistic knowledge and information they hold about the patient 
should inform any treatment and management decisions agreed at the 
MDM.  
Variation in participation in MDMs by different professions has been 
identified (Lanceley et al., 2008) and there is evidence that optimal 
methods for treatment decision-making in MDMs are currently not 
established (Lamb et al., 2013). Kidger et al. (2009) propose that teams 
need to ensure patient preferences and co-morbidities are consistently 
considered for all patients, arguably the key role of the CNS. 
 
2.1.1 Review of the evidence 
There are no known published studies exploring the effectiveness of the 
contribution of cancer CNSs to clinical decision-making in MDMs and 
there is growing evidence, albeit limited, that the information they hold 
about the patient is vital to ensure that the right treatment and 
management decisions are made at the MDM (Kidger et al., 2009, 
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Blazeby et al., 2006, Lamb et al., 2011d, Wood et al., 2008). There are 
studies that explore the factors that affect the quality of MDT working and 
decision-making, and within these there is some evidence suggesting the 
role of the CNS within MDMs needs further exploration. It is these studies 
that will be drawn on for the purposes of this review. 
A search of previous literature reviews on the Cochrane Database of 
Systematic Reviews (CDSR) and other electronic sources did not identify 
any reviews relevant to the one undertaken. 
 
2.2  Aim and objectives 
This review aimed to understand the evidence relating to the contribution 
of the CNS within the MDM. The review was undertaken to inform a mixed 
methods study exploring the contribution of colorectal CNSs to MDMs. 
The following were included as sub questions. 
a. How do CNSs contribute to the clinical decision-making process in 
cancer MDMs? 
b. What are the barriers and facilitators to CNSs contributing to decision 
discussions in the context of cancer MDMs? 
c. What are the consequences/impact of CNSs contributing to decision 
discussions in the context of cancer MDMs? 
d. In relation to the above is there any evidence relating specifically to 
colorectal cancer MDMs? 
Given the breadth of research questions and prior knowledge of the 
literature it was necessary to include different types of research evidence. 
Consequently a narrative approach was taken to review the literature, as a 
conventional systematic review was not appropriate given the nature of 
the evidence base relevant to the field of study. 
 
2.3  Methods 
The review of qualitative and quantitative studies covered the period from 
2000-2014. This fourteen-year period was considered adequate, as is the 
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period when MDT working in cancer care emerged as a major policy 
initiative in developed countries. 
 
2.3.1 Inclusion criteria 
x Types of studies: All empirical studies and designs were included within 
the scope of the review. 
x Primary research articles. 
x Types of participants: Participants included health care professionals 
involved in the process of the discussions with the MDM. The focus of the 
review was on the CNS and their contribution but it was not possible to 
limit to cancer CNSs attending the cancer MDMs and so included all 
members of cancer multidisciplinary teams. 
x Types of concepts: Clinical decision-making in cancer; multidisciplinary 
team meetings; and the role of the CNS within the decision-making 
process. 
x Studies published from 2000 to 2014 were included, as this is the 
period when multidisciplinary teams in cancer care became the national 
standard for making decisions about the treatment and management of 
newly diagnosed cancer patients both in the UK and other developed 
countries. 
x Published in English language peer reviewed journals since 2000 only. 
x Conducted in developed countries 
 
2.3.2 Search methods  
i. Electronic search 
Multiple bibliographic databases were searched (January 2000 – March 
2014) for primary research papers, published in English, conducted in 
developed countries where multidisciplinary cancer team meetings 
existed. Searches were restricted to research published from 2000 to 
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2014 in peer-reviewed journals. A detailed search strategy (Appendix 1) 
was used to identify papers from the databases listed below. 
Following the advice of the library support team the databases identified in 
Table 2.1 were most relevant to the research questions.  
 
Table 2.1: Databases searched 
Database Focus Time frame Date 
searched 
EMBASE in Ovid SP Biomedical 
literature 




Medline in Ovid SP ® Biomedical 
literature 












Index to Nursing and 






2000 to 2014 25 March 
2014 




2000 to 2014 28 March 
2014 
The Cochrane Library Medical 
research 
2000 to 2014 20 March 
2014 
 
ii. Search of other resources 
x Unpublished studies 
Contact was made with three leading academics who were known to have 
expertise in this area.  
x Reference Lists 
The reference lists of all relevant studies were also checked.  
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2.4 Data management 
2.4.1 Selection of studies 
Titles and abstracts of all studies identified by the searches were retrieved 
and reviewed. A number of papers were eligible for a further review. 
These studies were then categorized into excluded and included papers 
using a data eligibility form (Appendix 2). A further review of the eligibility 
of both included and excluded papers was undertaken by my academic 
supervisors (GR, CT &CT). There was no disagreement with regard to 
papers that should be included and this second review provided an 
important validity check.  
 
2.4.2 Data collection 
Studies not excluded at this point were retrieved in full text and assessed 
for eligibility. A data extraction form (Appendix 3) was developed and this 
was based on forms used for previously published reviews. This form also 
incorporated the review questions to ensure that eligible papers 
addressed at least one of the review questions.  
 
2.4.3 Data extraction  
Data relating to each of the four review questions were systematically 
gathered from each of the papers. A summary analysis of the qualitative 
studies was undertaken to address the review questions relating to the 
barriers and facilitators to CNS contribution. Similarly, data were 
descriptively extracted from the quantitative papers in relation to the 
review questions.  
 
2.4.4 Methodological quality 
To review methodological quality two different critical appraisal tools were 
used. One to assess the methodological quality of the quantitative studies 
(Law et al., 1998) (Appendix 4) and one for the qualitative studies (Critical 
Appraisal Skills Programme: Qualitative Research Checklist, 31.05.13) 
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(Appendix 5). The quantitative appraisal tool developed by Law et al. 
(1998) was used as it could be applied across a range of different 
quantitative designs. CASP (2013) was utilized for the qualitative studies, 
as it is a well known and used appraisal tool that covers a range of 
methodological issues. 
Neither of the appraisal tools used a summary scoring system as there is 
evidence (Higgins and Green, 2006) that use of scoring and classifying 
studies as high or low quality, whilst appealing in their simplicity, have not 
been shown to provide more reliable assessments of validity, may confuse 
the quality of reporting with the validity of the study and are more likely to 
include criteria that do not measure internal validity. For these reasons the 




2.5.1 Results of the search 
The searches identified a total of twenty-seven papers. Electronic 
searches identified seventeen potential studies. Hand searches identified 
four potential studies and contact with academics in the field identified six 
potential studies. Of these twenty-seven papers fourteen were eligible for 
inclusion.  
 
2.5.2 Included studies 
Fourteen studies met the inclusion criteria (ten qualitative studies and four 
quantitative studies).  
 
2.5.3 Excluded studies  
Thirteen studies were excluded after a review of the full papers as they did 













2.5.4 Findings of methodological appraisal  
Of the ten qualitative studies appraised against the CASP qualitative 
research checklist all were able to fully address seven or more of the ten 
appraisal questions (see Appendix 7). The main CASP categories that the 
papers did not meet related to three main areas. These included; 1. 
Making clear the relationship between the researcher and participants; 2. 
Data analysis not sufficiently rigorous; 3. Insufficient recording that ethical 
issues had been considered. This provided an indicator that the studies 
incorporated within the review were of good methodological quality but 
that there were some areas of methodological concern. 
Of the four quantitative studies appraised against the Law et al. (1998) 
tool all were able to fulfill most of the quality criteria (see Appendix 8 for 
full details). There was one area discrepancy that was observed in two 
studies and this related to a lack of justification of the sample.  
 
2.5.5 Data synthesis  
Appendix 9 provides a summary of the responses of each of the fourteen 
studies to the four review questions. Responses were variable and 
reflected the particular focus of the study. Eleven studies reported findings 
on how the CNS contributed; eleven on the barriers to them contributing; 
nine on the facilitators to contributing; one on the impact of their 
contribution and only one in relation to colorectal CNSs.   
Of the fourteen studies reviewed only three had as their primary focus the 
role of the CNS and these explored their contribution both within and 
outside of the MDM. No study within the review solely focused on the CNS 
within the MDM. See Table 2.2. 
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Table 2.2: Focus of studies and cancer types of meetings 
Primary 
Focus 
Within MDM only Within and out of MDM Cancer type of 
MDM 
Nurses only  Amir, Scully and Borrill (2004) Breast 
Willard and Luker (2005) Non-specific 
Willard and Luker (2007) Non-specific 
A range of 
MDT 
members 
Lanceley , Savage, Menon, Jacobs (2008)  Gynae  
Kidger, Murdoch, Donovan, Blazeby (2009) Gynae  
Lamb, Wong, Vincent, Green, Sevdalis (2011d) Urology 
Lamb, Sevdalis, Mostafid, Vincent and Green 
(2011c) 
Urology 
Lamb, Sevdalis, Arora, Pinto, Vincent and Green 
(2011b) 
Primarily urological 
and others  







Within MDM only Within and out of MDM Cancer type of 
MDM 
 Rowlands and Callen (2013)  Lung  
Lamb, Taylor, Lamb, Strickland, Vincent, Green and 
Sevdalis (2013) 
Non-specific 
Jalil, Ahmed, Green and Sevdalis (2013) Urology and GI 
Jalil, Akhter, Lamb, Green Taylor, Harris and 
Sevdalis (2014) 
Urology 
Patient Lamb, Jalil, Shah, Brown, Allchorne, Vincent, Green 
and Sevdalis (2014) 
 Prostate, Breast, 
UGI and Sarcoma 
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2.5.6 Overview of the studies  
A summary of the types of studies and methods used in the research 
papers included with this review is presented in Table 2.3. 
All of the quantitative studies focused on the development, testing and 
validating of tools to assess the performance of effectiveness of MDMs 
against key criteria. Within the ten qualitative studies a range of issues 
were explored and these will be discussed in later sections of this review. 
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Table 2.3: Studies and methods 
 Studies Types of 
Studies 
Methods Focus 
1 Lamb B, Wong H, Vincent C, 
Green J, Sevdalis (2011d) 
Quantitative Phase 1 review of evidence base on team 
performance 
Phase 2 structured observation: 
modification and testing of OTAS 
(Observational Teamwork Assessment for 
Surgery) in cancer MDTs 
Teamwork and team performance in 
multidisciplinary cancer teams: development 
and evaluation of an observational assessment 
tool 
2 Lamb, B, Sevadlis N, Mostafid 
H, Vincent C, Green J (2011c) 
Quantitative Structured observation using a validated 
observational MDT tool 
Survey: On line self report tool 
Quality improvement in multidisciplinary cancer 
teams: An investigation of team work and 
clinical decision making and cross validation of 
assessments 
3 Taylor, Atkins, Richardson, 
Tarrant and Ramirez (2012) 
Quantitative Observation and development of a 
structured observational assessment tool 
piloted 




 Studies Types of 
Studies 
Methods Focus 
4 Jalil R, Akhter W, Lamb B, 
Taylor C, Harris J, Green J, 
Sevdalis (2014) 
Quantitative Phase 1  MDM case discussion observed 
using structured assessment tool (MDT 
MODe): initial assessor training in tool 
Phase 2 in vivo observations of MDMs 
Phase 3 tool revision and refinement  
Phase 4  video recorded MDMs observed 
and assessed using MTB-MODe 
Validation of team performance assessment of 
multidisciplinary tumour boards 
5 Amir Z, Scully J, Borrill C  
(2004) 
Qualitative Observation and in-depth interviews The professional role of breast care nurses in 
multidisciplinary breast cancer teams 




 Studies Types of 
Studies 
Methods Focus 
7 Willard and Luker (2007) Qualitative Observation and semi structured interviews Working with the team: strategies employed by 
hospital cancer nurse specialists to implement 
their role 
8 Lanceley A, Savage J, Menon U, 
and Jacobs I (2008) 
Qualitative Participant observation and in-depth 
interviews 
Influences on multidisciplinary team decision 
making 
9 Kidger J, Murdoch J, Donovan J, 
Blazeby J (2009) 
Qualitative Observation and semi structured interviews  Clinical decision making in a multidisciplinary 
gynecological cancer team 
10 Lamb B, Sevdalis N, Arora S, 
Pinto A, Vincent C and Green J 
(2011b) 
Qualitative Semi-structured interviews (face to face and 
telephone) 
Teamwork and team decision-making at 
multidisciplinary cancer conferences: Barriers, 
facilitators and opportunities for improvement 
11 Lamb B, Taylor C, Lamb J, 
Strickland M, Vincent C, Green J, 
and Sevdalis N (2013) 
Qualitative Thematic analysis of free text responses 
from a national survey of MDT members 
Facilitators and barriers to team working and 
patient centredness in multidisciplinary cancer 
teams: Finding of a national survey 
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 Studies Types of 
Studies 
Methods Focus 
12 Rowlands S and Callen J (2013) Qualitative Interviews with 22 Lung MDT member (8 
doctors, 9 nurses and 5 AHPs) 
A qualitative analysis of communications 
between members of a hospital-based 
multidisciplinary lung cancer team 
13 Jalil R, Ahmed M, Green J, and 
Sevdalis N (2013) 
Qualitative Semi structured interviews Factors that can make an impact on decision 
making and decision implementation in cancer 
MDTs: An interview study of the provider 
perspective 
14 Lamb B, Jalil R, Shah S, Brown 
K, Allchorne P, Vincent C, Green 
J, and Sevdalis N (2014)  
Qualitative Focus groups Cancer patients’ perspectives on 
multidisciplinary team working: An exploratory 
focus group study 
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2.5.7 Narrative synthesis  
The following section provides a review of how the studies addressed 
each of the review questions. 
 
2.5.7.1 Review question 1:  
How do clinical nurse specialists contribute to the clinical decision-
making process in cancer multidisciplinary meetings? 
None of the identified studies had as their primary research endeavour an 




Four studies utilized a quantitative approach (Lamb, Sevdalis, Mostafid, 
Vincent and Green, 2011c; Lamb, Wong, Vincent, Green and Sevdalis, 
2011d; Taylor, Atkins, Richardson, Tarrant and Ramirez, 2012; Jalil, 
Akhter, Lamb, Taylor, Harris, Green and Sevdalis, 2014). The primary 
focus of these studies was to construct, and test the reliability and validity 
of an observational tool to assess team performance. In doing so they 
assessed the contribution of each core member to the decision-making 
process including the contribution of the CNS.  
Lamb et al. (2011d) were the first researchers to develop an observational 
assessment tool to assess cancer MDM performance. This was the first of 
a series of studies that aimed to test the reliability and validity of a variety 
of assessment tools. In this study Lamb et al. (2011d) developed and 
tested the MDM performance assessment tool with five urology MDMs 
(112 cases) and their results showed that the contributions of the CNSs 
and histopathologists were rated below average (inter-observer 
agreement was consistently high (ICC=0.70) for CNS contribution). When 
compared with other members of the team in terms of their contribution to 
team discussion CNSs scored lowest (observers; mean = 1.6, SD 1.07) 
and surgeons the highest (observers; mean 4.05, SD=1.26).  
Lamb et al. (2011c) then developed and tested an observational tool to 
assess the quality of information presentation and MDT members’ 
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contribution to decision-making using expert observation and also self 
reports from MDT members. Data were collected from 164 cases in five 
urology MDMs and 47 self-reported surveys from MDT members. The key 
finding in relation to this review was that surgeons and oncologists rated 
highest in terms of their contribution to decision-making, CNSs and the 
MDT coordinators rated lowest with others in between. Overall, positive 
correlations between the observational and self-assessments were 
adequate to strong across all MDTs, with self-reported results mirroring 
those of the observer. With regard to the quality of information 
presentation to the team, both observational and self-assessments by 
participants agreed that radiological information and case presentations 
were best presented and patients’ views and comorbidities/psychosocial 
issues were least presented (observed: Z=14.80,p<0.001; self-report: 
Z=3.70,p< 0.001; Jonckheere-Terpstra test). 
An interesting finding in relation to assessing the contribution of the CNS 
within the MDM is that the CNSs self reported a higher contribution than 
that assessed by the observers.  This tendency of participants to over rate 
aspects of their performance and contribution compared with that 
observed was pronounced in relation to patient-centred information 
(comorbidities, psychosocial issues and patient’s views); in other words 
teams viewed themselves to be significantly more patient-centred during 
their MDM discussion than the observers did. 
Taylor et al. (2012) using the observable ‘Characteristics of an Effective 
MDT’ guidance, developed and tested with ten colorectal cancer MDTS an 
assessment tool of MDM discussions. Their findings show that there was 
wide diversity in ratings of performance between teams across all 
observable characteristics.  Out of the ten teams, eight lacked contribution 
from the CNS or any other nurses. 
Jalil et al. (2014) further tested and refined the tool developed by Lamb et 
al. (2011d) with a larger sample of MDM case discussions and used both 
in-vivo and video recordings of MDMs to assess team performance. They 
tested the tool in vivo in fifteen urology MDMs (556 cases), and then 
subsequently 127 video recorded cases across five tumour types 
(colorectal, skin, UGI, head and neck and urology). They reported similar 
results in relation to the low participation of CNSs and found that case 
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reviews were largely driven by surgeons and whilst other physicians 
contributed significantly less, nurses contributed the least.  
 
Qualitative studies 
Three studies (Amir et al., 2004; Willard and Luker, 2005; Willard and 
Luker, 2007) focused solely on the role of nurses but these included 
exploring their role both within and outside of the meeting. With the 
exception of Lamb et al. (2014), who provided a patient perspective on the 
contribution of the CNS to the meeting, the remaining qualitative studies 
all focused on a range of clinical professionals within the team and across 
different cancer types.  
Most evident across the studies where contribution was studied was the 
finding that there was limited contribution by nursing (Willard and Luker, 
2007; Lanceley et al., 2008; Kidger et al., 2009; Lamb et al., 2011b; and 
Rowlands and Callen, 2013).  However, Amir et al. (2004), one of the 
earliest studies to consider the contribution of the breast CNS to the 
meeting report more positive findings on the nurses role as an informal 
leader with a significant role in co-ordination, communication and 
planning, offering expert advice and support to other team members in the 
meeting.  
Willard and Luker (2007) in investigating the challenges faced by cancer 
nurse specialists in the UK in providing supportive cancer care both within 
and out of the meeting introduce the notion of ‘service work’ undertaken 
by CNSs. This is defined as collecting notes, x-rays and scans for the 
meeting, making informal notes about treatment and decisions and 
returning everything to the secretaries rather than focusing on patient-
centred work. They argue that in their desire to be accepted and establish 
a role within the team, CNSs were very flexible about their role and 
boundaries and undertook this ‘service work’ to gain acceptance. The 
consequence of this was that their contribution to patient-centred care 
thus became diffuse and ambiguous to the team – resulting in uncertainty 
within the team about the nature of their role.  Willard and Luker (2007) 
argue that whilst ‘service work’ may be perceived as a strategy to embed 
themselves into the team, it may be potentially disempowering, by 
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reinforcing hierarchical relationships and hindering their ability to 
contribute effectively to patient-centred decision-making. 
Lanceley et al’s (2008), findings refer to the ‘silent way’ in which the CNS 
contribution was perceived. In this study participants viewed the nurses 
contribution as only emerging when they did not agree with a decision – 
“their participation is in a silent way. If they do not agree with something 
they let us know (Surgeon)”.  
Other studies also build on this ‘silent’ contribution. Rowlands and Callen 
(2013) discuss the physical ‘presence’ of the CNS within the meeting but 
with limited interaction and interviewees reporting that nurses and allied 
health professionals would offer an opinion, without being asked, only if 
they thought it was of crucial importance. Kidger et al. (2009) also report 
that nurses only contributed when ‘asked’ for information, specific 
questions or when they thought it was of significant importance. Thus 
presenting a view of the CNS contribution as minimal and reactive. 
The only study that explored the role and contribution of the CNS from a 
patient perspective (Lamb et al., 2014) puts forward a very clear and 
unambiguous finding. Within this study participants reported that they 
perceived the CNS as the member of the MDT with whom they had the 
best relationship and who they perceived was best placed to act as the 
patient advocate. It was evident that patients valued the CNS as the team 
member whom they related to the most and who they wanted to act as the 
interface between the patient and healthcare system. 
 
2.5.7.2 Review question 2: barriers 
What are the barriers to clinical nurse specialists contributing to 
discussions in cancer MDMs?  
None of the identified studies exclusively investigated the barriers to 
CNSs contributing in the MDMs.  
 
Quantitative studies: barriers 
Of the four quantitative studies reviewed (Lamb, Sevdalis, Mostafid, 
Vincent and Green, 2011c; Lamb, Wong, Vincent, Green and Sevdalis, 
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2011d; Taylor, Atkins, Richardson, Tarrant and Ramirez, 2012; Jalil, 
Akhter, Lamb, Taylor, Harris, Green and Sevdalis, 2014) none provided 
any results or findings regarding barriers to CNSs contributing within the 
meeting. 
 
Qualitative Studies: barriers 
A thematic analysis of the barriers to CNS contribution was undertaken 
across the ten qualitative studies included in the review. Four key themes 
emerged from the findings as barriers to the CNS contribution. Table 2.4 
provides a summary of the themes and related studies. Each theme will 
be discussed in turn. 
 
Table 2.4: Main themes across studies 
Theme Studies 
Dominance of the treatment 
agenda 
Willard and Luker (2005); Lanceley et al. 
(2008); Kidger et al. (2009); Lamb et al. 
(2011b) 
Power dynamics Amir et al. (2004); Willard and Luker 
(2005); Willard and Luker (2007); 
Lanceley et al. (2008); Lamb et al. 
(2011b); Lamb et al. (2013); Rowlands 
and Callen (2013); Lamb et al. (2014) 
Role issues Amir et al. (2004); Willard and Luker 
(2005); Willard and Luker (2007); Lamb 
et al (2011b); Lamb et al. (2013); Lamb 
et al. (2014) 
Team issues Kidger et al. (2009); Lamb et al. (2011b); 




Dominance of the treatment agenda 
Dominance of the treatment agenda was a major finding that appeared to 
be a significant barrier to the CNS contributing patient-centred information 
to the meeting discussion. Willard and Luker (2005) in investigating the 
role of the clinical nurse in providing supportive care to cancer patients 
through observation and interviews found that the biggest challenge to the 
delivery of supportive care by CNSs lay in the central importance of the 
treatment agenda. Using grounded theory to explore the role of the CNS 
their analysis showed that it was apparent that the dominance of the 
treatment agenda shaped the organisation of services and, in particular, 
the type of support offered and in turn relegated psycho-social support to 
a subordinate position in patient care.  
Similarly, Lanceley et al. (2008) in their ethnographic study of a 
gynaecology oncology MDM (using participant observation and in depth 
interviews with core team members) report that the precedence given to 
determining diagnosis and causation at the start of the meeting set limits 
on the construction of the discussion. Instead of discussing individual 
patients with a variety of priorities, patients were presented within the 
meeting as “the semi predictable embodiment of medical science” 
(Lanceley et al, 2008, p219). It was consequently difficult for nonmedical 
members of the team (nurses, allied health professionals, social workers 
and psychologists) to construct a non-biomedical perception of the patient 
in the meeting and thus their contribution was limited. They also report 
that this particular way of talking about the patient was never open to 
challenge. 
Kidger et al's (2009) study of clinical decision making in a gynecological 
cancer team also found a differential emphasis on different types of 
information, with the unsystematic consideration of patient related factors 
such as co-morbidity, psychosocial issues, and patient wishes and the 
privileged role of information relating to disease pathology in decision-
making. In sum disease-centred information took precedence over patient-
centred factors.  
Lamb et al. (2011b) explored the barriers and facilitators to effective 
teamwork and team performance by undertaking semi-structured 
interviews with nineteen MDT members (five surgeons, five oncologists, 
five nurses and four MDT coordinators). They reported that contributions 
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to team decision-making were perceived, as typically coming from 
surgeons and the view from participants that the discussion was not 
balanced equally across groups with the meeting not sufficiently open. A 
key barrier to contribution identified by participants was the view that the 
discussion environment was not one of equality and that disease centred 
information took precedence over any patient-centred information, and 
that when included, was usually ignored.  
 
Power dynamics  
Power dynamics and the relationship between doctors and nurses also 
played a key role in inhibiting the CNS from contributing to the meeting 
(Amir et al., 2004; Willard and Luker, 2005; Rowlands and Callen, 2013; 
Lanceley et al., 2008; Lamb et al., 2011b; Lamb et al., 2013; and Lamb et 
al., 2014).  
Amir et al, (2004) in exploring which factors mitigated against effective 
team work in high and low performing breast care teams found that wider 
power dynamics of the consultant/nurse ‘gendered’ relationship had an 
impact on team working, and whilst breast care nurses were 
acknowledged as ‘informal leaders’ within the team there was no evidence 
to show they had been promoted as an official team leader.  
Willard and Luker (2005) in investigating the challenges to clinical nurses 
delivering supportive care report on the difficulties CNSs had in controlling 
the content and boundaries of their work. The key finding was that doctors 
did not always agree on the constituent component parts of the CNS role 
and had views on what ‘their nurse’ should do.  The impact of this power 
interplay on the nurse’s role was to make her/him vulnerable to the 
demands of role expansion and often ‘doctor substitution’ or roles often 
undertaken by junior doctors.  
Similarly, Rowlands and Callen (2013) in their interviews with twenty two 
lung cancer team members including eight doctors, nine nurses and five 
allied health professionals found that standard patterns of communication 
were based on role, and in the opinion of some members of the team, the 
influence of medical dominance between team members was particularly 
seen at the MDM where most communication occurred between doctors. 
The meeting whilst deemed ‘multidisciplinary’ was primarily a decision-
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making forum for the doctors. Some doctors acknowledged this perceived 
failure of the MDM as a communication forum: 
 
”medically dominated….in some ways it kind of has to be to get the 
medical decisions made that need to be made - but I think that is 
potentially an issue as to whether there is enough openness for other 
people to contribute to the discussion and even other medical people” 
(Rowlands and Callen, 2013 p 26) 
 
Less overt displays of power were reported by Lanceley et al, 2008; Lamb 
et al., 2011b; Lamb et al., 2013; and Lamb et al., 2014 who concluded that 
the structural position of team members, hierarchies of profession, and 
feelings of low professional status all played out within the MDM, the 
consequence of which was to marginalize the contribution of patient-
centred information by nurses – a view that was often shared by a range 
of members: 
 
“I never get the opportunity to speak, when I have tried you’re told it’s 




Some qualitative studies reported on findings that related to the 
construction of the CNS role as a barrier to contributing to discussions 
within MDMs (Amir et al., 2004; Willard and Luker, 2007; Lamb et al., 
2013; and Lamb et al., 2014). Findings were varied and related to a 
number of different issues, which included: a lack of an evidenced based 
description of the advanced practice role (Amir et al., 2004); role 
ambiguity (Willard and Luker, 2007); a lack of contact with the patient 
(Lamb et al., 2013); and an increasing administrative workload (Lamb et 
al., 2014). 
A lack of clarity with regard to the CNS role within MDMs was a key 
theme. This was reported in a number of studies. Willard and Luker (2007) 
describe this as role ambiguity, a lack of role boundaries and role 
descriptions to enable the nurses to have a protected role with the MDM. 
They also report that interviewees often had few role models and that 
further role ambiguity emerged when they had to negotiate boundaries 
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with other nursing colleagues to agree content and avoid duplication – for 
example with a palliative care CNS whose remit would also be to have a 
patient-centred approach but with a focus on palliative care issues. 
Two further findings related to role were reported on in the studies as 
impacting on contribution. These were a lack of personal contact with the 
patient resulting in a lack of knowledge of patients views (Lamb et al., 
2013), a discussion point also reported in the quantitative studies; and an 
increasing administrative workload which compromised the advocacy role 
of the CNS (Lamb et al., 2014) by eroding the time she had available to 
see patients prior to the MDM. Collectively these role issues all 
contributed to minimize the potential impact and participation of the CNS 
within the MDM discussions. 
 
Team issues  
A number of issues relating to team processes and dynamics and their 
impact on the contribution of CNSs were reported in the qualitative studies 
(Kidger et al., 2009; Rowlands and Callen, 2013; Lanceley et al., 2008; 
and Lamb et al., 2011b). The fast pace of the meeting with limited time for 
discussion, and with large numbers of patients to be discussed was a 
limiting factor (Kidger et al., 2009; Rowlands and Callen, 2013) with 
nurses reporting that they often felt hesitant to speak due to the perceived 
pressure to move the meeting discussion on. At other times team 
dynamics played a key part with nurses, when they did contribute, being 
‘talked over’ (Lanceley et al., 2008) and patient-centred information ‘being 
ignored’ (Lamb et al., 2011b). The consequence of this led to an 
entrenched lack of inclusivity and insufficient openness within the meeting 
to allow others to contribute (Rowlands and Callen, 2013).  
 
2.5.7.3 Review question 2: facilitators 
What are the facilitators to clinical nurse specialists contributing to 




Quantitative studies: facilitators 
Of the four quantitative studies included in the review none reported any 
facilitators of CNS contribution to the meeting discussions.  
 
Qualitative studies: facilitators 
Of the ten qualitative studies reviewed six provided some findings relating 
to facilitators to CNS’s contributing to meeting discussions. Perhaps 
inevitably, they were the reverse of the identified barriers and centre on 
two main themes. These include: building relationships with doctors; and 
establishing role boundaries. Table 2.5 provides a summary of the studies 
relating to these two themes. 
 
Table 2.5: Studies addressing these themes 
Theme Studies 
Building relationships with doctors Amir et al. (2004); Willard and 
Luker (2007); and Rowlands and 
Callen (2013) 
Establishing role boundaries 
 
Willard and Luker (2007); Kidger et 
al. (2009); Lamb et al. (2013); 
Rowlands and Callen (2013); and 
Lamb et al. (2014) 
 
 
Building relationships with doctors 
Three studies specifically report that an important facilitator to improving 
the CNS’s contribution to the meeting would be the establishment of better 
relationships with their medical colleagues (Amir et al., 2004; Willard and 
Luker, 2007; and Rowlands and Callen, 2013). All offered slightly different 
reports on what this meant in practice: Amir et al. (2004) in their in-depth 
interviews of 139 members of sixteen breast cancer teams, found that 
participants reported that better relationships would provide an improved 
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platform to challenge the ideas of other team members. Within this study 
they found that using humour to do this often resulted in a higher 
performing team.  
Willard and Luker (2007) reported in their study of twenty-nine cancer 
nurses that to gain acceptance of their role and contribution, CNSs used a 
number of strategies, the most important being building effective 
relationships with key medical colleagues (Willard and Luker, 2007). This 
study reports that by successfully building relationships the nurses were 
able to more easily implement their role and as the CNS was often the 
only nurse within the MDT, which was dominated by medical staff and 
medical decision-making, it was crucial they develop relationships with 
senior doctors. The need to build these relationships meant that CNSs’ 
interactions with senior medical colleagues were characterized for their 
diplomacy, discretion and courtesy and that by avoiding criticism and 
adopting a gentle approach to change they were generally successful in 
developing relationships with colleagues. This improved their status within 
the team and enabled them to contribute to decision-making. Willard and 
Luker (2007) also note that the maintenance of this delicate relationship 
was, at times, difficult for the nurses in their study, and participants 
reported tensions when they had to adopt a more direct approach.  
 
Establishing role boundaries 
Five of the qualitative studies (Willard and Luker, 2007; Kidger et al., 
2009; Lamb et al., 2013; Rowlands and Callen, 2013; and Lamb et al., 
2014) found that establishment of clear role boundaries and clarity with 
regard to the role of the CNS within the meeting would make a significant 
difference to the contribution of the nurses within the meeting.  
Unambiguous role descriptions with protected professional titles were 
seen as important to ensure that roles were consistently patient-centred 
and not subject to the variable views of medical colleagues (Willard and 
Luker, 2007). That nurses should systematically take a more central role 
in the discussion of every patient within the meeting (Kidger et al., 2009) 
and that this should be recognized within their job plan (Lamb et al., 2013) 
with all team members understanding their role and the role of others 
within the meeting (Rowlands and Callen, 2013) were considered critical. 
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Patients were also clear that the CNS role should be restructured to 
reduce the administrative burden and strengthen their role as the patients 
advocate within the meeting (Lamb et al., 2014). 
 
2.5.7.4 Review question 3: 
What is the consequence/impact of clinical nurse specialists 
contributing to MDM discussions? 
One quantitative study (Lamb et al., 2011a) and three qualitative studies 
(Amir et al., 2004; Willard and Luker, 2007; Kidger et al., 2009) referred to 
the consequences/impact of CNSs contributing to the meeting discussion. 
 
Quantitative studies 
Lamb et al. (2011d) in investigating teamwork and clinical decision-making 
with five urology MDMs (112 cases) using a structured observational tool 
of behavioural markers, report that nurses have little impact on team 
discussions as determined by observational metrics and that nurses have 
a peripheral role in decision making.  
 
Qualitative studies 
Of the two qualitative studies that referred to the impact or consequences 
of the CNS contribution in the meeting these focused on 1) the nurse 
speeding up bureaucratic processes (Amir et al., 2004); and 2) 
undertaking ‘service work’ (Willard and Luker, 2007). 
Amir et al’s 2004 study explored which factors led to effective team 
working and involved 16 breast teams within which 139 core MDT 
members were interviewed (including 24 breast care nurses).  Whilst most 
of their findings were concerned with the general role of the breast care 
nurse and not limited to the MDM the study did find that there was a 
perception that the breast care nurses through their coordinating role were 
effective in speeding up processes for patients which resulted in better 
outcomes for patients. The breast care nurses would report back on their 
progress in coordinating the patient’s pathway at the MDM. This function 
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was perceived as having a significant impact in streamlining the patient’s 
journey.  
Undertaking ‘service work’ (Willard and Luker, 2007) was reported as a 
useful and effective mechanism to ensure the smooth functioning of the 
team and MDM and this was viewed as a positive impact for the team as a 
consequence of specific CNS work. Service work has been described 
earlier in this chapter but essentially was work undertaken by the CNS to 
help to fill the gaps left by inadequate service provision. Whilst the 
consequence of this may have been viewed as beneficial for the team 
Willard and Luker (2007) make the important point that service work was 
potentially detrimental to the establishment of the CNS role as it detracted 
from the core purpose of the role – to support and advocate for patients.  
 
2.5.7.5 Review question 4: 
In relation to review questions 1-3, is there any specific evidence 
relating to colorectal cancer MDT meetings? 
One quantitative study (Taylor, Atkins, Richardson, Tarrant and Ramirez,  
2012) developed and tested with ten colorectal cancer MDTs an 
assessment tool to review the performance of MDM discussions against 
key quality criteria. One of the four observable domains developed and 
tested related to ‘patient-centred clinical decision-making’.  
Ten MDMs were then videoed in vivo and assessed against the domains 
using the rating scale. Teams discussed an average of 13 patients (range 
6-21) per MDM and a key finding was that no team was rated as ‘very 
good’ for sufficiently acknowledging patient-centred factors in the 
discussion. Two teams were rated as ‘good’ and the remaining eight 
teams were rated as ‘very poor’ and ‘poor’ in relation to this domain. This 
is the only study that specifically investigates the inclusion of patient 
related factors into the MDM discussions of colorectal teams and whilst 
the study did not set out to exclusively observe CNS participation a key 
finding was that their contribution was noted as absent in most teams with 
the key finding that in eight out of the ten colorectal teams there was 
minimal contribution from the CNS or any other nurses.  
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2.6 Discussion  
2.6.1 Quality of the evidence in relation to stated aims 
This review of the evidence on the contribution of CNSs in the delivery of 
patient-centred care within cancer MDT meetings has been limited by a 
lack of studies within the field that focus on the nursing contribution. 
Further high quality research is needed to better understand the nature of 
the nursing contribution. 
Most studies within the review had differing aims and objectives, with 
variation in design with most qualitative in nature. There were a small 
number of quantitative studies that focused on developing and validating 
observational tools to assess team performance. No study within this 
review researched exclusively the role and contribution of the CNS within 
the context of the MDM, the barriers and facilitators to contribution and no 
study focused specifically on the role of the colorectal cancer CNS. 
A number of key issues emerge from the findings of this review. Whilst 
there appears to be a growing evidence base in relation to the quantitative 
assessment of team performance of cancer MDTs there is a lack of 
primary studies on the contribution of CNSs in the delivery of patient-
centred care. What is important and relevant to note is that a number of 
the quantitative studies identified that the contribution of the CNS within 
the MDM was minimal or absent and where patient-related factors were 
assessed that this was done minimally and poorly. The findings from the 
qualitative studies were naturally more exploratory and illuminating and 
indicated that there were problems in relation to CNS participation within 
the MDM with some important insights into the barriers and facilitators to 
contribution. Whilst hypotheses were speculative within the discussion of 
many studies no study has, to date, investigated the underlying reasons to 
low participation and poor contribution. 
Patient-centred information is seen as central to high quality decision 
making with evidence to show that in MDTs where such information is not 
considered there is less chance of reaching clinically appropriate 
decisions that are acceptable to patients and also a greater risk of delays 
in treatment if decisions have to be reconsidered (Bumm et al., 2007, 
Wood et al., 2008, Stalfors et al., 2007, Lutterbach et al., 2005). The 
importance of ensuring that patient-centred issues are incorporated into 
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treatment decisions has also been highlighted in the NICE Guidance for 
Supportive and Palliative Care, 2004b; Department of Health, 2007; 
Department of Health, 2010; Independent Cancer Taskforce, 2015 and it 
is expected that CNSs should play the key role in representing patient 
related issues within the MDT decision-making process.  
In terms of understanding the barriers to their contribution there was some 
evidence from the qualitative data (none from the quantitative data) that 
several factors may be at play; dominance of the treatment agenda within 
the meeting; issues of power imbalance between professional groups and 
a range of team issues. However, no study focused on barriers to 
contribution as a research objective and so the evidence remains broad 
and inconclusive. 
With regard to understanding the facilitators that enable contribution a 
number of the qualitative studies (none from the quantitative studies) 
highlighted two broad enabling factors to contribution. These were 
focused on establishing relationships with doctors and establishing role 
boundaries. Again these studies are few in number and did not specifically 
set out to explore factors that enabled contribution. 
The issues identified in relation to barriers and facilitators are well known 
within the wider literature and indicative of the problems often associated 
with multiprofessional team working (Lemieux and McGuire, 2006; 
Nembhard and Edmondson, 2006; Baxter and Brumfitt, 2008; Reader et 
al., 2009). These often centre on issues of professional hierarchies and 
status, medical dominance, role boundaries and the impact that these 
have on group processes and team outputs. It was evident from the 
qualitative studies that these issues were important factors but the depth 
of exploration of how these factors contributed to participation or lack of 
participation was under investigated and thus it remains unclear to what 
extent each of these issues impacted on the CNS contribution. 
Finally, this review was particularly interested in reviewing the evidence in 
relation to the role of the CNSs within colorectal teams as this is the focus 
of the current study. Only one relevant (quantitative) study was found and 
this did not exclusively explore the role of the CNS but rather the 
effectiveness of the MDM against specific quality criteria. The key finding 
that few colorectal CNSs contributed to case discussions is important and 
adds to the need for further investigation. 
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2.6.2 Potential factors to explore in empirical research 
Team processes  
There were a number of team processes identified as facilitators. Many of 
these were put forward as hypotheses within the discussion section of the 
studies included in the review. 
They can be grouped into the following categories;  
x Leadership by the chair (Lamb et al., 2011b; Rowlands and Callen, 
2013)  
x Team interactions (Kidger et al., 2009; Lamb et al., 2011b; Lamb et 
al., 2013; Rowlands and Callen, 2013) 
x The structure of the discussion (Kidger et al., 2009; Lamb et al., 
2011b; Lamb et al., 2013; Lamb et al., 2014) 
 
Leadership by the chair 
In terms of leadership by the chair the main issues centred on the 
importance of the chair’s role in fostering inclusivity within the discussion 
and ensuring that all voices were heard (Lamb et al., 2011d). One 
important dimension related to the perception by allied health 
professionals and nurses that inclusivity seemed to correlate with the 
personal perceptions of the chair; in other words, if the chair viewed 
patient-centred issues as important to include this influenced the 
contributions of others (Rowlands and Callen, 2013). These findings 
reinforce the importance of effective leadership to encourage inclusive 
and open discussion, thereby helping to avoid both marginalisation of 
team members and poor decision-making. There are important links 
between these observations and the theoretical literature that shows that 
leader behavior has been shown to affect the internal dynamics of a team 
and in particular the psychological safety of team members (Baron, 1990; 





Team interactions  
Team interactions and behaviours were also hypothesized as factors that 
could act as a barrier or facilitator to the contribution of the CNS. In 
particular there was a view that more set rules about behaviour within the 
meeting and more mutual respect and understanding of the roles of others 
would better enable the contribution of others to discussion (Lamb et al., 
2011b; Lamb et al., 2013; Rowlands and Callen, 2013). This is consistent 
with the literature on team effectiveness and interprofessional working 
(Carrier and Kendall, 1995) which highlights the difficulties of  ‘tribalism’ 
(Beattie, 1995), within and across professions and that issues of 
professional identity and professional status are so deeply embedded that 
often respect for the autonomy of different professional groups is difficult 
and these differences often prevent collaborative joint working (Elwyn et 
al., 1998). 
 
Structure of discussion in MDMs 
One issue was highlighted as an untested suggestion in relation to the 
structure of the discussion. That there should be a systematic and 
standardised approach to team discussion ensuring that both medical and 
patient-centred issues are factored into the discussion (Kidger et al., 2009; 
Lamb et al., 2011d; Lamb et al., 2013; Lamb et al., 2014).  
Team communication is a key teamwork process and relates to the 
transfer of information, ideas and opinions between members of a team 
(Flin et al., 2008). Team communication failures are known to be a 
common cause of inadvertent patient harm (Leonard et al., 2004). An 
increasing appreciation of the complexity of health care and the limitations 
of human performance have attracted certain specialties with healthcare 
such as ICU, obstetrics and ambulatory care to adopt communication 
practices used in high reliability industries such as aviation, military and 
nuclear power. Teaching team members to use a predicable structure to 
their communication is a key part of concisely communicating critically 
important pieces of information in a predictable structure. The hypotheses 
therefore that a standardized approach to team communication that 
enables all professional groups to input is therefore grounded in evidence 
and one that should be further explored. 
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2.6.3 Chapter summary  
What this review has shown is that the evidence on the CNS contribution 
is sparse and that what is emerging from studies on MDT and MDM 
working is that there appears to be a problem with contribution and 
participation of the CNS within the MDM. There is some evidence that the 
CNS is involved in undertaking what has been characterised as ‘service 
work’ within the meeting and that the CNS is generally ‘silent’, contributes 
infrequently and only speaks when invited to give an opinion. Across all 
the studies where contribution had been observed the results indicated 
that contribution was minimal or absent with very little patient-centred 
information being fed into the MDM discussion. This predicament is 
detrimental for patient care and not good for the oncology nursing 
profession and indeed effective team working. 
Whilst many of the studies included within the review acknowledged there 
was a problem with CNS contribution no study investigated this as a key 
research objective. Across studies there was limited investigation of the 
content of the CNS contribution, the interactions by and with the CNSs 
within the MDM or an exploration of the perspectives of the CNS and 
other core members about the role of the CNS within the meeting. These 
are important questions to consider, as answers to these would help to 
ensure that decisions made within the MDM are indeed patient-centred.  
All of the studies within this review were either of a quantitative or 
qualitative design and none involved the use of mixed methods to address 
their research objectives. The research questions underpinning this study 
suggested that both quantitative and qualitative data, used in combination, 
could provide comprehensive answers to my research objectives. A mixed 
methods design was therefore considered an appropriate and pragmatic 
approach to addressing the research questions within this study. This will 
be discussed in more detail in Chapter three. 
This review indicates that there are barriers to CNSs incorporating patient-
centred information into decision-making discussions. The nature of the 
problem is not fully understood and needs further in-depth exploration to 
ensure that expert nursing practice informs decisions about patient 
treatment and care.  
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The following chapter will describe the rationale and details of the design 













Chapter Three: Research 




Previous chapters have discussed the importance of patient-centred 
information being incorporated into the decision-making process within 
cancer MDMs. 
The following chapter sets out the methodology and methods undertaken 
within the study.  
 
3.2 Aims of the study 
The overall aims of the study were to, firstly, explore the nature and 
content of the CNS contribution to discussions at multidisciplinary team 
meetings and, secondly, investigate the factors that inhibit and enable 
CNSs from bringing a patient-centred perspective to bear on decision-
making processes in MDMs.  
 
3.3 Research questions 
In attempting to meet the aims of the study specific research questions 
were considered: 
x What is the nature and content of the CNS contribution at the cancer 
MDM? 
x What is the perception of the CNS of their role and contribution at 
the MDM? 
x What is the perception of other MDT members of the role and 
contribution of the CNS in the MDM? 
x What factors inhibit or enable colorectal CNSs contributing patient-
centred information into the discussions at the MDM? 
x What changes to practice would enhance the CNS role at the MDM 
and improve patient-centred decision-making processes in the 
future?  
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3.4 Study design 
Mixed methods research provides more evidence for studying a research 
problem than either quantitative or qualitative research alone and helps to 
answer questions that cannot be answered by quantitative and qualitative 
research alone (Cresswell and Plano Clark, 2011). The research 
questions within this study called for a mixed methods design for a 
number of reasons. Firstly, it was important to understand if participant 
views converged or diverged from observed practice and secondly a 
mixed methods design afforded the opportunity for the qualitative 
interviews to explain the quantitative results.  
A mixed method and multi-phased approach was therefore adopted in this 
study. The quantitative approach was used to collect and quantify data on 
which patient-centred dimensions the CNSs contributed on and also the 
types of interactions they had within the MDM. The qualitative approach 
was used to gather and interpret data on the perceptions of the CNS 
contribution from a range of perspectives. Whilst the qualitative 
component was the dominant approach, both the qualitative and 
quantitative components functioned as complementary strands and 
strengthened the study findings since the qualitative findings were able to 
elaborate and expand on and offer explanations for the quantitative 
findings. Thus it was intended that this approach would offer a broad, rich 
and in depth understanding of how both approaches can contribute to a 
better understanding of these complex issues. The following discussion 
further considers the rationale for the use of mixed methods research and 
considers some of its challenges in relation to the current study.  
 
3.4.1 Rationale for a mixed method design 
Mixed methods research has evolved considerably over the last three 
decades and has been referred to as the ‘third methodological movement’ 
(Tashakkori and Teddlie, 2003), or ‘the third research paradigm’ (Johnson 
and Onwuegbuzie, 2004).  
Greene et al. (1989) and Brannen (2005) highlight four purposes of mixed 
methods studies. These include: 
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1. Complementarity, in which the findings of one approach is intended to 
elaborate, enhance, and illuminate the findings from another approach 
2. Development, in which the findings from one approach are used to 
inform the findings of another approach 
3. Initiation, where both approaches are used to discover paradoxes and 
contradictions 
4. Expansion, where different approaches are used to expand the breadth 
and range of enquiry.  
Within this study the issues of complementarity, initiation and expansion 
were particularly relevant. Phase 1 (quantitative) identified issues in 
relation to contribution that would not have been elicited from Phase 2 
(qualitative) but the combination of these approaches enabled expansion 
and further exploration of the contradictions from within these data. 
Mixed method designs are known to have several advantages. O’Cathain 
(2010) has identified four justifications for using a mixed methods design. 
These include: 
1. Comprehensiveness where using both qualitative and quantitative 
methods enables an issue to be more completely addressed because of 
the strengths of different methods  
2. Increasing confidence in findings where the findings from two different 
methods agree and thereby increasing validity 
 3. Development of facilitation, where one method guides the sampling, 
data collection or analysis of the other and  
4. Emancipation where the use of a variety of methods ensures that the 
voices of the marginalised can be represented. 
Using a mixed method approach enabled the issue of contribution of the 
CNS to be comprehensively explored allowing issues identified in Phase 1 
to be explicitly explored in Phase 2. Whilst there are considerable 
similarities between the rationales put forward by Greene et al. (1989), 
Brannen (2005) and O’Cathain (2010) the justification of ‘emancipation’ 
(O’Cathain, 2010) was relevant to this study. The ‘voice’ of the CNS within 
the MDM process had been presented, within the literature review, as 
marginalized and a mixed methods design enabled a more in depth 
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exploration of the underlying issues whilst also understanding the extent 
of the problem. 
The rationale for using a mixed methods design within this study, 
therefore, incorporated a number of the above justifications. Using one 
data source was not felt to be sufficient to provide a complete picture of 
the research problem. The review of literature indicated there was a lack 
of evidence with regard to understanding the contributions of the CNS with 
the MDM. As each MDM would be likely to review between 25 and 30 
cases at each meeting, the MDM offered an opportunity to assess the 
frequency of patient centred dimensions which the CNS contributed to. 
Rating their contribution on this large number of cases therefore gave 
more strength to the findings and allowed a more confident exploration of 
issues in the qualitative phase. 
Both qualitative and quantitative research provide a different perspective 
and each has certain limitations. Using a qualitative approach to study a 
few individuals would reduce the ability to generalise from the study 
findings and conversely, solely using a quantitative approach to examine 
the behaviour of a larger sample would diminish the in-depth perspective 
of the individual. Hence the limitations of one method can offset the 
strength of the other and the combination of both methods affords a more 
complete understanding of the research problem than either approach 
could have achieved by itself (Cresswell and Plano-Clark, 2011). 
A quantitative approach was used to collect systematic and standardised 
data on the nature and content of the contribution of the CNSs for each 
case presented (Phase 1). Qualitative fieldnotes were also taken in 
Phase1. A qualitative approach was used to gather and interpret data on 
the role and contribution of the CNSs during the meetings and interpret 
what practices enhanced and inhibited their contribution (Phase 1 and 2). 
A mixed methods sequential design was used with the quantitative phase 
undertaken prior to the qualitative phase. This was purposefully done so 
that I could explore further findings identified from the quantitative phase. 
On completion of Phases 1 and 2 data were then integrated at the results 






Figure 3.1: Explanatory sequential mixed methods design (Cresswell 
and Plano Clark, 2007) 
 
3.5 General discussion on methods of data collection 
The following section provides a discussion of the methods used to collect 
data within the study and builds on the rationale for the use of a mixed 
method design. 
 
3.5.1 Quantitative  
Structured observation  
The utilisation of observation as a mechanism for generating data is used 
in somewhat different ways and for different outcomes in both positivist 
and interpretive research approaches (Mulhall, 2003). Observation 
methods fall into two main categories – structured and unstructured. 
Structured observation lends itself to the more positivist tradition in which 
the researcher is attempting to test a known theory by the observation of a 
set of predetermined behavioural features that are believed to underpin 
the theory in question. Unstructured observation sits within an interpretive 
research paradigm and uses observation as a means to explore, 
understand and then interpret social phenomena within a particular social 
context. 
Often the primary reason for observational research is to check out the 
correlation between what people say they do and what they actually do – 
but it is more than this. The intellectual logic and rationale for using 
observation is that the researcher believes that they can ‘capture’ naturally 
occurring phenomena as they occur and that social explanations and 
arguments are complex and require in depth and multidimensional data 
rather than surface comparisons. Relying on retrospective accounts and 
reconstructed versions of interactions have their place but are likely to be 
Following 
up  
Interpretation QUALITATIVE data & results 
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data & results 
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selective and provide a particular construction of the phenomenon. The 
researcher using observation views retrospective account of interactions 
as inadequate and the situational dynamics reported by interviews one-
dimensional providing only partial knowledge. An important criticism of this 
is that the researcher is also a “knower” with a particular perspective and 
this raises questions about representation and voice in interpretation and 
presentation of the data. As the researcher is seen as actively 
constructing knowledge about the world according to certain principles 
reflexivity and the ability to transcend the partiality of any perspective 
becomes an important consideration for the researcher. 
The classic typology used to classify the role of the researcher in 
observational methods is that developed by Gold (1958). This 
distinguishes between the potential roles the researcher can adopt in 
terms of how much they participate in the field they are observing. These 
are (1) complete observer (2) the complete participant, as in ethnography, 
(3) the observer as participant and (4) the participant as observer. This is 
an important consideration for the researcher and each position has 
implications on the type of data generated from the field. For example, the 
complete observer is likely to have less direct interaction with participants 
than the participant as observer and so the depth and complexity of data 
will be different. 
The Phase 1 observational period was the main quantitative component of 
the mixed methods approach. To avoid any potential bias and change in 
behaviour emerging as a result of my presence at the meetings I chose to 
be a complete observer (non-participant observation) and avoided as 
much as possible any interaction with team members. A structured 
observational tool was also used to record the interactions of the CNSs 
and the presence or absence of key dimensions of patient centredness 
embedded within each case discussion. Development of this instrument 
will be discussed in the Phase 1 section of this chapter. During Phase 1 I 
also took field notes during the observations and so this phase did also 





Semi structured interviews 
The interview is the most commonly used method of producing data in 
qualitative health research (Green and Thorogood, 2009). Often, 
interviews are classified according to how far the researcher directs the 
interview in relation to the topic areas covered. At one extreme there is the 
structured interview often associated with survey interviews and at the 
other informal interviews, which are naturally occurring and unstructured. 
The most commonly used types of interviews in qualitative research are 
often classified as (i) semi-structured interviews - the researcher sets the 
agenda (ii) in-depth interviews - the interviewee is given time to develop 
their own accounts and (iii) narrative interviews - the interviewee tells their 
story. The strength of qualitative interviewing is the opportunity it provides 
to collect and rigorously examine narrative accounts of social worlds 
(Miller and Glassner, 2004) and the job of the interview is to ensure that 
the relevant contexts are bought into focus so that situated knowledge can 
be produced (Mason, 2011).  
Semi-structured interviews were used in this study as a means of 
exploring the ‘social worlds’ or the perceptions and experiences of MDT 
members in relation to the role of the CNS within MDMs. As a number of 
research questions needed to be addressed this warranted a semi-
structured approach to ensure that the relevant topic areas were explored. 
Development of the interview topic guide will be discussed in the Phase 2 
section of this chapter. 
 
Focus groups 
Focus group methodology is a way of collecting qualitative data which 
involves engaging a small number of people in an informal group 
discussion, focussed around a particular topic or set of issues (Wilkinson, 
2004). The informal group discussion is usually based around a series of 
questions (the focus group schedule) and the researcher acts as the 
moderator whilst asking the questions, keeping the flow of discussion and 
enabling participants to contribute fully. Focus group interactions allow 
respondents to react and build upon the responses of other group 
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members’, thus creating a synergistic effect (Stewart and Shamdasani, 
1990). 
The collective context of focus groups creates a process that is very 
different from in-depth interviews mostly because data are generated by 
interaction between group participants (Ritchie et al, 2014). Additional 
thoughts of the individual is triggered in response to the thoughts of others 
and as the discussion evolves individual responses are sharpened and 
refined and generally move to a deeper and more considered level. Focus 
groups are therefore synergistic (Stewart et al., 2007) in that it is the group 
interaction that is explicitly used to generate data (Bryman, 2012).  
Within this study one focus group was conducted with CNSs following 
completion of Phase 2. The purpose of the focus group was to generate 
discussion about the findings from Phase 2 and to get feedback from the 
group on proposals that had been suggested during the interview phase 
relating to improving the contribution of patient-centred information by 
CNSs in MDMs.  
 
3.6 Ethical considerations 
Before discussing each phase and the relevant research procedures 
undertaken for each phase a number of ethical considerations that applied 
across the whole study will be addressed first. 
 
3.6.1 Ethical approval 
Ethical approval was sought from King’s College London University and 
granted in December 2012 (PNM/12/13-26). Given that the study only 
involved the recruitment of NHS staff NHS REC was not required. NHS 
R&D permission was then sought from each sampled site and approval 
from all sites was finally gained by April 2013. 
 
3.6.2 Informed and written consent 
A study information pack (Appendix 10) was developed and provided to all 
potential participants. All Phase 1 participants received the same 
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information. Only those purposefully sampled for Phase 2 received 
information on this Phase and only the CNSs received information on 
Phase 3 of the study. All invited participants were given my contact details 
to ensure that any queries could be responded to promptly. All potential 
participants were advised that they could withdraw their consent, at any 
time, up to the point of data analysis. 
Team members were asked to provide separate written consent for Phase 
1 (observation of the meetings), Phase 2 (participation in the semi-
structured interviews) and Phase 3 (the focus group).  
 
3.6.3 Study title 
The wording of the study title on the participant information sheet was 
carefully constructed (with no reference to the CNS) so as to not 
influence/alter the natural behaviour of the CNS and other team members 
within the meetings, interviews and focus group. I did not reveal to 
participants that the focus of study was on the CNS as it was felt that this 
would have had the potential to change their behaviour and significantly 
impact on the study findings. This issue had also been identified and 
stipulated within the ethical approval application and was not deemed an 
ethical problem by the approving ethical committee as no ‘harm’ was 
being caused by the exclusion of this information. 
 
3.6.4 Anonymity 
Any details revealed within the observations, interviews and focus group 
identifying patients, participating organisations and staff were removed at 
the point of analysis and to further maintain anonymity participants were 
assigned pseudonyms in the resulting interview transcripts.  
 
3.6.5 Disclosure 
Within the participant consent form it was identified that if, at any point, 
during any of the observations, interviews and focus group issues of 
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clinical competence were raised these would be referred to the clinical 
lead of the colorectal team. This did not occur during the study. 
 
3.7 Phases of the study 
The study was conducted in three phases: Appendix 11 provides a 
timeline of the phases of the study. 
Phase 1: Non-participant observation of sixteen multi-disciplinary team 
meetings held by four different colorectal teams. A structured 
observational tool was developed for the study and used to assess the 
observable components of patient-centred care made by the CNSs for 
each case and the interactions of the CNSs within the meetings. 
Fieldnotes of each meeting were also taken. 
Phase 2: Semi-structured interviews with eighteen MDT members from 
across the four teams. 
Phase 3: A focus group with the CNSs from across the four teams was 
undertaken. 
Table 3.1 provides a summary of the data collection methods and 




Table 3.1: Summary of data collection methods, and instruments in 
relation to research questions and phases 
Research Questions Phase Method Instrument 
What is the content and 
nature of the CNS 
contribution at the cancer 
MDM? 














What is the perception of 
the CNS of their role and 






What is the perception of 
other MDT members of 
the role and contribution 
of the CNS in the MDM? 





What factors enable or 
inhibit cancer CNSs 
contributing patient-
centred information into 
the discussions at the 
MDM? 







What changes to practice 
would enhance the CNS 
















The following section outlines each Phase of the study and includes 
issues related to the setting, sampling, identification of participants, 
process of recruitment, confidentiality, data collection procedures, 
managing data collection and analysis. 
 
3.8 Phase 1: observation of the MDTs 
3.8.1 Setting 
The four teams recruited for this study were all from one Integrated 
Cancer System (ICS). An Integrated Cancer System is a virtual network of 
cancer care providers (acute hospital sites) who come together to 
collectively agree on the pathways of care for the geographic populations 
they serve. The ICS consisted of thirteen acute hospital providers of which  
three were Cancer Centres, which meant that not only did they provide 
care for patients with common cancer (breast, lung, colorectal and 
prostate cancers) but they also provided services for patient with rarer 
cancers and received referrals from outside the local geographical area. 
 
3.8.2 Sampling strategy 
A sample of four colorectal MDTs was randomly sampled from the thirteen 
colorectal teams within the ICS. This was achieved by giving each site a 
number from 1-13 and then using a random number table system to pick 
four numbers. The sites with those four numbers became the sampled 
sites. Four teams were chosen as it was considered that this would be 
sufficient to demonstrate any potential contextual variability between the 
teams that could impact on the study aims.  Using four teams also 
seemed manageable and practical in terms of the research resources 
available and would still allow for in-depth study of the teams.  
Within national guidance, as set out by Improving Outcomes Guidance 
(NICE, 2004a) for colorectal teams, all are deemed to be local colorectal 
teams, in that they treat and manage all patients for a particular local 
population and are required to comply with national recommendations as 
to their constitution and the numbers of patients they are required to treat 
per year. There are no tertiary providers of colorectal cancer services and 
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therefore all teams should meet the same requirements. Stratified 
sampling of the teams was, therefore, not required for the purposes of this 
study. 
Each of the MDTs consisted of a minimum of ten professional staff as 
recommended by the Improving Outcomes Guidance for Colorectal 
Cancer. These MDTs meet weekly to review all new cases of colorectal 
cancers received through the Trust’s referral processes. The purpose of 
these weekly MDMs was for the team to collectively agree the treatment 
and management plan for an individual patient based on the assessments 
and information provided by different professionals within the MDM.  
 
3.8.3 Identification of participants 
Prior to data collection I made contact with the chair/clinical lead of the 
MDT at each site to introduce the study. From this initial contact I was 
invited to discuss the study either before or after an MDM and attended a 
meeting at each site to introduce the study. Following each presentation I 
requested a list MDT members from the chair/clinical lead or MDT co-
ordinator and contacted all MDT members by email and invited them to 
participate and included a participant information sheet outlining the 
details of the study (Appendix 10). 
 
3.8.4 Process of recruitment and consent 
After this initial meeting all teams agreed to participate and no individual 
refused to be observed. NHS permission was sought and gained from all 
sampled sites in accordance with the R&D department’s requirements.  
Ensuring that all members consented was a complicated process and 
required that I take measures to ensure that new and invited 
members/guests to the meeting understood that they were being 
observed as part of a study. This involved ensuring that participant 
information sheets and consent forms were readily available at each 
meeting and the placing of a sign on the door to the meeting room 
explaining that I was undertaking an observational study. No members 
refused to participate. If a core MDT member had refused to participate I 
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would have had to randomly sample another team and seek NHS 
permission to recruit there.  
 
3.8.5 Confidentiality 
No patient details were recorded during the observation phase and I 
ensured that no identifiable patient information was recorded on any 
written records or field notes. Additionally, no clinical professional was 
identifiable by name within any records or field notes.  
 
3.8.6 Development of phase 1 structured observational tool 
Before discussing how the data were collected it is necessary to detail the 
development of the key observational instrument used in the quantitative 
component of the study. 
The tool used in Phase 1 was developed to assess two elements – the 
content of the CNSs verbal contributions to each case discussion in 
relation to patient-centredness, and the nature of any interactions (verbal 
and non-verbal) involving the CNS within the case discussions. The 
structured observation tool was based on: 
1.The Institute of Medicine’s six dimensions of patient-centredness (US 
Institute of Medicine, 2001)  
2. A modified version of the Bales Interaction Process Analysis (IPA) 
(Bales, 1950) categories as a mechanism for systematically capturing the 
interactions of the CNS.  
There were no available tools to comprehensively assess the observable 
dimensions of patient-centredness and the IOM definition provided a 
framework to examine the different aspects of the content of the CNS’s 
patient-centred contributions. It was also important to report on the non-
verbal elements of their contribution and was aware that there would be 
different types of interactions that would occur in the MDM. Bales IPA 




3.8.7 Institute of Medicine six dimensions of patient-centred 
care 
The US Institute of Medicine’s definition of quality in healthcare, which is 
widely used throughout the world, includes patient-centred care as one of 
the six pillars of high quality care (IOM, 2001). The IOM prioritises six 
dimensions of patient-centredness as crucial to providing high quality 
care. The structured observational tool was developed to reflect these 
dimensions and in the absence of any existing instrument underpinned by 
the IOM definition of patient-centredness it was felt appropriate to use 
these dimensions as a basis for assessing the patient-centredness of the 
CNS contribution to the discussion. Table 3.2 lists each of the six 




Table 3.2: Institute of Medicine’s dimensions of patient-centred care  
DIMENSION  COVERS  
Respect for patient 
values, preferences and 
expressed needs  
Sensitive to individual and cultural differences. 
Fundamental for shared-decision-making. 
Change over time and as patients become more 
experienced.  
Co-ordination and 
integration of care  
Includes information about tests, consultation 
and procedures. Smooth transitions from one 





Information about diagnosis; prognosis; what can 
be done. Answers to questions in language 
patient understands. Includes variety of media-
face to face; telephone; email. Also quality 
relationships within which communication 
occurs: sensitivity; trust etc.  
Physical comfort  
Attention to pain and physical discomforts; 
shortness of breath, fatigue. Timely, tailored and 
expert management of symptoms. Patient’s 
experience of physical environment of care 
including perceived cleanliness.  
Emotional support - 
relieving fear and 
anxiety  
Emotional and spiritual suffering; fear of pain; 
disability; disfigurement; loneliness; financial 
impacts and effects on family.  
Involvement of family 
and friends 
Accommodating the people on whom the patient 
relies; involving as appropriate in decisions; 
support for care-givers; welcoming contribution; 
recognising their needs in health settings. 
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3.8.8 Bales Interaction Process Analysis 
Bales (IPA) is a tool that has been designed to specifically measure 
observed group behaviour (Bales, 1950). It originated from research on 
problem solving and has been used to identify complex group interactions 
and doctor/patient communication. In particular it investigates both task-
orientation interactions and socio-emotional interactions that are classified 
into 12 categories. The observer screens each act or gesture to determine 
which of the functions it is most directly relevant to. See Appendix 12 for 
an outline of the original Bales IPA categories. 
The intention within this study was to explore the interactions involving the 
CNSs in order to provide some understanding of their level of participation 
within the discussions and the types of interactions they had with others in 
the team. The Bales IPA tool was therefore not used to look at the 
behaviours of the whole MDT but rather used to classify and quantify 
interactions involving the CNSs. To do this the Bales IPA categories were 
modified and expanded to enable me to more easily and systematically 
record the CNS interactions only. Table 3.3 shows the modified Bales IPA 
categories with the new categories highlighted in bold. 
Five modifications were made to the original tool and these related to 
adding the category ‘CNS is asked for’ to the categories of ‘suggestion’, 
‘opinion’ and ‘information’.  The modifications were made to explore within 
team interactions if the CNSs were ever ‘asked’ for their contribution by 
team members within the meeting in relation to these dimensions. To the 
category of ‘agrees’ and disagrees’ the category ‘non-verbal’ was also 
added to both, to delineate how the CNSs might be seen to non-verbally 
agree and disagree with information presented within the meeting. All 
other categories remained identical to the original instrument.  
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Table 3.3: Modified Bales IPA categories 
 Bales IPA 
category 
Definition of the ‘act’ 
1 (BIPA1): CNS 
seems friendly 
Any act showing hospitality, being neighbourly, 
expressing sympathy, or similarity of feeling 
2 (BIPA2): CNS 
dramatizes 
Any act that emphasizes the hidden or emotional 





Any act that shows accord, concurrence, or 




*Any act which shows accord, concurrence, or 
assent about facts, inferences or hypotheses 
through non-verbal body language signals 




Any act that takes the lead in the task direction. 
Includes routine control of communication and 
directing the attention of the group to task 





Any act that involves a moral obligation offers a 
major belief or value or indicates adherence to a 
policy or guiding principle. Includes expressions 





Any act reporting factual or potentially verifiable 
observations or experiences. Statements are 
objective, noninferential, not emotionally toned, 
not vague and in principle testable 
8 (BIPA5a): 
CNS asks for 
information 
Any question that requests a factual, descriptive, 
or objective type of answer, an answer based on 
experience, observation or empirical research. 
Questions that require the giving of a simple 




 Bales IPA 
category 
Definition of the ‘act’ 
9 (BIPA5b): 
CNS asks for 
opinion 
Any act that seeks an inferential interpretation, a 
statement involving beliefs or attitudes, a value 
judgement, or a report of one’s understanding or 
insight  
10 BIPA5c: CNS 
asks for 
suggestions 
Any act that requests guidance in the problem-
solving process, is neutral in emotional tone, and 
attempts to turn the initiative over to another  
11 (BIPA6a): 
CNS is asked 
for 
information 
*(As above BIPA5a and scored if asked by 
another team member) 
12 (BIPA6b): 
CNS is asked 
for opinion 
*(As above BIPA5b and scored if asked by 
another team member) 
13 (BIPA6c): 
CNS is asked 
for 
suggestion 
*(As above BIPA5c and scored if asked by 





Any initial act in a sequence that rejects another 






*Any initial act in a sequence that rejects 
another person’s statement of information, 
opinion, or suggestion through body 
language (i.e. facial grimacing, shaking head, 
rolling eyes) 
16 (BIPA8): CNS 
shows tension 
Any act that exhibits conflict between submission 
and nonconformity yet does not clearly show 
negative feeling toward another person 
17 (BIPA9): CNS 
seems 
unfriendly 
Any act that is personally negative; it is not 
content orientation, but is oriented toward another 
person 
(* Added as additional categories) 
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3.8.9 Pilot of the tool 
The structured tool was piloted with Team 1 for two meetings. These data 
were not used as the tool was modified after the first pilot. The reason for 
this modification was due to the fact that the component of the tool 
recording the CNS interactions needed to be expanded to capture 
additional interactions (as described above) in the meeting. The tool was 
re-tested at a second meeting and further adjustments made to make the 
tool easier to use in terms of layout and utility. After this second test the 
tool was confirmed as ready to be used. 
A template to capture field notes was also piloted with the structured tool 
for two meetings with Team 1. This was also amended and modified to 
capture the content and different aspects the CNS’s pre and post meeting 
discussions. (Appendix 13). 
 
3.8.10 Data collection procedures 
Phase 1 consisted of non-participant observation of sixteen MDMs. Each 
site was observed sequentially over a period of nine months. I collected 
data using the structured observational tool (Appendix 14) for each case 
presented at the meetings. Two hundred patient case discussions totalling 
twelve hours of observation across the four teams were observed during 
this period for evidence of patient-centred dimensions in the verbal 
contributions of the CNSs.  Alongside this observations of their 
interactions were also recorded using the modified Bales IPA categories.   
For each case I listened carefully for any contribution to the discussion 
that related to any of the six IOM dimensions whilst at the same time 
recording any ‘act’ representative of the Bales IPA categories. When a 
contribution or interaction fitting either component of the tool was heard or 
observed during the meeting it was recorded on the proforma. This was 
undertaken for all case discussions across the sixteen meetings observed 
during Phase 1 of the study.  
Field notes were also taken in accordance with guidelines provided by 
Spradley (1979) and formed a continuous description of the setting, the 
people, relationships, hierarchies, interactions, rules and other key 
variables important to understanding the contribution of CNSs to the 
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MDM. A system of shorthand codes were developed for recording routine 
phenomena.  These included: 
x The numbers of team members present/absent  
x Non-verbal interactions 
x The pattern of dialogue  
x Flow of the meeting 
x Position of members within the room, 
x Room layout 
x Numbers of patients discussed  
x Length of meeting.  
Data from the structured proforma were recorded onto an Excel database, 
developed for this phase of the study, after each meeting and I wrote up 
all field notes, in full, within 24 hours of each observation to avoid recall 
bias. All records of field notes were kept and made available to satisfy any 
queries as to the reliability of the data. 
 
3.8.10.1 Data security 
All data were handled and managed in compliance with Good Clinical 
practice guidelines and Data Protection Act 1998.   
Records of Phase 1 observations including the field notes of the MDM 
meetings were transferred to a password protected computer and 
encrypted.  
 
3.8.11 Analysis of phase 1 data  
3.8.11.1 Structured observations 
The quantitative data set consisted of the results from the structured 
proforma relating to 1) the presence or absence of any of the IOM patient-
centred dimensions expressed by the CNSs for each case during an MDM 
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and 2) the presence or absence of any of the Bales IPA ‘acts’ or 
interactions by or with the CNS as observed by myself.  
A codebook for all data items was developed (Appendix 15) and using 
these codes the data were entered into SPSS software package (version 
22). Following this, the data set was ‘cleaned’ to check for errors and 
ensure the accuracy of the data set, in accordance with the guidance 
provided by Loewenthal (2001). The data were initially explored using 
descriptive statistics to provide frequencies (median and range). Cross 
tabulations were then undertaken on all IOM and Bales IPA variables 
across all four teams so as to determine variability between teams.  
 
3.8.11.2 Observational field notes  
Field notes made during the observations consisted of literal, interpretive 
and reflexive readings (Mason, 2011) and were viewed as more of a 
developmental mechanism for formulating my understanding of the 
setting. The field notes of all sixteen observations were reviewed and from 
the ‘literal’ perspective a summary of meeting characteristics were 
compiled across a number of key domains, which included: 
x Numbers of observations per team 
x Numbers of CNSs 
x Numbers in attendance 
x Numbers of patients discussed 
x Length of meetings 
 
The more interpretive elements of the observations were also summarised 
and key themes were identified from these descriptive observations. The 
reflexive readings of my field notes, which explored my role and 
perspectives in the process of generating and interpreting the data were 
not included as ‘raw data’ but rather used as points of reflection on my 
role in the research process and thus ensuring a degree of reflexivity 
within the research.  
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3.9 Phase 2: interviews with MDT members 
3.9.1 Sampling strategy 
Twenty core MDT members were purposively sampled and invited to 
participate in the semi-structured interviews. The sample size reflected the 
recommendation that in studies with semi-structured interviews little that is 
‘new’ comes out of transcripts after twenty people within the same 
category, in this case MDT members, have been interviewed (Creswell, 
1998). Hence the sample of twenty MDT members was expected to 
provide sufficient data to meet the stated research objectives. All CNSs 
from each MDT and a range of other MDT members from each of the four 
teams were purposively sampled.  
Purposive sampling is a deliberate non-random method of sampling, 
which aims to explicitly select interviewees who are likely to generate 
appropriate and useful data (Bowling, 2009, Green and Thorogood, 2009). 
The pre-determined criterion for this was that they were a core member of 
the MDT. As the study sought specifically to explore and understand the 
experience of CNSs, a total sample of all CNSs from the four teams were 
invited to be interviewed to ensure a wide range of views were explored 
and in sufficient depth. Key non CNS MDT members classified as ‘core’ 
included colorectal surgeons, oncologists, radiologists, pathologists and 
MDT coordinators. 
A sample of eighteen core MDT members was interviewed as data 
‘saturation’ (similar themes raised by different participants) was reached 
by this number.  
 
3.9.2 Identification of participants 
After the observation phase was completed at each site I contacted all 
CNSs from each team and invited them to participate in phases two and 
three of the study. Four additional members from each team (excluding 
the CNS) who had been purposively sampled on the basis of being a 
‘core’ MDT member (as discussed above) from a list of MDT members, 
held by the chair of the MDM, were also invited to participate but only for 
Phase 2 (semi-structured interviews). 
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3.9.3 Process of recruitment and consent 
Recruitment to Phase 2 was more straightforward as I was able to 
approach selected participants directly and most had already understood 
from Phase 1 that they might be approached. Identified participants were 
sent an information sheet (Appendix 16) and consent form prior to the 
interview and all interviews were conducted after the observation phase. 
Full consent was obtained from all participants to have their interviews 
audio recorded and transcribed.  
 
3.9.4 Confidentiality 
All interview data were anonymised and interview participants were given 
pseudonyms within transcripts and all identifiable participant information 
remained confidential. I complied, at all times, with good clinical practice 
guidelines with regard to data protection.   
 
3.9.5 Development of phase 2 interview protocol 
Mason’s (2011) stepped approach to planning and preparing for the 
interview was used as a framework for developing the topic guide. 
Additionally, careful consideration was undertaken as to the sequencing of 
questions within the protocol and the ‘funnel’ approach to questions was 
used (Stewart and Shamdasani, 1990) which employs broad questions, 
before asking more pointed questions. This is often used for sensitive 
topics to allow for rapport to build up before moving onto to more sensitive 
questions. 
The interview protocol was piloted with two core MDT members (a CNS 
and oncologist) from another colorectal team that was not part of the study 
sample. These were audio recorded and transcribed and allowed me to 
assess if the topic areas and phrasing of the questions were generating 
useful data. Undertaking this pilot was also helpful in assessing my 
interview skills and keeping a critical eye on interview techniques. My 
academic supervisors also reviewed these two transcripts as a further 
assessment of the appropriateness of the interview topic guide and also 
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my interview skills. Appendix 17 shows the final interview protocol used 
for the semi-structured interviews.  
 
3.9.6 Data collection procedures 
Phase 2 consisted of semi-structured interviews with eighteen core 
members across the four MDTs. These interviews were conducted after 
all the observations had been completed for each site. This was purposely 
done to ensure that any issues raised within the interview process could 
not impact on the behaviours of the team members during the team 
meetings and also to ensure that any issues identified within the 
observations would be built into the interview process. As discussed an 
interview protocol was developed for this phase, informed partly by initial 
findings from the observation phase, and also the key research questions. 
The protocol was used to ensure comprehensive coverage of key 
research questions but attention was paid to allow participants to explore 
issues they perceived also to be relevant. 
Demographic and background data was also collected from each 
participant at the start of the interview. The purpose of collecting these 
data was to allow for a more comprehensive understanding of participants 
in terms of their background and experience and also to put participants at 
ease and focus on familiar areas at the start of the interview.  
Interviews were conducted face-to-face, individually and in a quiet location 
of the participant’s choosing. Each interview was recorded using a 
Dictaphone (Phillips Voice Tracer) and lasted between twenty-seven and 
fifty-five minutes. Audio-recordings rather than making extensive notes 
was undertaken, to enable a more relaxed interaction. Each interview was 
followed by a quick debriefing session, in which the participant had the 
opportunity to discuss any issues arising, give feedback and comment on 
the experience of being interviewed. This allowed me the opportunity to 
ensure that the participant was not distressed by any of the topics 
discussed.  
In addition, after each interview notes were made of the interview in a 
reflective diary. Impressions and personal reflections of the interview were 
documented and included comments relating to how at ease the 
interviewee was or any distractions during the interview such as 
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interruptions by people or phones. This diary was used as a means of 
accounting for any biases (mine and the participants) that may have 
impacted on the interview.  
Following the interviews participants’ responses were typed verbatim to 
form a transcript. Identifying details including names and locations were 
removed during transcription and participant’s assigned pseudonyms.  
 
3.9.6.1 Data security 
Participants were informed that the digital interview recordings would be 
stored as encrypted files. As agreed with the REC and Research and 
Development offices, participants were also informed that data would be 
stored for a period of five years and then destroyed. Signed consent forms 
were stored separately from all data in a locked cabinet and secure office.  
Each team was allocated a code and individuals within each team a 
unique pseudonym. These codes and pseudonyms were stored 
separately from consent forms and destroyed after the data were 
analysed as they were not needed after this point. 
 
3.9.7 Analysis of phase 2 data 
3.9.7.1 Semi-structured interviews  
Framework analysis was the method chosen in this study for analyzing the 
qualitative data (Pope et al., 2000, Green and Thorogood, 2004) and was 
developed in the 1980s at the National Centre for Social Research. It is 
widely used by qualitative researchers and is explicitly geared towards 
generating policy and practice-orientated findings (Green and Thorogood, 
2009). Additionally, Framework analysis offers a systematic, 
comprehensive and transparent process of analysis and so enables a very 
explicit understanding of analytic outputs and conclusions. This avoids the 
criticisms of qualitative data analysis that it can lack transparency (Ritchie 
et al., 2014).  
One of the key aims of this study was to explore the perspectives of the 
CNS contribution across different professional groups and teams and to 
determine what changes could be implemented to improve practice. 
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Framework analysis is a method of managing data that allows the 
comparison of themes across groups and this was important for this 
research given the specific sampling of CNS and ‘other’ core MDT 
members across four different teams. This method therefore enabled me 
to examine data within and between groups and teams and determine key 
differences in perspectives. 
Framework analysis consists of five stages; the application of these 
stages in the current study is outlined below (Table 3.4). 
Following the process of abstraction and interpretation as outlined in stage 
five of Framework Analysis (Ritchie et al., 2014) I charted and 
summarised the data then moved into the ‘descriptive’ phase. This 
involved reading through all the cases and listing the elements present in 
the responses, and identifying the dimensions that differentiated them. 
Responses that were judged to be about ‘the same thing’ were grouped 
and then labelled (categorisation). When all the dimensions were distilled I 
was then able to encapsulate the themes and subthemes (classification). 
Appendix 18 provides a worked example of this process for the research 
question relating to the role and contribution of the CNS within the 
meeting from the perspective of the CNS and the medical consultants. 
This process was undertaken for each of the research questions where 
the interview data was relevant.  
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Listened to interviews and read all 18 transcripts 
making notes and analytic comments and topics of 
interest. List of topics checked against the interview 





Deductive codes generated from the key themes 
from the interview topic guide and inductive codes 
generated from a review of five interviews 
transcripts to determine codes beyond those 
framing the research objectives.   
Developed an initial thematic framework that 
grouped categories and sub categories.  Five main 
themes and relevant subthemes developed to form 
the thematic index. NVivo 9 used and the thematic 
index (nodes in Nvivo 9) labelled and set up to 
assist with managing the data. Included an ‘other’ 
code under each category to avoid ignoring data 
that did not fit. 
All Interview transcripts uploaded to NVivo 9. 
See Appendix 19 for Thematic Index 
Stage three: 
Indexing and sorting 
Indexing: Worked through each interview and 
assigned textual data to each theme/sub theme of 
the thematic index. 
Sorting: thematic sets created for each theme. 




All data extracts for each theme reviewed and 
‘other’ categories reviewed to determine if there 
were any additional themes that needed to be 
included. There were none. All Interviews checked 
to ensure there were no data that had not been 
indexed and sorted. All data had been captured by 
coded themes and sub themes. 
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Stage five: Data 
summary and 
display 
Using the above data extracts by theme I 
developed the framework matrix in Excel for each 
of the five themes/subtheme.  
Each participants’ responses were summarised 
and condensed accordingly whilst staying close to 
the raw data (i.e. key quotes used for 
substantiation). This was to ensure the data were 
not overly simplified. 
The output of this process was five charts to reflect 
the five themes and sub themes and participants 
summarised responses populated this.  
Appendix 20 Chart 3: Perception of CNS role 







b) Categorising and 
classifying 
Using charts 3 and 4 I undertook a process of 
detecting elements from each participant relating to 
the research question 3, 4 and 5 and then sorted 
according to an underlying dimension. 
These groupings were then classified. See 
Appendix 18 Perception of the CNS (role and 




These data formed the basis of the findings to the key research questions 
in relation to perception of the CNS contribution within the MDM, the 
factors that enable and inhibit the CNS contribution and also informed the 
next stage of the study which was to consider the changes to practice as 
identified by team members that could be implemented to improve the 
CNS contribution within the MDM. 
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3.10 Phase 3: focus group 
3.10.1 Sampling 
A focus group with CNSs from the participating sites was conducted on 
completion of Phase 1 and 2. A total sample population of eight CNSs 
from participating colorectal MDTs were invited to participate.  
 
3.10.2 Identification of participants 
All CNSs from participating colorectal MDTs were identified from a list of 
MDT members and contacted by telephone and email and provided 
information on the Phase 3 focus group. All had previously agreed to 
participate in Phase 3 when they had consented to Phase 2. 
 
3.10.3 Process of recruitment and consent 
Recruitment to Phase 3 required all eight CNSs to attend a focus group. 
Despite two attempts to bring all the CNSs together to contribute to this 
phase of the study only three CNSs participated on the day of the focus 
group. Those participating all consented to the group discussion being 
digitally recorded and transcribed. 
 
3.10.4 Confidentiality 
Confidentiality when conducting the focus group was an important 
consideration as there was the possibility that other participants could 
share data of a personal nature either during or after the focus group 
about their colleagues (who were also participants in Phase 1 of the 
study). I addressed this in two ways. Firstly, during the consent process by 
requesting that participants agree that discussions in the focus group 
should remain confidential between participants, and secondly that before 
the focus group commenced clear ground rules were established to 
ensure ethical considerations were addressed and adhered to during the 
meeting. 
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The participant information sheet (Appendix 21) made it clear that due to 
the nature of the focus group it would be difficult to withdraw an 
individual’s participant’s data from the project (as doing so would make it 
difficult to retain the context of other participant data). I ensured that this 
was fully explained and was part of the consent process.  
 
3.10.5 Focus group protocol  
In accordance with good practice for conducting focus groups (Krueger 
and Casey, 2009) a protocol was developed to ensure that all the relevant 
research questions were addressed (see Appendix 22). This protocol was 
reviewed by my academic supervisors to ensure that the focus group 
would address the key research questions. The protocol was approved 
with no modifications. 
 
3.10.6 Data collection procedures 
A focus group consisting of CNSs was conducted after the completion of 
Phases 1 and 2. It had two main aims. First, it provided an opportunity for 
the CNSs to validate the conceptual issues identified in Phases 1 and 2; 
and second participants were asked to explore, augment, prioritise and 
rank the ideas and statements generated from the interviews that could 
improve the contribution of the CNS to the clinical decision-making 
process of the MDM (Appendix 23). 
All participants consented to be audio recorded and as has been 
previously discussed issues of confidentiality were explained. The focus 
group was undertaken with a co-researcher experienced in conducting 
focus groups and was conducted in the Support and Information Centre of 
one of the participating sites. This was a central location and easy for 
participants to access. 
In terms of conducting the focus group, as moderators, we used Ritchie et 
al’s (2014) guidance for understanding and ordering the key stages of a 
focus group: These included: 
1. Stage one: scene-setting and ground rules 
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2. Stage two: individual introductions 
3. Stage three: the opening topic 
4. Stage four: discussion 
5. Stage five: ending the discussion 
This allowed us to ensure that we had a common approach to the 
organisation of the focus group and so did not inadvertently interfere with 
the group discussion. I led the discussion and my fellow moderator took 
notes and kept us to time. 
Both myself and fellow moderator had received training and previous 
experience of running focus groups and therefore took all the necessary 
practical steps in relation to timing, venue, hosting, and recording to 
ensure the group were sufficiently comfortable to take part in the 
discussion. 
The focus group lasted ninety minutes and the focus group protocol and 
topic guide were used to help facilitate the discussion.  
Following the focus group participants’ responses were then typed 
verbatim to form a transcript.  
 
3.10.6.1 Data security 
All identifiable information was removed from the transcript and 
participants were given a unique identification number. Both recording and 
transcription were stored in a secure computer accessed only by myself. 
 
3.10.7 Analysis of phase 3 data  
3.10.7.1 Focus group 
Whole group analysis (Ritchie et al., 2014) was used to analyse the focus 
group data. This is an analysis process that uses the techniques and 
stages of Framework and treats the data produced by a group as a whole 
without delineating individual contributions. The group therefore became 
the unit of analysis and was treated in the same way as a unit of individual 
data. This approach was chosen as the numbers in attendance at the 
focus group were small and I wanted to pay specific attention to the group 
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perspective. Furthermore, a focus group does not allow for an in depth 
exploration of the individual perspective as the time has to be ‘shared’ by 
the group and so the individual view of any single participant would have 
been limited.  
The transcript of the focus group was reviewed on several occasions, as 
was the audio recording of the group discussion. The key analytic outputs 
from this process was to explore and delineate the CNSs views in relation 
to the proposed changes to practice they had described in Phase 2 and to 
prioritise these proposals in terms of their feasibility and acceptability. 
 
3.11 Integration of the quantitative and qualitative data  
Integration, defined as the process of linking quantitative and qualitative 
findings in the course of analysis (Bryman, 2007) is key in mixed methods 
research. Whilst integration is increasingly being viewed as a critical 
aspect of mixed methods research (Creswell et al., 2004) it remains a part 
of the mixed methods research process that has received little attention 
with researchers rarely discussing the type of integration used in their 
research (O’Cathain et al., 2008). Without this integration the knowledge 
yield from a mixed methods study is essentially equivalent to that an 
independent quantitative and qualitative study. 
Techniques designed to combine the results of quantitative and 
quantitative data have, however, emerged in the last few years  
(O’Cathain et al., 2010) and the technique used within this study was that 
of a mixed methods matrix (Cresswell and Plano Clark, 2007; Wendler, 
2001). This approach has been designed for integration to occur at the 
analysis stage of the research process. This technique was used as a 
unique aspect of this study was the availability of both qualitative and 
quantitative data on the same ‘cases’ i.e. the structured observation of 
Phase 1 (quantitative), the fieldnotes in Phase 1 (qual) and the interviews 
of Phase 2 (qualitative) were all conducted with the same MDTs.  
Within a mixed methods matrix, the rows represent the cases for which 
there is both quantitative and qualitative data, and the columns represent 
different data collected on each ‘case’. A ‘case’ being individuals, groups 
or organisations.  
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Data from both the quantitative and qualitative components were analysed 
using their respective analysis methods and the main findings from each 
of these were then put into a matrix as described above. This process of 
comparing the findings from the quantitative and qualitative data was 
undertaken to address the key research question relating to perception of 
the CNS role within the MDM. These data findings were then reviewed to 
determine convergence, contradictory findings or where there was no data 
to support a finding from that data source this was identified. 
The goals of data analysis were to provide a detailed understanding of 
how a mixed method approach contributed towards providing a broad, rich 
and in depth understanding of the contribution of the CNS to the clinical 
decision-making process within the MDM and also generating hypotheses 
for supporting future research and practice.  
 
3.12 Trustworthiness of the data 
The quality of mixed methods research has been considered (O’Cathain 
et al., 2008; Dellinger and Leech, 2007) but there are currently no agreed 
assessment criteria (Creswell and Plano Clark, 2007). As each method 
was linked to a particular paradigm I had to ensure that that the criteria 
used to assure quality within that particular method was adhered to at 
each stage of the study. 
Rigour in quantitative research should be considered and assessed for 
each stage of the study design, data collection processes, measures used 
and approach to data analyses. Every attempt was made to limit bias and 
assure reliability and validity. This involved a number of approaches and 
included random sampling of the teams, using non-participant observation 
to minimise any interaction with the teams, using a well accepted 
definition of patient-centredness and a standardised approach to 
assessment of patient-centredness across the four teams. In terms of 
analysis all good practice was maintained to ensure that all data analysis 
was transparent. This included developing a codebook for all variables, 
using SPSS (v22) to store and analyse data and working with my 
academic supervisors to ensure I had a robust analysis plan. 
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Lincoln and Guba’s (1985) evaluative criteria for establishing the 
trustworthiness of research were used to judge the qualitative components 
of the research. These criteria included: 
- Credibility - confidence in the 'truth' of the findings 
- Transferability - showing that the findings have applicability in 
other contexts 
- Dependability - showing that the findings are consistent and 
could be repeated 
- Confirmability - a degree of neutrality or the extent to which 
the findings of a study are shaped by the respondents and not 
researcher bias, motivation, or interest. 
 
Techniques for ensuring the data were credible included prolonged 
engagement with the teams accompanied by persistent observations. In 
addition to this the focus group provided an opportunity for ‘member 
checking’ of the concepts identified within the interviews and Lincoln and 
Guba (1985) argue that this is a crucial technique in establishing 
credibility. 
The main technique for establishing transferability is that of ‘thick 
description’ and involves describing a phenomenon in sufficient detail one 
can begin to evaluate the extent to which the conclusions drawn are 
transferable to other times, settings, situations, and people. This I 
achieved through conducting the semi-structured interviews and also the 
field note observations made during Phase 1.  
Dependable data came through ensuring that there was consistent 
understanding of the study by participants at all four sites. The main 
technique for assuring dependability relates to ‘external auditing’ where 
both the process and product of the research is examined consistently. 
Regular meetings with academic supervisors to monitor adherence to the 
agreed study methods was achieved through the life span of this study.  
Confirmability relates to the extent to which the findings are grounded in 
the data and not researcher bias. Using Framework analysis ensured a 
clear audit trail of how I arrived at my key themes and I was able to clearly 
describe all my analytic steps in this process. A level of reflexivity is also 
an important technique for confirmability and I did, at all times, maintain a 
reflective diary to ensure that surfacing issues not always grounded in the 
data could be explored with my academic supervisors. 
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Finally, whilst there were no agreed quality criteria for mixed methods 
research there is, however, guidance on good reporting of mixed methods 
studies (GRAMMS) developed by O’Cathain et al. 2008. Whilst it was not 
possible to formally use within the reporting of this thesis I was careful to 
ensure that all the key components were integrated into the thesis and 
used the criteria as a checklist (Appendix 26). 
 
3.13 Summary 
This chapter has provided a comprehensive discussion of the design and 
methods used within this mixed methods study outlining the rationale and 
justifications for key methodological decisions. The following chapter will 


















The overall aim of the study was to explore the nature and content of the 
CNS contribution to discussions at MDMs and investigate the factors that 
might inhibit and enable CNSs from bringing a patient-centred perspective 
to bear on decision-making processes in MDMs.  
The following chapter provides the results of the study. The chapter is 
divided into two sections. Results 1 section begins with an outline of the 
characteristics and features of each of the four teams and a summary of 
the differences and similarities. Results 2 section presents the findings for 
each of the research questions drawing on the qualitative and quantitative 
data to support and illustrate the analytic findings. These data are then 















Results: section one  
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4.2 Characteristic features of the teams: phase 1 
Four colorectal teams were invited to participate in Phase 1. All four teams 
were distinct but shared a number of common features. All teams were 
based within London and classified as local colorectal MDTs. This meant 
that they received referrals and provided care for a specified local 
population. Drawing on field notes from Phase 1 and the semi-structured 
interviews from Phase 2 the following section provides a brief summary of 
the similarities and differences for each team and then a longer contextual 
description of the characteristics of each host organisation, MDT and 
MDM. 
 
Table 4.1 provides a summary of the characteristic features of each of the 
four MDTS and MDMs. 
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Table 4.1: Characteristic features of each MDT 
 Team one Team two Team three Team four 
Organisational Characteristics     
Size of population served 1.3 million  440,000 2.5 million 700,000. 
Centre or Unit Centre Unit Centre Centre 
Number of in-patient beds 665 450 2,020 900 
Team characteristics     
How long MDT established 13 years (2000) 13 years (2000) 12 years (2001) 11 years (2002) 






 Team one Team two Team three Team four 
Full Core membership  (see IOG for Colorectal 




No (no palliative care 
representative) 
Yes  No (no 
Gastroenterologist) 
Yes  
Appointed Team Lead (length in post) Yes (5 years) Yes (six months) Yes (3 years) Yes (1 year) 
Number of colorectal CNSs 2 1 3 2 
Meeting characteristics     
Day & time Thursdays 1-2pm Fridays 8.15 - 9.15am Wednesdays 8-9am  Wednesdays 8.30 - 
9.15am 
Frequency Weekly Weekly Weekly Weekly 
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 Team one Team two Team three Team four 
Time allocated 1 hour 1 hour 1 hour  45 minutes 
Actual length of meetings in mins (range) 28-40 40-55 47-69 25-35 
Numbers of patients discussed (range) 14-16 7-12 14-18 8-15 
Appointed Chair (whether also team lead) Specialty Yes (also Team 
Lead) 
Gastroenterologist 
Yes (also Team Lead) 
Colorectal Surgeon 
Yes (also Team 
Lead) 
Colorectal Surgeon 
Yes (also Team 
Lead) 
Colorectal Surgeon 
Number of health professionals in attendance in room 
(range) 
23-31 16-24 20-37 20-27 
Layout of room Lecture  Lecture Boardroom  Lecture 
Case presentation led by CNS led Doctor led Chair (doctor led) Doctor led 
Decision outcome recorded by whom (format) CNS (real time) Chair (paper) MDT Co (paper) MDT Co (paper) 
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4.2.1 Brief summary of similarities and differences 
Three of the four teams were cancer centres meaning that they provided 
cancer services for rare and rarer cancers and treated patients from a 
wider geographic population. In particular Team 3 was a very large 
hospital with a significantly larger geographic population to serve and a 
greater number of in-patient beds than the other three hospitals.  
Two teams did not have full membership as specified by the Improving 
Outcomes Guidance for colorectal cancer at the time of Phase 1. In terms 
of leadership and chairing of the teams all were colorectal surgeons with 
the exception of Team 1 who was a gastroenterologist and who also had 
been in the lead post for a longer period of time than the other leads.  
Of note, and different from the other teams is the observation that Team 1 
CNSs introduced the cases at the MDM and also recorded the decisions 
of the team in real time. This was done by either the chair or MDT 
coordinator in the other teams. 
 
4.2.2 Team one 
Organisational characteristics 
Team one was based in a large teaching hospital and Cancer Centre 
providing 665 in patient beds to a local population of 1.3 million. It 
provided cancer care and treatment for the management of common 
cancer types (breast, lung and colorectal) to a local population and also 
specialised and highly specialised cancer services for the population of 
southeast England. It was a large campus style hospital providing 
significant radiotherapy, chemotherapy inpatient, outpatient and 
ambulatory services.  
 
Team characteristics 
The colorectal team had been in operation as an MDT since 2000. Data to 
substantiate this came from interviews with long standing core members 
who had been involved in the development of the MDT.  
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The core team had, therefore, been established for thirteen years when 
the study was conducted and many of the surgical and oncology staff and 
one of the CNSs had been in the team since its inception. One of the 
CNSs had been instrumental in setting up the team structures and 
processes as she had been in the Trust for fifteen years (on a colorectal 
ward initially) and with the team for over ten years. 
Throughout the observation period the only core member not in 
attendance was the Palliative Care team representative. All other core 
members were present at every observed meeting. In each of the 
observed MDMs there were at least three surgeons, two oncologists, two 
CNSs, one radiologist, one pathologist and one gastroenterologist. The 
Team had a clinical lead for the service who was a Gastroenterologist and 




The meeting was held weekly on a Thursday afternoon in the main 
hospital in-patient building and commenced at 1pm with an allocated time 
of one hour. A Consultant Gastroenterologist who, as stated, was also the 
clinical lead for the colorectal service chaired the meeting. 
The room was accessed by electronic staff security passes thus making it 
difficult at times for staff to enter if they were guests or staff had forgotten 
their ID. Numbers in attendance however were high, ranging from 23-31 
attendees. Many of these included trainee doctors, research doctors and 
research nurses who for the most part of the meeting made no 
contribution to the discussion and were there for a range of reasons, 
mostly educational in remit. 
The layout of the room was lecture style with all chairs in rows and facing 
a screen covering an entire wall split into two sections. On one side was 
the radiological imaging and the other pathology slides. On the window 
side of the room there was allocated seating for the radiologist, 
pathologist, MDT coordinator and CNS. They all sat in front of a computer 
enabling each case to be discussed with the relevant information 
accessible from the computer.  
 104 
There was an ordered pattern to the dialogue, which generally started with 
the CNS reading the patient’s clinical details from a proforma projected 
onto the screen. There was also a list of the patients to be discussed 
(agenda), on the desk where the MDT coordinator sat, which members 
picked up as they signed into the meeting. This ‘agenda’ would include 
name, diagnosis, referral date, investigations and treatment to date. Then 
the radiologist and pathologist would provide their opinion and this would 
be directed at the surgeons and oncologists within the room. After this 
there was often a short moment of silence and reflection until the 
discussion commenced.  
The meeting was fast paced and often it was difficult to ascertain when a 
decision had been made as there was often no formal summary of the 
decision made out loud. It appeared that the CNS role was to complete 
the ‘real time’ recording of the decision onto the computer and often the 
CNS would have to interrupt to check the decision with the group so that 
she could complete this on the ‘outcomes’ section of proforma projected 
on the screen.  
During the study period between 14-16 patients were discussed at each 
meeting and the meetings lasted between 28-50 minutes, thus always 
finished early. At the end of the meeting the CNS and MDT coordinator 
would always stay behind to complete any gaps in the documentation and 
often the surgeons and oncologists would approach the CNSs to clarify 
any outstanding issues relating to patients discussed in the meeting and 
patients not discussed in the meeting. 
 
4.2.3 Team two 
Organisational characteristics 
Team two was based in a district general hospital with 450 in-patient beds 
serving a population of 440,000. Unlike the other teams no specialised or 
centralised cancer services were hosted by the hospital and was therefore 
classified as a Cancer Unit which provided chemotherapy services to 
patients with common cancers (breast, lung and colorectal). This hospital 
had merged with a local community provider and so provided an 
integrated health care system across acute and community care. This 
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meant that the organisation had one site for acute provision and a number 
of community providers spread across the local community.  
 
Team characteristics 
The team had been in place since 2000 and the CNSs and one of the 
three surgeons had been with the team since it had started. Most of the 
core team had joined within the last eight years and so there were more 
new members and less organisational memory about the inception of the 
team. Throughout the study period all core members were present except 
for the Palliative Care CNS who was absent for two of the four 
observations.  
There was one colorectal CNS within the team and she had been with the 
team for thirteen years and although had longevity with the team indicated 
that she had not been involved in the operational developments of the 
MDT as the CNS had been in Team one. 
A new consultant surgeon who had been in post for a year and more 
experienced pathologist of ten years jointly held the clinical lead role for 
the colorectal service. This they had done for six months only. The 
surgeon who acted as the co-lead for the service chaired the meeting. 
 
Meeting characteristics 
The meeting was held at 8.15 am on a Friday morning and was allocated 
an hour. The meeting was chaired by the surgical co-lead for the service. 
Numbers in attendance ranged from (16-24) persons and with the 
exception of the Palliative Care CNS all core members were present for 
the Phase 1 observations.  
The room was small with blackout blinds to improve the visibility of 
radiological and pathology images. The lighting was dimmed and the 
seating was again arranged in a lecture style format and there was a small 
stage to the right of the wall upon which there was a desk and an 
allocated computer and station for the radiologists. They, therefore, faced 
the others in the room. The surgeons sat on the front row and the 
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colorectal CNS sat in the second row behind the other core team 
members.   
As with other teams all core members were required to sign in and as they 
did so took an agenda with all patient details. Importantly, on this agenda 
was recorded the decision required of the team at the meeting in relation 
to each case. This made for a very focussed and organised meeting with 
team members clear as to what professional opinion was required for the 
respective case. 
Different doctors presented their patients in this team and on most 
occasions the chair confirmed and recorded the decision after each 
patient discussion on a paper proforma and then moved onto the next 
presenter. The CNS was not responsible for presenting the patients in this 
team. The format of the dialogue usually went from responsible clinician, 
and then radiologist, pathologist (where relevant) and then any other 
relevant professional could then contribute. This group of doctors brought 
a lot of the patient’s background in terms of family issues and social 
circumstances into the discussion.  
The number of patients discussed at each meeting ranged from (7-12) 
patients and the length of the meetings ranged from (40-55) minutes, 
therefore always finishing within the allocated hour. The meeting often 
finished abruptly after the last patient was discussed and the CNS and 
MDT coordinator were always the last to leave the room, often with the 
CNS trying to clarify certain points with the surgeons before they rushed 
out. 
 
4.2.4 Team three 
Organisational characteristics 
Team three was based in a large hospital, having been formed by the 
merger of a number of hospitals in recent years. It was a large provider of 
acute services, serving a population of several million and a total of 2,020 
in-patient beds. The Trust had three acute hospitals and three specialist 
sites and was a Cancer Centre providing both chemotherapy and 
radiotherapy services for all common cancers and some rarer cancer 
types. The hospital site within which this MDM took place was new and 
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parts were still being built.  
 
Team characteristics 
The colorectal MDT had been in existence since 2001 and only two 
members of the core team (oncologist and one surgeon) had been in the 
team since it started. For the study period there was notable absence of a 
Gastroenterologist for three of the observations. All other core MDT 
members were present.  
There were three CNSs within the team. Two were responsible for the 
surgical pathway and one for the oncology pathway. This approach was 
different from other teams where the CNS was not only responsible for the 
surgical part of the patient’s pathway but also for seeing the patient 
through other aspects of oncology treatment. The reason for this division 
of responsibilities was that Team 3 also had a colorectal oncology CNS 
who solely managed the oncology treatment pathway.  This was a new 
post. All three were present at the meetings. 
The CNSs had variable length and type of experience as colorectal nurse 
specialists. Of the two surgical CNSs, one had been in the role for eight 
years and the other for three years but had had significant surgical 
experience prior to this. The oncology CNS had been in post as a CNS for 
six months and so was relatively inexperienced. None of the CNSs had 
been in post when the MDT had started. 
The clinical lead for the colorectal service and the chair for the MDT was a 
surgeon who had been in the Trust for eight years and in the role of lead 
and chair for three years. 
 
Meeting characteristics 
The MDT meeting took place weekly on a Wednesday morning from 8am 
to 9am. The meeting was held in a radiology room, which had very 
modern radiological projection equipment unlike the other teams. This 
team had a significant number of attendees with a range of 20-37 persons 
in attendance. Unlike the other meetings there were a significant number 
of junior doctors and medical students who always sat at the back, did not 
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contribute and at times were disruptive and distracting. 
The chairs were laid out in boardroom style facing the screen. To the side 
of the screen were a few chairs and this was where the radiologist and 
CNSs sat facing into the room and able to make eye contact with team 
members. As with the other meetings the surgeons and oncologists were 
seated on the front row but unlike the other meetings the chair always sat 
next to the CNSs. The MDT coordinator was responsible for ensuring that 
team members signed in and the list of patients was circulated to all in 
attendance. Unlike the other meetings there was more decorum offered by 
the chair with a proper ‘good morning’ and purposeful signaling that the 
meeting had begun.  
The chair presented most of the patients and was explicit with the team 
about what was being asked with regard to the decision required. 
Dialogue in the meeting was not fast paced and very thorough in terms of 
utilising the diagnostic data though the discussion was highly medical. The 
MDT coordinator was responsible for recording the outcome of the 
decisions on a paper proforma. 
During the study period the numbers of patients discussed at the meetings 
ranged from 14-18 patients. This team had the longest meetings ranging 
from 47-69 minutes across the observations. The meetings finished 
abruptly and there was minimal post meeting discussion or corridor 
conversations. This was due to another meeting scheduled to take place 
at 9am in the room and required everyone to leave quickly. 
 
4.2.5 Team four 
Organisational characteristics 
Team four was based in a single site teaching hospital, which provided 
services for common cancers (breast, lung and colorectal) and some 
specialised cancer services. It was classified as a Cancer Centre and 
provided both radiotherapy and chemotherapy services. It served a 





The colorectal MDT had been in existence since 2002. Many of the core 
members had been with the team for a significant period of time and in 
particular the three core member surgeons had been with the Trust for 
fifteen years or more. There were two CNSs and both had been with the 
team for four years but both had worked in the Trust for several years 
prior to taking on their current positions. 
The team had full core team membership and the clinical lead for the 
service and chair for the MDM was a senior surgeon who had been at the 
Trust for fifteen years but only taken on these roles in the last year. 
 
Meeting characteristics 
The meeting took place weekly on a Wednesday morning at 8.30am with 
an allocated time of forty-five minutes (shorter than the other three teams). 
Access to the room was complicated with door codes restricting access. 
Members who did not have an office in the department often had to wait 
for others to open the door and so members were frequently late to the 
meeting. The room was dark and windowless, rather shabby and old. The 
computers and projection equipment was also old. Numbers of attendees 
ranged from 20-27 and consisted of core members, trainee doctors and 
some medical students. 
The layout of the room was in rows facing the screen, lecture style, with a 
line of chairs also down the sides of the wall. The radiologist and 
pathologist had dedicated seats near a computer on the sidewall. The 
surgeons sat in the front row and the oncologists on the other sidewall. 
The MDT coordinator sat on the front row next to the chair and the CNSs, 
palliative care consultant, stoma nurse and junior doctors sat at the back 
around a small table. 
This meeting was characterised by a fair amount of disruption. It was 
common for members to be late, to leave early, to answer their phone in 
the meeting and to be texting and emailing throughout the discussions. At 
no point did the MDM chair ever address this.  
The meeting always began with the chair confirming to all that the team 
had ‘core’ members present and so could begin. Cases were discussed 
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quickly, mostly presented by the surgeons and very focused on agreeing 
the treatment and management decisions. The chair was consistent in 
summarising decisions after each case and worked in tandem with the 
MDT coordinator to ensure she had the correct decision recorded on the 
paper proforma. As in all the other teams members talked to the screen 
whilst reviewing the radiology and pathology images. There was little eye 
contact throughout with team members often talking to the back of another 
member’s head.  
Over the study period the numbers of patients discussed ranged between 
8-15 patients, the smallest cohort per meeting. Consequently the length of 
time taken was significantly less ranging from 25-35 minutes. The meeting 
was over quickly with another team waiting to access the room for a 
scheduled meeting at 9.15am. The CNS and medical staff would often 













Results: section two 
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4.3  Introduction 
The previous section highlighted some of the key characteristics of the 
MDTs and the MDMs from Phase 1.The following section focuses on the 
characteristics of participants in Phase 2 of the study.  Following this the 
results from both Phase 1 and Phase 2 are presented and this is 
structured around addressing each of the research questions in turn. 
 
4.4 Characteristics of participants: phase 2 
Eighteen core MDT members therefore participated in the semi-structured 
interviews. As the study sought specifically to explore and understand the 
experience of CNSs, a total sample of all CNSs from the four teams (n=8) 
were invited to be interviewed to ensure a wide range of their views were 
explored and in sufficient depth. All CNSs agreed and were interviewed.  
Of the eighteen participants eight were CNSs, one an MDT coordinator 
and nine doctors from a range of specialties, which included five 
oncologists, three surgeons, one radiologist. All doctors were consultant 
grade medical staff. 
Table 4.2 shows the characteristic features of all interview participants 
















1 Alice Female CNS 14 10  10  
1 Belinda Female CNS 7  1.4  1.4  
1 Don Male Medical 
Oncologist 
20 20 10 
1 Rachel Female MDT 
Coordinator 
NA 10 6 
1 Harry Male Clinical 
Oncologist 
25 25 10 
2 Caroline Female CNS 28  16  12 
2 Janice Female Medical 
Oncologist 
12 12 5 
2 Larry Male Surgeon 2.5 2.5 
(Lead) 
2.5 
3 Emma Female CNS 12 1 1 
3 Fran Female CNS 15 9 9 
3 Ginny Female CNS 17 3 3 
3 Imran Male Surgeon 8 3 
(Lead) 
8 
3 Kevin Male Medical 
Oncologist 
22 22 10 
4 Olivia Female CNS 14 4 4 
4 Queenie Female CNS 10 5 3 
4 Michael Male Surgeon 18 1 
(Lead) 
12 
4 Nora Female Medical 
Oncologist 
10 10 10 
4 Peter Male Radiologist 12 12 12 
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Overall the CNSs had been qualified for a significant period of time 
ranging from 7-28 years. However, there was less of a range in terms of 
their experience as a CNS, ranging from 1-16 years, with most (5/8) 
having been in a CNS role for five years or less.  
All the oncologists had been qualified for a minimum of ten years with a 
range of 10-25 years and so had a wealth of experience. With regard to 
the colorectal surgeons (n=3), they were few in number but varied in 
experience ranging from a relatively new consultant surgeon  (2.5 years) 
in Team two to the very experienced (18 years as a consultant) in Team 
three. What was also notable was that most participants, with the 
exception of two CNSs, had been a member of the MDT for at least two 
and a half years. 
 
4.4.1 The research questions 
The following sections present the results in relation to each of the 
research questions. Each question was addressed within a specific phase 
of the study and by one or more specific data source(s). Table 4.3 outlines 
the relevant research question, phase and data source. 
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Table 4.3: Research questions by phases and data sources 
Number Research Questions Study 
phase 
Method/Instrument 
1 What is the nature and 
content of the CNS 
contribution at the 
cancer MDM? 
Phase 1 - Structured observation 
of MDMs using a 
proforma consisting of: 
i. Institute of Medicine’s 
(IOM)  six dimensions of 
patient-centred care 
ii. Modified Bales 
Interaction Process 
Analysis (IPA) 
- Field notes 
2 What is the perception of 
the CNS of their role and 
contribution at the 
MDM? 
Phase 2 Semi-structured 
interviews 
CNSs (n=8) 
3 What is the perception of 
other MDT members of 
the role and contribution  
of the CNS in the MDM? 
Phase 2 Semi-structured 
interviews 
MDT members (n=10) 
4 What factors enable or 
inhibit cancer CNSs 
contributing patient-
centred information into 
the discussions at the 
MDM? 
Phase 2 Semi structured 
interviews 
All participants (n=18) 
5 What changes to 
practice would enhance 
the CNS role at the 
MDM?  
Phase 3 Semi structured 
interviews Participants 
CNSs (n=8) 
Focus group with CNSs 
(n=3) 
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4.4.1.1 Research question 1  
What is the nature and content of the clinical nurse specialist 
contribution at the cancer multidisciplinary team meeting? 
Each of the four multidisciplinary colorectal teams was observed on four 
separate occasions totaling sixteen observations of the weekly meetings. 
At each of the meetings I observed the fifteen minute period prior to the 
meeting and where permissible a short period of time after the meeting. At 
these points field notes were taken and these are drawn on where 
relevant in this chapter.  
During the MDMs I observed and recorded the patient-centred 
contributions made by the CNSs within the meeting for each patient 
discussed and also the interactions of the CNSs with team members 
within the meeting. Table 4.4 shows a number of features of each MDM 
meeting.  
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Table 4.4: Characteristic features of meetings at each site from field 
notes 
 Team 1 Team 2 Team 3 Team 4 Total 
Number of 
observations 












23-31 16-24 20-37 20-27 16-37 
Core team 
present for N 
(%) of cases 
30(51%) 30(79%) 47(75%) 31(78%) 138 (69%) 
CNS present in 
case discussion 




37(63%) 2 (5%) 5 (8%) 3(8%) 47 (24%) 
 
 
Field note observations 
Caseloads and allocated time 
Team 3 appeared to discuss more cases and therefore took the longest 
time, often going over time. Team 1 had the second largest caseload, 
never took the allocated hour and always finished early. Team 2 and 4 
had similar numbers of patients discussed over the four observations but 
Team 4 always finished at least 10 minutes early and Team 2 never 
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required the full allocated hour. With the exception of Team 3 all other 
Teams never used all their allocated time. 
 
Core team  
No Team had the full core team present for all cases discussed with Team 
1 having the full core team present for only half of cases discussed. The 
CNSs were present for all cases discussed for all observations.  
 
Cases presented by CNSs 
In terms of the CNSs presenting cases Team 1 appeared different from 
the other Teams. The CNS presented the case to the MDM for 63% of 
cases discussed in Team 1 and this was remarkably different from other 
Teams where the CNSs presented the cases minimally.  
 
Structured observation 
Observation of patient-centredness 
Two hundred cases across the four teams were observed for evidence of 
patient-centredness in the dialogue of the CNSs. These data were 
examined at meeting level. A lack of variability in the data (mostly ‘0’ – 
nothing observed) meant that no further sub analysis was possible. Table 
4.5 shows the results for all teams and the percentage of cases in which a 
particular patient-centred domain was evidenced.  
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Table 4.5: Results of IOM dimensions observed across all teams 
 Number of cases for which domain is present 
Observations of 
CNSs across 












Respect for patient 
values, 
preferences and 
expressed needs  
7 (12%) 0 (0%) 0 (0%) 3(8%) 10 (5%) 
(IOMB) 
Co-ordination and 
integration of care 





2 (3%) 0 (0%) 0 (0%) 0 (0%) 2 (1%) 
(IOMD) 
Physical comfort 
4 (7%) 0 (0%) 1(2%) 0 (0%) 5 (3%) 
(IOME) 
Emotional support, 
relieving fear and 
anxiety 
2 (3%) 0 (0%) 0 (0%) 0 (0%) 2 (1%) 
(IOMF) 
Involvement of 
family and friends 




Presentation of patient-centred issues by CNSs was very limited across 
five of the domains and across all teams. The one exception to this related 
to the dimension ‘co-ordination and integration of care’ (IOMB).  
Across all four teams this was the only dimension where there was at 
least some evidence of CNS input from each of the teams.  
 
Respect for patient values, preferences and expressed need (IOMA) 
Of the two hundred patients discussed during the sixteen meetings only 
5% (10) of patients had contributions relating to this dimension put forward 
by the CNSs. This was observed in Team 1 for 12% (7) patients and 
Team 4 for 8% (3) patients. No contributions for this dimension were 
observed for Team 2 or 3.  
 
Coordination and integration of care (IOMB) 
This dimension featured most commonly across the four teams with 
contributions relating to this domain being observed for 34% (67) of 
patients. Team 1 demonstrated this dimension for 95% (56) of observed 
cases compared with the much smaller proportions observed at Team 2 
(8% , n=3), Team 3 (8% , n=5) and Team 4 (8% , n=3).  
 
Information, communication and education (IOMC) 
This dimension was rarely observed with only 1% (2) of case discussions 
incorporating these elements. Team 1 CNS were the only team to provide 
input on this dimension of patient-centred care with 3% (2) of the total 
cohort of 59 cases having input on this dimension. 
 
Physical comfort (IOMD) 
Across all four teams 3% (5) of the two hundred cases discussed had 
input from the CNSs in relation to issues of patient physical comfort. 
Teams 1 and 3 demonstrated this dimension in 7% (4) and 2% (1) of 
patients discussed respectively. For Teams 2 and 4 the CNSs made no 
observable contributions with regard to the patient’s physical comfort or 
discomfort. 
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Emotional support, relieving fear and anxiety (IOME) 
Across all four sites only 1% (2) of patients had contributions relating to 
emotional support presented by the CNS in case discussions. Team 1 
was the only team in which the CNS contributed information in relation to 
emotional suffering or support required. This occurred in 3% (2) of the 59 
patients discussed across the four meetings. There were no observable 
contributions reported by the CNSs for this dimension in Teams 2, 3 and 
4. 
 
Involvement of family and friends (IOMF) 
Across all four Teams only 1% (2) of patients had contributions on this 
dimension from CNSs within case discussions. Only Team 1 CNSs 
contributed any information in relation to recognising and accommodating 
the views of the people whom the patient relied on. This was minimal and 
occurred in 3 % (2) of the 59 cases discussed across the four meetings in 
Team 1. No observable contributions by CNSs were recorded for the 
cases discussed in Teams 2, 3 and 4.  
 
Observations of interactions 
The second component of the structured observations involved capturing 
and recording any interactions involving the CNSs within each team 
meeting. This was achieved by using a modified version of the Bales 
Interaction Process Analysis (IPA) categories (Bales, 1950). For each 
case discussed I observed the team and CNSs for any interaction either 
initiated by her or directed at her. The categories also allowed for non-
verbal interactions to be recorded and these too were observed. Appendix 
24 provides a summary of the results across the four teams by the IPA 
categories. 
To aid comparative analysis across the four teams the results of the Bales 
IPA observations have been grouped in the following way: 
x When the CNS ‘gives’ something in an interaction 
x When the CNS ‘is asked for’ something in an interaction 
x When the CNS ‘asks’ something in an interaction 
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x When the CNSs ‘agree or ‘disagree’ in an interaction 
x Subjective rating of CNS behaviour/manner 
 




There were few interactions in terms of the CNSs ‘giving’ information, 
opinion and suggestions across the four teams and in only 18% of cases 
were these interactions observed (Table 4.6). Team 1 CNSs were 
different when compared with the other teams. On all the BIPA categories 
relating to ‘giving’ Team 1 CNSs were recorded more frequently as  
‘giving’ information, opinion or suggestion when compared with the CNSs 
from the other teams.  
 
Table 4.6: ‘Gives’ categories across the four teams 

















8 (14%) 0 (0%) 0 (0%) 1 (3%) 9 (5%) 
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Is asked for 
Table 4.7 shows that overall CNSs were infrequently ‘asked’ for 
information, opinion and suggestions across cases and teams.  There was 
some variability across the teams in terms of the CNS being asked for 
information within the meetings. Team 1 stands out in relation to this 
category with CNSs being ‘asked’ more frequently than Teams, 2, 3 and 
4. It was rare for CNSs to be ‘asked’ their opinion in case discussions 
ranging from 0 cases (Team 2) to 4 cases (Team 3). Notably the CNSs 
were never ‘asked’ for a suggestion by team members in any of the case 
discussions observed across all four teams. 
 
Table 4.7: ‘Is asked for’ categories across the four teams 





Team 1 Team 2 Team 3 Team 4 Total 
4 (BIPA6a) 
CNS is asked 
for information 
13 (22%) 1 (3%) 7 (11%) 6 (15%) 27(14%) 
10 (BIPA6b) 
CNS is asked 
for opinion 
3 (5%) 0 (0%) 4 (6%) 1 (3%) 8 (4%) 
17 (BIPA6c) 
CNS is asked 
for suggestion 







Table 4.8 shows that across all teams CNSs infrequently ‘asked’ for 
information, opinion or suggestions from team members. Team 1 CNSs 
were most likely to ‘ask’ for information, opinion or suggestions from other 
team members. Asking for information, an opinion or suggestion required 
the CNS to be proactive in an interaction and these data suggest that this 
was an area of difficulty for the CNSs. 
 
Table 4.8: CNS ‘asks’ categories across the four teams 





Team 1 Team 2 Team 3 Team 4 Total 
5 (BIPA5a) 
CNS asks for 
information 
12(20%) 1 (3%) 2 (3%) 3 (8%) 18 (9%) 
11 (BIPA5b) 
CNS asks for 
opinion 
5 (9%) 0 (0%) 0 (0%) 1 (3%) 6 (3%) 
13 (BIPA5c) 
CNS asks for 
suggestions 
2 (3%) 0 (0%) 0 (0%) 0 (0%) 2 (1%) 
 
 
Agrees and disagrees 
Table 4.9 shows that in terms of agreeing/disagreeing within case 
discussions CNSs infrequently disagreed (non-verbally or verbally) and 
more frequently agreed non-verbally. Team 1 more frequently agreed 
verbally than the other teams and Team 3 agreed non-verbally more 
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frequently in case discussions. Team 2 and 4 had low frequencies across 
all these categories. Most notably, rarely did the CNSs disagree either 
verbally or non-verbally. 
 
Table 4.9: ‘Agrees and disagrees’ categories across the four teams 























1 (2%) 0 (0%) 0 (0%) 1 (3%) 2 (1%) 
 
 
Subjective rating of CNS behaviour/manner 
Table 4.10 presents the frequencies for the four teams across categories 
that were more subjective in nature and where I made a judgment within 
the observations with regard to the CNSs non-verbal expressions.  
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Table 4.10: Subjective categories across the four teams 























0 (0%) 0 (0%) 0 (0%) 1 (3%) 1 (1%) 
 
 
In general the CNSs appeared to have few interactions both verbal and 
non-verbal and therefore making observational judgments as to the nature 
of their non-verbal interactions was, at times, challenging. This was 
compounded by the observation that they often made notes in the meeting 
and were ultimately preoccupied with this task with their heads down and 
making very little eye contact.  
The CNSs in Teams 1 and 2 appeared friendlier. This may have been 
attributed to the fact that these CNSs had been within those teams since 
they began and felt more at ease with team members. Rarely did the 
CNSs appear unfriendly within the meetings. However, some tension was 
shown by CNSs in Teams 1 and 4 though only in relation to very few 
cases. Team 1 CNSs appeared generally to be more expressive by the 
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fact that they seemed to be ‘more friendly’, showed ‘more tension’ and 
were more ‘dramatic’ than the CNSs within the other three teams. 
 
Overall summary 
In summary the data show that the CNSs made very little verbal or non-
verbal contributions to case discussions. In relation to patient-centred 
issues the CNSs most frequently contributed on issues related to the 
‘coordination and integration of care’ (67 of 200 cases) and in terms of 
their interactions the most frequent item observed related to them ‘giving 
information’ in 35 of 200 cases.  
Team 1, however, appeared to stand out both in terms of the CNSs 
contribution to patient-centred issues (though only marginally for 5 of the 6 
dimensions) and also in relation to their interactions within the meetings. 
The CNSs in Team 1 exhibited more frequent behaviours on all of the 
patient-centred items and on 8 of the 17 Bales IPA categories when 
compared with the CNSs from the other three teams. In particular the 
CNSs in Team 1 gave more information; were asked for information; 
asked more for information; gave opinion; gave suggestions; and asked 
for an opinion much more when compared with the other teams. Though 
the proportion of these interactions was still generally very low. 
 
Summary of key findings: research question one 
1. CNSs contribute minimally in the MDT meeting 
2. Coordination and integration of care are the most common issues 
contributed by CNSs in the meeting 
3. CNSs give information for a few cases only in the meeting 
4. Team one CNSs are more vocal than other CNSs 




4.4.1.2 Research question 2 
What is the perception of the clinical nurse specialist of their role 
and contribution at the multidisciplinary team meeting? 
To address this research question semi-structured interviews were 
conducted with all the CNSs from the four teams (n=8). The interviews 
were undertaken after all the team observations had been completed. The 
purpose of the interviews was to explore CNSs perceptions of the CNS 
role within the team meetings. 
 
Characteristics of the CNSs 
Table 4.11: Characteristic features of the CNSs 
Team Participant 
pseudonym  










1 Alice Female CNS 14 10  10  Oncology 
1 Belinda Female CNS 7  1.4  1.4  Surgery 
2 Caroline Female CNS 28 16 12 Surgery 
3 Emma Female CNS 12 1 1 Oncology 
3 Fran Female CNS 15 9 9 Oncology 
3 Ginny Female CNS 17 3 3 Surgery 
4 Olivia Female CNS 14 4 4 Surgery 
4 Queenie Female CNS 10 5 3 Oncology 
 
 
Table 4.11 provides a summary of the characteristic features of the CNSs 
across all four teams. With the exception of one of the CNSs from Team 1 
all had been qualified for ten years or more with two CNSs (one from 
Team 1 and Team 2) having been in the CNS role and Team for more 
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than 10 years. In terms of background there was an equal number of 
CNSs who had been trained in either colorectal surgery or oncology. 
 
Perceptions of the CNS role 
Four key themes emerged in relation to the perception of CNSs of their 
role and contribution within the meeting discussions.  These included: 
x Multiple roles of the CNS 
x Role uncertainty amongst MDT colleagues 
x Not speaking up 
x Feeling variably valued 
Each theme had a number of sub themes as shown in Table 4.12. 
 
Table 4.12: Themes and subthemes: perception of CNS role and 
contribution by CNS 
Themes Sub themes 








Not speaking up Lack of confidence 
Meeting culture 
Lacking knowledge of the patient 
Feeling variably valued Valued 




This theme and its sub themes emerged from the responses to the 
interview questions to CNSs: ‘Can you tell me about your role within the 
meeting?’. The responses indicated that they fulfilled multiple roles in the 
meeting and within the interviews the following roles emerged as 
subthemes; organiser, advocate, pathway coordinator and translator. 
 
Organiser 
This subtheme related to the preparation and organisation of the meeting. 
Many of the CNSs spoke of having a key role in ensuring that the lists 
were prepared for the meeting and that relevant patients were on the list 
for discussion. There was, however, some inherent conflict with this role in 
terms of the CNSs feeling that actually this was the responsibility of the 
clinician and caused her concern to have this sole responsibility: 
 
 “Well my role is pivotal because a lot of the time unless I physically 
put the patients electronically on to the meeting I guess they wouldn’t 
go on the meeting which is a bit alarming but I think a lot of the time 
people rely on me …... to get the patients on the meeting. So in some 
respects it kind of takes away the responsibility of the clinician, they 
think oh it’s in hand. ….. and that part of it I’m not very comfortable 
with because sometimes patients can get missed.” Caroline Team 2  
 
There were other aspects to organising and preparing for the meeting 
undertaken by the CNS. These included arranging investigations, scans 
and appointments for patients so that prior to the meeting everything was 
completed: 
 
“Preparing and making sure that the patients are on and doing their 
proformas. If there is a big long list for MDT it can take me a whole 
morning to prepare if there are lots of new patients and you are 
having to go through the whole of CDR (electronic records) to find out 
what’s going on with them because you don’t, you just get a name 
and a lump, they don’t tell you anything else you have to work that bit 
out yourself.”  Alice Team 1 
 
 131 
This coordination function was viewed as a formal and legitimate 
component of the CNS role to the point that she would provide the ‘cover’ 
for the official MDT coordinator when she was away: 
 
“Yes I mean that’s devised in our job plans that we have to work 
closely with the MDT coordinators and that is part of my plan so if the 
MDT coordinator for some reason wasn’t working then it would be my 
job actually to ensure that all the information is gathered correctly but 
that is outlined in my job plan to do that.” Olivia Team 4 
 
Particularly in Team 1 the CNSs would take on the role of chairing the 
meeting due to a lack of leadership exhibited by the formal chair. Being 
the ‘unofficial chair” within the meeting was a key function of the CNS 
within this team and considered an element of coordinating the meeting. 
There were some anxieties that accompanied this function as highlighted 
by Belinda (Team 1) who reported that presenting in the meeting 
prevented her from bringing a more nursing perspective to the discussion: 
 
“I think also there’s a certain amount of anxiety on my part in that I’m 
always very anxious to present everything and make sure that I have 
all the facts and I’m quite religious about writing it all down and 
making sure because obviously what we present impacts on the 
decision making massively and if we give the wrong information it can 
really change the outcome so I think maybe I concentrate too much 
on that side of things and making sure that everything is presented 
correctly whereas if we were actually, if our roles changed within the 
meeting I would maybe feel that I could put my nurse perspective in 
more.” Belinda Team 1  
 
Advocate 
All of the CNSs spoke of being an advocate for the patients within the 
meeting. They all perceived this as a primary function and that this was 
what they were there to provide and put forward in the discussion: 
 
“I think that’s the joy of being the CNS, you get to know your patients 
so well that you kind of know how they are going to respond to 
something and can bring in extra resources when they are available if 
you know you need them, which I don’t think the surgeons or the 
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oncologists really pick up so much because they don’t spend so much 
time with them.” Alice Team 1 
 
In terms of fulfilling this advocacy role some examples were given of 
advocacy in action. This example shows the importance of the CNS 
representing the views of the patient and family within the meeting and the 
significance of this information to the outcome of the decision:. 
 
“…he isn’t capable mentally of making (a decision), of either one 
consenting or two retaining the information and understanding why 
he’s having it so I’d spoken to the son and said what would you like us 
to do, what would you like me to convey to the team when I speak to 
them in the meeting and he had said to be honest with you I’d rather 
leave well alone and so I then went to the MDT and said that this is 
what he said and this is what they believe the gentleman would like 
and they said fair enough let’s leave well alone. So in that respect I 
think they do take our decisions on and respect those.” Belinda Team 
1 
 
The CNSs also thought their role was multifaceted and that they had a 
number of varying functions to fulfill in the meeting. As Olivia comments 
below, part of her role was to sort out the investigations and procedures 
and the other to “bring forward” more holistic concerns: 
 
“I think part of it is medical management and ensuring that I have the 
investigations or any procedures, any things completed and ordered 
but I think the other one is then that if there is any concerns around 
emotional, mental health, physical health of the patient then I think it’s 
my role to bring forward.” Olivia Team 4 
 
They all felt that their primary role in the meeting was to represent the 
voice of patient:  
 
“I think our role is to be there primarily as the patient’s advocate and 
to speak up and to say, give our opinions, give our observations. I 
think it’s about yes for us its patient advocate for me in the meeting.” 




Whilst most saw representing the patients’ voice as their primary role in 
the meeting, most also talked about the importance of navigating the 
pathway. By this, the CNSs meant they were also there to ensure that the 
patient had a smooth journey through the pathway from diagnosis to 
treatment. The MDT meetings acted as key points along the pathway 
where progress with that journey was reported on and it was a key role for 
the CNS to ensure that the pathway was progressing as planned or not 
and to report back on this: 
 
“…one navigates within the system on behalf of the patient. So you 
are there because in the system you are there as a key worker so you 
know and at times we are also able to if the CT’s were not ready on 
time or the pathology is not ready in time and you pick that up even 
though the MDT coordinator will be chasing up that you have noted 
down that you still need to follow it up with radiology and pathology so 
next week that patient can be discussed with everything together.  So 
I think it’s because the duties of a clinical nurse specialist most of the 
time is coordinating care in the system so I have the surgical side, I 
have the radiographers, the pathology, the consultants and it’s like 
you are there in the middle.” Emma Team 3 
 
Translator  
During the observations it was noted in field notes that the CNSs were 
often quiet within the meeting and spent considerable time writing notes 
on the MDT patient list. This was followed up during the semi-structured 
interviews and the CNSs were asked about their quietness within the 
meeting. Most acknowledged this and explained that a key role was to 
convey the story pertaining to the decision-making process to the patient 
and that to do this effectively required them to listen attentively and also 
take notes about the discussion:  
 
“I suppose we’re there to help ensure that there is a plan for the 
patient, that they know treatment options and that we can then 
understand that enough to be able to convey that to the patient 




Many referred to the fact that it would usually be the CNS that relayed the 
discussion and decisions from the meeting back to the patient and not the 
Consultant and hence they felt very aware of the need to ensure that what 
they relayed was accurate: 
 
“ OK, one I’m able, at least, to listen to the decisions that are being 
made and because I would say as a clinical nurse specialist I’m the 
patient’s key worker, they can’t get hold of the consultant as easily as 
they would get the clinical nurse specialist so as a key worker the 
good thing is I hear and I know about the patient so when I go and 
feedback and the patient gets a bit confused of what is happening as 
a clinical nurse specialist who has been in an MDT I’ll be able to sit 
with them and reinforce what the consultants have said.” Emma Team 
3 
 
This translating of information was not confined to the patient and often it 
was perceived by the CNSs that it was their role to provide the decision 
and information from the meeting to other team members and 
professionals not present at the meeting: 
 
“…. so it’s important for me to be here when they (the patients) are 
being discussed because probably Dr K will not even be in the clinic 
when they come and most of the time the other consultants will come 
to me and say what was the decision (in the meeting) because this is 
what is in paper can you remember what that decision was….” Emma 
Team 3 
 
Role uncertainty amongst MDT colleagues  
Whilst the CNSs were able to articulate the multiple roles they felt they 
undertook within the meeting they reported that the oncologists and 
surgeons had variable understanding of the CNS role in the meeting.  
 
Oncologists 
The CNSs perceived that oncologists had a more holistic approach to 
patients and recognised the psychological aspects of care provided by the 
CNSs whereas the surgeons were less psychologically oriented and 
hence appreciated more the logistical support provided by the CNSs:  
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 “I think that’s probably to do with the fact that generally the oncology 
patients need more psychological support and I think the oncologists 
look to us massively for that and the surgeons don’t really recognise 
any psychological needs and therefore for the surgeons (we) are 
more there to sort out logistical things …” Alice Team 1 
 
Surgeons 
The CNSs felt that the surgeons perceived it was a core CNS function to 
sort out the ‘logistics’ and ‘practical deliverables’ in relation to the patient’s 
pathway. They were not always accepting of this perception. 
 
“ …they (the surgeons) see us more as delivering on some of the 
practical things like if an investigation needs doing ….” Ginny Team 3 
 
Some of the CNSs reported that the surgeons had their own particular 
views on the role of the CNS in the meeting and that these did not always 
reflect the CNSs.  
 
“Yes, I think there needs to be a greater understanding of what we do 
and our role within the team and meeting I think because it’s so grey 
as it were because the line gets blurred and I think sometimes we’re 
seen as administrators, make that appointment, see that that letter 
gets sent, make sure that is booked. I think sometimes that is how we 
are viewed in the meeting whereas the first thing you see about the 
role of the CNS it says on the proforma, key worker so that in itself for 
me points to the fact that we are the key person to that patient and I 
always say to the patients I am your middle man, I’m between you 
and all those…..” Queenie Team 4 
 
In addition the CNSs often referred to the idea that the surgeons actually 
did know what the CNS role was in the meeting but tried to ‘bend the CNS 
role’ to meet needs that were not provided by others:  
 
“I think they know what my role is but sometimes I suppose they can 
try to bend it, bend the rules a little bit”. 
LC: “What does that mean?” 
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Olivia: “As in their expectations that they would expect that anything 
that is discussed or recommendations, the plan of action, following 
the MDT that I would automatically do it so I think their expectations 
that way is a bit much, you know…”  Olivia (Team 4) 
 
An important issue that resonated with many responses was this view that 
the surgical doctors in the team saw the CNS role as flexible and could 
alter to respond to gaps in the team. This was particularly the case for one 
team where the junior medical staff had been withdrawn and the CNS was 
left to undertake those roles normally carried out by the junior medical 
team: 
 
“They, as in the surgeons, I think they expect me to ensure that every 
patient that is on the MDT for discussion that all investigations are up 
to date…Any jobs as in investigations, diagnostics that need booking 
that I would carry out that role after the MDT and that could include 
clinical appointments, investigations to have a look into the colon or 
surgery, palliative care referrals, oncology, chemotherapy, getting 
patients ready for that. I think they think I’m more like a practitioner 
like a junior FY1 role to ensure that’s all required.” Olivia Team 4 
 
Not speaking up 
A finding within the semi-structured interviews was the perception by the 
CNSs that they did not ‘speak up’ within meeting discussions. This was 
accompanied by an expressed desire to be more vocal:   
 
“ I mean we’ve had patients in the past that we felt it wasn’t the right 
thing for them to have a stoma and it wasn’t the right thing for them, 
they weren’t really fit enough for an operation and we have said that 
but I do recognise we probably should be more vocal.”  Fran Team 3 
 
“Yes I mean I do feel that we are respected but the bottom line for me 
is I think sometimes we lose coming back to again …we don’t always 
look at the patient holistically… I think probably comes down to us as 
the nurses really that we should be more vocal.”  Ginny Team 3 
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When explored further their reasons for not being vocal were varied and 
have been grouped around the following subthemes; lacking confidence; 
the culture of the meeting; and lacking knowledge of the patient. 
 
Lack of confidence 
This lack of confidence to speak in the meeting was a common 
perception. Although many said that they felt their opinions were valued, 
many expressed a lack of confidence to give their opinions within the 
meeting.  
 
The extract below is a reflection from Ginny who spoke of a patient she 
had cared for where she had not given her opinion in the meeting due to a 
lack of confidence to speak out. Had she of done she indicated that she 
would have challenged the MDT decision to treat the patient with 
chemotherapy and perhaps enabled the patient to have some quality of 
life rather than a period of treatment with consequent side effects. The 
patient did die having had treatment and in her opinion, poor quality of life 
prior to his death. 
 
“I’m not saying otherwise, I’m not questioning the reasons why it was 
done and everything but the patient hasn’t had that quality of life and 
at a young age died and you think he’s left a 10 year old daughter 
behind and no mum, and so I feel now that I need to say these things 
because for me, I mean, I really struggled with that particular patient.  
LC:  What would help, what do you think would help to make your 
contribution? 
I think for us to have the confidence sometimes but I think sometimes 
you sit there and you know the power of the surgeons, the power of 
the expertise of the oncologists etc.…. So I think it’s just having the 
confidence to say right this is how I feel about it, I’ve seen them every 
day and this is what I’d like you to listen to what we see day in and 
day out on the ward really.”  Ginny Team 3 
 
Whilst Ginny had clearly learnt from this experience it was evident that 
she had lacked confidence to express her opinion in a culture that she 
experienced as potentially oppressive. 
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For some of the other CNSs they too expressed a lack of confidence to 
‘speak up’. They valued what they had to say but lacked the confidence to 
do it. 
 
“Well I think sometimes it is quite hard to speak out and I suppose it’s 
not because I don’t think I’ve got a valid point I don’t know, maybe it’s 
just me.”  Fran Team 3  
 
“ ….I don’t like to ruffle too many feathers and I like to do a good job 
in the background and I’ve always been like that so I would find it 
difficult to say I don’t think it’s working like this…. Maybe over time 
that will change and I will become more confident to say things could 
work differently.”  Belinda Team 1 
 
Meeting culture  
As has been discussed the CNSs perceived their role in the meeting to be 
multifaceted with their primary function being that of advocating for 
patients. They often defined advocacy as representing the views of 
patients within the meeting and ensuring that the patient’s position and 
perspective was put forward into the decision-making discussion. There 
was a view, however, that the culture of the meeting did not enable this to 
occur and that the meeting was not geared to include holistic, patient-
centred issues, and that it was essentially a medically, dominated 
discussion that viewed the holistic concerns of the patient as peripheral 
and irrelevant to the decision-making process. 
  
“ ….I think it is a real shame because the MDM very, very much 
focuses on the physical and there is very, very little focus on anything 
other than that which I suppose is appropriate in terms of deciding 
treatment plans and whether chemotherapy or surgery is the way 
forward but I think we are missing something there.”  Belinda Team 1  
 
Many of the CNSs worked around the meeting and admitted that they 
often discussed patient-centred and non-medical issues after the meeting 
with the relevant individual doctor and team member.  
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“I think most of the chats to be quite honest happen after the MDM 
and is when I would probably sit down and talk to the oncologist 
separately about patients and each surgeon actually separate. I think 
it happens afterwards rather than during…” Olivia Team 4 
“It can be difficult to speak out and also if the team are focusing on for 
instance the x-rays and the histology they are things that are quite 
black and white and decisions are often made on those. So perhaps 
the softer issues can be broached afterwards.”  Fran Team 3 
 
There seemed to be an internal conflict. Whilst they believed that patient-
centred issues were important to the discussion they did not feel that the 
culture of the meeting, with its focus on the disease and ‘tumour’, allowed 
them opportunities to engage in a dialogue about the holistic concerns of 
their patients. Indeed they themselves found other ways, outside of the 
meeting, by which to express their views and opinions about particular 
patients. 
 
This perceived ambivalence toward incorporating holistic concerns into 
the discussion resulted in the CNSs only ‘speaking up’ when they ‘had to’ 
and this usually occurred if they knew of information that would impact on 
the acceptability, by the patient, of the agreed MDT decision.  
 
“I think if it was a case of I really felt that something nurse related 
needed to be brought up I would definitely feel comfortable to say 
hang on a sec I don’t think this is the way forward and for example we 
discussed somebody today that I’d already spoken to on the phone 
and I knew what the decision, I knew that they didn’t want to go down 
the route that the MDT had recommended and I said I really don’t 
think that’s what the patient is going to want and changed the MDT 
outcome as a result. So I do think they respect our decision, well 
maybe not our decision but they respect our input definitely.”  Belinda 
Team 1 
 
As the meeting was primarily focused on agreeing a treatment and 
management plan for the patient the CNSs perceived that they had little 
remit in this decision-making process and that decisions about treatment 
were not perceived as involving nurses. The following provides four 
perspectives from different CNSs as to their role in the decision-making 
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process. None thought they played an important part in the decision 
making itself. 
 
“ Well I think they would make the decisions anyway for example if I 
wasn’t there but I do think they would value my opinion about patients 
but I think the decision making would still go ahead in my absence.” 
Caroline Team 2 
 
“On the decision-making process probably not hugely, probably not 
hugely. Our work is after the meeting to coordinate everything once 
the decisions have been made but I don’t think, I don’t think we 
contribute enough to the decision-making process to say that we are 
a part of that.” Queenie Team 4 
 
“I think there may well be things that we might discuss with the 
consultant afterwards once we’ve got a plan that perhaps we could 
bring up more in the meetings.” Alice Team 1 
 
“ I don’t think they really look to us for a clinical decision, which I think, 
is fair enough because they’re the doctors and we’re the nurses.” 
Belinda Team 1 
 
Lacking knowledge of the patient 
A key finding from the semi-structured interviews was that a significant 
number of the CNSs (five out of eight) indicated that they would not have 
met between thirty to fifty percent of new patients discussed at the 
meeting. This had an impact on their ability to bring any holistic or patient-
centred concerns into the meeting discussion for those patients and 
consequently limited their contribution to the meeting. 
 
“ So yes there is an element of that which can make things difficult 
which just means all you are really looking at is the x-rays, the results 
and then making your decision based on the anatomy of the patient 





Feeling variably valued 
The CNSs responses to the interview question ‘Do you always feel your 
contribution is valued in the meeting?’ prompted a range of responses. 
Many had the view that their colleagues positively valued their contribution 
in the meeting and some held a much more negative perception.  
 
Valued 
As previously discussed some of the CNSs felt more respected by the 
oncologists rather than the surgeons as they perceived the oncologists to 
be more ‘holistic’ and therefore had a better understanding of what the 
CNSs were contributing when they did attempt to input patient-centred 
information into the meeting discussion. 
 
“ Yes. I do feel that there is, I think with the nurse/doctor thing there’s 
always going to be a nurse/doctor divide unfortunately and I think 
that’s probably expected, I don’t think that’s ever going to change. I 
would say perhaps that the surgical perspective is slightly different 
from the oncology perspective partly because obviously our 
knowledge is probably more limited in terms of the surgeons, I think 
the oncologist probably sees things more from the holistic perspective 
so I would say the oncologist respect our contributions more than the 
surgeons.” Belinda Team 1 
 
Most responses related to the value they felt from medical colleagues and 
very little reference to how non-medical colleagues valued them. 
 
“ I feel that all our consultants well the gastroenterologists and the 
surgeons I think they have a great value of the role of the CNS and I 
think they would value anything we would say and wouldn’t hush hush 
us.. Caroline Team 2 
 
Not valued 
Some of the CNSs also felt that they were not valued and this translated 
in many ways. Some expressed a sense of being thought of as ‘those 
nurses’ or ‘just a nurse’ meaning they were not ‘equivalent’ in terms of 
status to the consultants or that the consultants, at times, undermined the 
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nursing contribution and the sense of professionalism they felt towards 
their patients. 
 
“I think the surgeons still very much think that we’re just a nurse and 
you do whatever you’ve got to do but this is my patient and I often get 
they’re not your patients and it’s like well, they are my patients in my 
caseload and my work.” Alice Team 1 
 
Some CNSs felt disrespected within the meeting and, at times, when they 
did attempt to contribute they were either talked over whilst talking or ‘shot 
down’ making them feel that their opinion was not valued. The 
consequence of this was a loss of confidence and tentativeness in 
speaking at other times. 
 
“It can only be better for the patient’s experience if we feel more able 
to speak up and that we feel that what we have to say is more valued 
and I think that’s the thing, the times when we have said ‘oh actually’ 
you are immediately shot down and made to feel that actually your 
opinion is invalid then the next time you think twice before you speak 
up and I think that’s the attitude….”  Queenie Team 4 
 
Summary of key findings: research question two 
 
1. CNSs have multiple roles in the meeting 
2. MDT members have a different perception of the CNS role from the 
CNSs 
3. CNSs have difficulties speaking up in the meeting 
4. CNSs perceived that MDT colleagues had mixed views about the value 
of the CNS in the meeting 
 
4.4.1.3 Research question 3 
What is the perception of other multidisciplinary team members of 
the role and contribution of the clinical nurse specialist in the 
multidisciplinary team meeting?  
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Characteristics of participants 
To explore the perception of the CNS role in the meeting from the 
perspective of other colorectal MDT members, ten semi-structured 
interviews were undertaken with other core MDT members who were not 
CNSs. These included five consultant oncologists, three consultant 
surgeons, one radiologist and one MDT coordinator (table 4.13). With the 
exception of one participant (Rachel) all were consultants, so the 
perceptions of the medical staff were therefore dominant, most of whom 
were male (n=7). 
 
Table 4.13: Other core MDT members interviewed 
Team Professional Group Participant Name 
1 Consultant Oncologist Don 
1 Consultant Oncologist Harry 
2 Consultant Oncologist Janice 
3 Consultant oncologist Kevin 
4 Consultants oncologist Nora 
2 Consultant surgeon Larry 
3 Consultant Surgeon Imran 
4 Consultant Surgeon Michael 
4 Consultant Radiologist Peter 
1 MDT coordinator Rachel 
 
Perceptions of CNS role 
Within the semi-structured interviews all participants were asked to 
respond to the questions ‘Can you tell me what you think of the role of the 
CNS within the MDT meeting and specifically within the clinical decision-
making process?’ And ‘do you think there are any particular issues for the 
CNSs in the meeting?’ 
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Three subthemes emerged relating to core MDT member’s perceptions of 
the CNSs role within the meeting. These were; 
x Patient-centred – Participants perceived that the CNSs were 
focussed on the holistic concerns of the patient and fulfilled an 
advocacy role and there to present the patients perspective. 
x Lacking ‘voice’ – Participants perceived that the CNSs were quiet 
and silent in the meeting and provided a range of reasons to 
explain their silence. Of note was that participants expressed a 
desire for CNSs to be more vocal in the meeting. 
x Highly valued – Participants spoke highly of the role of the CNS in 
the meeting and in particular felt that they were the ‘glue’ that held 
the meeting together and also that of the patient’s pathway through 
their co-ordination role. 
Table 4.14 shows the themes and subthemes that emerged from 
analysis of responses to these questions. 
 
Table 4.14: Themes and subthemes: perceptions of CNS role and 
contribution from core MDT members 
Themes Subthemes  
Patient-centred Advocacy role  
Lacking ‘voice’ Passive 
Subservient 
Lack of confidence 
Voice wanted 






There was a dominant perception from the participants, most of whom 
were doctors that the role of the CNS both within and outside of the 
meeting was to advocate for the patient. Many participants also 
acknowledged and recognised that understanding these patient-centred 
issues were important factors in formulating a decision about treatment. 
This contrasted with the CNS perception that whilst it was their role to 
advocate they did not feel inputting these issues made any difference to 
the decision. 
 
“…They know more about that patient actually and how he is in terms 
of is he working, has he got time off, what is the social situation like, 
has he got issues with his family, is there tension going on, they 
actually make a big difference to that actual decision at the end 
whereas on the scan the cancer and blob when I see him in clinic was 
a right hand colectomy and actually it’s not as easy as that…” Imran 
Team 3 
 
At times there was a perception that whilst the CNS role was to advocate 
for the patient they often needed encouragement to do so in the meeting. 
 
“Yes, when she (the CNS) gets her opportunity to speak, and there 
are occasions where the surgeons have got carried away talking 
about something somebody wants but I’m pretty sure she always 
needs a prompt so I’ll often look at her face and I think if she’s looking 
uncomfortable I’ll say ‘Caroline is that your assessment?  Do you feel 
that’s?’ And then she’ll often pipe up, no actually the patient doesn’t 
want a stoma. Janice Team 2 
 
Lacking ‘voice’ 
The perception that the CNS was not vocal in the meeting was common 
amongst other core MDT members and there seemed to be a number of 
ways in which this was perceived. Some ascribed this to being passive; 
some attributed it to possible feelings of subservience and deference 
toward doctors, in particular surgeons and some described it as a lack of 
confidence. What was evident was that there was a view that they would 
like the CNS to have more of an opinion and presence in the meeting and 
felt frustrated that the CNS was not more forthcoming. 
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Passive 
That the CNSs were passive and timid within the meeting was a view 
particularly held by the doctors.  
 
“I don’t think I’ve ever heard Caroline speak in the meeting… she’s 
totally passive and has got a lot of work on… Larry Team 2 
 
“She’s quite new and she’s very good but she never says anything or 
very little, she knows what’s going on, the patients like her and we like 
her….” Kevin Team 3 
 
In terms of understanding the reasons for this passive nature there were a 
range of ideas put forward. Some thought this might be related to a ‘timid’ 
nature and a sense that they were unsure how to contribute. 
 
“I suppose they are also probably timid …. it’s not their fault it’s just 
the way it’s been run and I think they’re not sure how much they can 
contribute…” Imran Team 3 
 
One consultant did speculate that the CNSs might feel intimidated. 
 
“I notice that the CNS’s don’t speak up too much and they’ve known 
us for a long time so I would hope they didn’t feel intimidated…” Kevin 
Team 3 
 
And one consultant medical oncologist provided a very good example of 
how she acknowledged this passivity but was able to work with the CNS 
by picking up on her non-verbal cues. This, however, was quite unusual 
but testimony to some of the complexities of contributing within the 
meeting. 
 
“No, no I think the nurse certainly has a role and I think she does 
bring it in she’s just not very vocal about it. So say for example there 
is a patient, 90 year old, something which is a bit clearer, a patient 
who is frail and maybe not even that old and so we then say well, 
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chemotherapy based on the information you have, that’s what we 
would offer but then it requires making eye contact with Olivia and 
she’d say “hmm” or something, it will not even be verbalized, it will be 
something where it will be clear to me what she means and I have 
known her long enough to be able to make out of it. So in a way she 
brings it in it’s just not in that sort of way that she sits in the front and 
brings that in and its part of the discussion.” Nora Team 4 
 
Subservient 
Some of the doctors within the teams, mostly the female medical 
oncologists, had a perception that the CNSs may have felt subservient to 
consultant colleagues, in particular the surgeons. 
 
“She does occasionally (speak) but she’s so lovely but she’s quite 
subservient so she will really only speak if she’s spoken to or her 
opinion is sought and she’s quite deferential towards the senior 
surgeons so she would never speak out of turn. I don’t know why that 
is because she’s an amazing girl and they (the surgeons) absolutely 
rely on her to run the service.”  Janice Team 2 
 
One consultant oncologist also spoke about the traditional hierarchies and 
patterns of behaviour that she had noticed between female CNSs who 
had come from a surgical background and male surgeons and thought 
that there maybe traditional patterns of behaviours emerging within the 
meeting that contributed to inhibiting the CNS contribution. 
 
“And also I mean I think you have, most of the nurses are surgical 
nurses and I would say that some sort of traditional patterns are still 
very existent there… Yes and it’s also all the nurses are female, the 
vast majority of surgeons are male etc. so I think some of it is, you 
know, quite traditional stuff.”  Nora Team 4 
 
Lack of confidence 
Many of the consultants spoke of the CNSs lacking confidence to 
proactively participate in the meeting. Some consultants clearly had a 
tremendous respect for the CNSs and the contribution they made within 
the meeting, when it occurred, and attributed and accepted this absence 
of contribution as a lack of confidence. 
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“Having said that when she does speak out in the group she’s 
perfectly coherent and fluent and all the rest of it but I think that she 
doesn’t like to stick her head above the parapet.” Larry Team 2 
 
“Yes. But she’s interesting she never sits at the back she always sits 
behind the surgeon and it’s almost like reminding them ‘I’m here’. I 
don’t think for one minute if they said something and she thought  (no) 
she would definitely pipe up then but it’s always done in a lovely ‘can I 
remind you Mr O or do you remember it was that patient’, so she’s 
very good at prompting the surgeons. Does that make sense? So 
she’s the knowledge base, she’s the classic she hides her light under 
a bushel..” Janice Team 2 
 
Voice wanted 
Although the perception was that they were silent during the meetings all 
core MDT members expressed a view that they very much wanted the 
CNS to contribute and to voice their opinions about the patient in the 
meeting.  
 
“We should all be the advocate and they do assume that role because 
they see the other side of the equation and a few times they haven’t 
voiced their opinions but they voice them to me separately and I say 
right why didn’t you say that in the meeting, just voice your opinions 
because you got it right, if you’d said that at the meeting we would 
have gone down a different path. So I think they’ve got a lot to add 
value to the MDT.” Imran Team 3 
 
“Really, just if they’ve seen the patient then I think they should 
interject and say this patient is fit, they’ve got functional status of 
whatever and I know that their initial views are that they want 
everything doing as opposed to I know their initial thoughts are that 
she’s very frail and her family don’t want anything too aggressive. So 
just a little flavour of what the contact with the patient has been like.”  
Larry Team 2 
 
Valued 
All participants expressed a view that they valued highly the contribution 
the CNSs made both within and outside of the meeting. Participants 
recognised their value in different ways. Some recognised the unique 
relationship CNSs had with patients and the importance of this to the 
decision made about the patient’s treatment. Others acknowledged the 
 149 
sheer volume of work the CNSs undertook to keep apace of the patient 
throughput. 
 
“It’s very important because we’ve known forever really that what the 
doctor knows and gleans is often quite different from what the nurse 
will pick up and understand for a variety of reasons, we ask different 
questions, patient’s attitudes are often different to doctors than they 
are to nurses so they are of pivotal importance to the outcomes in the 
meetings.” Harry Team 1 
 
“…They’re just work horses, beautiful work horses and they are. 
Nothing is too much for them but actually they are completely put 
upon.”  Janice Team 2 
 
In terms of being highly valued there were two main perceptions of the 
CNS role and contribution commonly held by core team members. These 
related to the idea that the CNSs were the ‘glue’ that held it all together 
including the meeting and also that their role in ‘navigating’ the patient’s 
pathway meant that the requirements necessary to make a decision at the 
meeting were enabled by the CNSs. 
 
The glue 
There was understanding from participants that the CNSs were a key 
point of contact and support throughout the patient’s pathway. Whilst there 
was, at times, a frustration that the CNSs were not vocal in the meeting, 
there was an understanding and appreciation of the work they did outside 
of the meeting to ‘hold the whole thing together’. 
 
“ I think they play an absolutely invaluable role, do they get the right 
recognition? I’m not sure they do, I think the process is a little bit of a 
pyramid and you’ve got this surgeon who is identified as the person 
who makes the major difference, I think you could easily turn the 
pyramid upside down and the thing that probably the patients interact 
with the most and the thing that they remember most at the end of 
their hopefully successful episode of care it’s the CNS they’ve been 
speaking to, the person whose mobile number they’ve had who 
they’ve called about 20 little things and 5 major things and the 
surgeon they saw once in clinic, once on the day of the operation and 
once on the ward afterwards, I’m not denigrating the surgical role 
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because obviously without them there would be no service but I think 
the CNS do an absolutely fantastic job at multiple different ways of 
pathway from the moment the endoscopist spots the tumour through 
to the last cycle of chemo it’s the CNS who is the glue that holds the 
whole thing together.” Peter Team 4 
 
Navigator 
This navigator role was also critical in ensuring the smooth execution of 
the patient’s treatment plan. They was recognition that the CNS would act 
as the ‘go between’ and expected that she would relay the information 
from the meeting to the patient. 
 
“ Once decisions have been made she is the go between who can 
speak to the patient.” Michael Team 4 
 
Additionally, it was recognised that the CNS would be the main 
professional in the team to ensure that patient’s pathway was ‘on course’ 
and that she would ensure that the patient was not ‘lost’ in the system.  
 
“ Oh without them there would be no MDM. They are everything I 
think…I suspect they do a lot of the preparation of the list so they 
identify the names to be sent to the MDM coordinator. They are there 
as the mental prompt for the clinician who has briefly forgotten about 
Mr X …they organise the follow up tests that are discussed, they are 
there to pick up the pieces when the patient falls through the net. … 
the list is probably as long as the time we’ve got this morning to 
discuss. I think without the CNS there would be no MDM and it would 
fail within a few weeks because the clinicians may have a list of things 
they would like to happen following the discussion and I suspect the 
vast majority of them are organised or delivered by the CNS…. the 
patient would get lost somewhere in the system.”   Peter Team 4 
 
 
Summary of key findings: research question three 
 
1. CNSs are patient-centred in the meeting 
2. CNSs are not vocal in the meetings 
3. Core team members would like CNSs to contribute more 
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4. CNSs are the ‘glue’ that hold the meeting together 
5. CNSs are highly valued by core MDT members 
 
4.5 Integration of mixed methods 
As both quantitative and qualitative methods were used to answer the 
research questions it was necessary that the results of both methods 
should be integrated to determine where findings from each method 
converged, were contradictory or where there were no data in either 
direction. Integration, the interaction between the qualitative and 
quantitative components of the study are presented here and further 
interpretation of these findings will be elaborated upon within the following 
chapter.  
As discussed in Chapter 3 a mixed method matrix approach was used to 
integrate the results (O’Cathain, 2010). This approach was employed for 
research questions 1 to 3 only as these were the questions where both 
quantitative and qualitative data had been collected to inform the overall 
findings. 
For each of these three research questions a mixed method matrix was 
developed and the key findings for each question populated. (See tables 
4.15, 4.16 and 4.17). The following section considers the findings of each 
matrix for research questions 1 to 3. 
 
4.5.1 Research question 1:  
What is the nature and content of the clinical nurse specialist 
contribution at the cancer multidisciplinary team meeting? 
Table 4.15 presents the mixed method matrix showing the key findings 
from the quantitative data – research question one. 
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Table 4.15: Mixed method matrix – research question one 


















































✓ ✓ ✓ ✓ - 
Bales IPA 
 
✓ - ✓ ✓ ✓ 
Qualitative 
data 











✓ ✓ ✓ - ✓ 
Field notes  
 
✓ ✓ ✓ ✓ ✓ 
Results converge = ✓ Results contradictory = ✗ No data = - 
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Table 4.15 shows considerable convergence in relation to the key findings 
across both the quantitative and qualitative data with no contradictory 
results. In particular these data support the findings that the CNSs 
contributed minimally within the meeting (key finding 1), that to, a greater 
extent, the CNSs focused on the patient-centred dimension of 
‘coordination and integration of care’  (Key finding 2) and that the CNSs 
‘gave’ information for a few cases only within the meeting (key finding 3) 
and were rarely asked for their opinion from other MDT members (key 
finding 5).  
These findings from Phase 1 resonated within the semi-structured 
interviews of both the CNSs and other core MDT members and were 
corroborated by the field notes of the observations, which consistently 
reported minimal verbal interaction on the part of the CNS.  
A key finding from the quantitative data was that Team 1 CNSs 
contributed more within the meetings than any other of the CNSs (key 
finding 4). This was also corroborated by the field notes of the 
observations. Within the semi-structured interviews Team 1, like the other 
teams, also indicated a level of difficulty in contributing. What was different 
was that they had the specific role to present the patients’ details for each 
case. This formalization of role seemed to make a difference and increase 
their verbal contributions. 
Finally, all data sources, with the exception of the IOM data, showed that 
the CNSs were rarely asked for their opinion.  The IOM component of the 
tool did not assess this particular aspect and so could not corroborate or 
contradict. There was an acknowledgement from all participants that the 
CNSs were not asked for their opinion in a systematic manner and this 
was also evidenced by the Bales IPA component of the structured 
observations, which showed that in only 4% of the 200 cases were the 
CNSs asked to give their opinion. 
 
4.5.2 Research question 2:  
What is the perception of the clinical nurse specialist of their role 
and contribution at the multidisciplinary team meeting? 
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Table 4.16 presents the mixed method matrix showing the key findings 
from the semi-structured interviews with the CNSs – research question 
two. 
 
Table 4.16: Mixed method matrix – research question two 
Key 
Findings: 




























the value of 








✗ - ✓ - 
Bales IPA 
 
✗ - ✓ - 
Qualitative 
data 











✓ ✓ ✓ ✗ 
Field notes  ✗ - ✓ - 
Results converge = ✓ Results contradictory = ✗ No data = - 
 155 
The key finding that the CNSs had multiple roles within the meeting was 
corroborated by the semi-structured interviews with other core MDT 
members. However, both the field note data and the quantitative data did 
not support this finding. Field notes of the MDT observations reported that 
the CNSs were mostly silent during the meeting with the exception of 
Team 1 where the CNSs took a lead role in presenting the patients’ 
clinical history at the outset of each case. Also, the quantitative data does 
not support the perception of the CNSs exhibiting multiple roles in the 
meeting but rather that their primary role related to co-ordination and 
integration of care – only one dimension of patient-centred care. 
Additionally, the Bales IPA recordings were low. These contradictory 
findings between the qualitative data and quantitative data were important 
as this showed that what the teams perceived was different from what 
occurred in practice. 
One key area of convergence that all data sources supported was the 
finding that CNSs had difficulties speaking up within the meeting. Both the 
quantitative and qualitative data supported this finding and the factors 
underpinning this will be explored in the analysis for research question 
four later in this chapter. 
Of note is the finding that the CNSs had mixed perceptions as to whether 
their MDT colleagues valued their contribution. Some felt highly valued 
and others felt undermined and intimidated by their colleagues. However, 
the semi-structured interviews with other core MDT members indicated 
that they all held the CNSs in high regard and that they wanted the CNSs 
to contribute more actively within the meetings. 
 
4.5.3 Research question 3:  
What is the perception of other multidisciplinary team members of 
the role and function of the clinical nurse specialist in the 
multidisciplinary team meeting? 
Table 4.17 presents the mixed method matrix showing the key findings 
from the semi-structured interviews with other core MDT members - 
research question three. 
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Table 4.17: Mixed method matrix – research question three 
Key Findings: Phase 2   






































✗ ✓ - ✓ - 
Bales IPA 
 
✗ ✓ - - - 
Qualitative 
data 











✓ ✓ - ✓ Partial 
Field notes  
 
✗ ✓ - ✓ - 
Results converge = ✓ Results contradictory = ✗ No data = - 
 
The key findings from this part of Phase 2 was a perception from other 
core MDT members that the CNSs were patient-centred in their approach 
and contributions in the meeting. This was also the perception held by the 
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CNSs themselves. However, both the field note data and that of the 
structured observations did not corroborate this finding. Once again, there 
was a variance between what they perceived they did and what actually 
occurred within the context of the meeting.  
Whilst the CNSs were thought to be patient-centred in the meeting context 
this was contradicted by the key finding, across all data sources, that the 
CNSs were not vocal in the meeting. The perception was that they were 
patient centred but the actions of the CNSs as well as perceptions of the 
actual role, in the meeting, did not corroborate this.  
This finding that the CNSs were the main co-ordinators (the glue) was 
reported on in all other data sources with the exception of the Bales IPA 
component of the structured observation, which was not, a dimension 
assessed by the tool. 
 
4.5.4 Research question 4  
What factors inhibit and enable cancer clinical nurse specialists 
contributing patient-centred information into the discussions at the 
multidisciplinary team meeting? 
Within the semi-structured interviews all participants were invited to 
respond to the question ‘Are there any things that you think enable or 
inhibit others’ contributing in the MDT meeting?’ In addition to this all 
participants were asked if they thought there were specific issues for the 
CNSs contributing patient-centred information into the case discussions 
within the meeting. 
The results and findings are presented separately for the CNSs and the 
oncologists/surgeons.  
 
Factors that inhibited the CNS contribution  
Clinical Nurse Specialist perspective 
For the CNSs there were a range of factors that they perceived as 
inhibiting their contribution in the meeting (Table 4.18). These were varied 
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and related to a number of issues, which included; those related to the 
CNS, to the team, and to the wider organization.  
 
Table 4.18: Factors that inhibit CNS contribution (CNS perspective) 
Individual to CNS Team Organisational 
Lack of confidence Undermined and 
undervalued by 
consultants 
Lack of knowledge of 
the patient 
Taking of notes Meeting rushed Insufficient time to 
prepare 





From an individual CNS perspective the main inhibitors related to feeling 
under confident to speak within the meeting. This was compounded by the 
fact that, unlike the other core members, the CNSs took notes of the 
meeting decisions and this impacted on their ability to be attentive and be 
ready to contribute to the discussion. Additionally, as previously 
discussed, the CNSs were unclear about what was expected of them in 
the meeting and this contributed to their silence. 
From a team perspective they often reported feeling undermined and 
undervalued by the consultants in the team and a fear that if they did 
express an opinion that this would be overruled or that they would be ‘shot 
down’. There was a sense that they did not feel ‘safe’ to speak and that 
they would be professionally undermined. 
 
“And I was kind of shot down by the consultant and I thought to myself 
well why are we here, on one hand you are asking us to be here we’re 
supposed to be the voice of the patient, we’re supposed to have their 
best interests at heart, we’re the middle man, the key worker, and it 
seems, I sometimes get the feeling that our, certainly with some 
doctors, that our opinion is only valid or wanted provided it meets 
what they want.” Queenie Team 4 
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Other team factors included the fact that the discussion was medically 
driven with few opportunities to input non-medical information. There was 
a sense that the fast pace of the meeting and the requirement to ensure a 
decision was made with regard to treatment and management meant that 
the meeting just felt too rushed making it difficult to speak. 
 
“I suppose in some meetings you can go in and it can be kind of, 
surgeons sometimes if they operate on that day they could be quite 
rushed.” Olivia Team 4 
 
From an organisational perspective a key inhibitory factor for the CNS 
related to the fact that, on occasions, she had not seen the patient prior to 
the meeting due to either insufficient time within the job plan or that she 
was unaware of the patient. 
 
Medical consultant perspective 
From the perspective of the medical consultants there were also a range 
of factors that they felt impacted on the ability of the CNSs to contribute 
(Table 4.19). Some within the individual control of the CNS and others 
considered to be at the team or wider organisational level. 
 
Table 4.19: Factors that inhibit CNS contribution (consultant 
perspective) 
Individual to CNS Team Organisational 
Lack of confidence Intimated by medical 
colleagues 
No knowledge of 
patient 







With regard to those issues categorised as ‘individual to CNS’ there was 
significant congruence between the CNS and consultant perspectives. In 
particular, both expressed views regarding the CNSs lacking confidence 
to speak within the meeting and that there existed a lack of clarity or 
ambiguity with regard to their role in the meeting. In terms of team factors 
there was recognition from consultants that the CNSs felt, at times, 
intimidated by medical colleagues and this too was congruent with the 
CNS perception that they did, at times, feel undermined by their medical 
colleagues and that this did inhibit them from contributing.  
 
“The CNS’s still are slightly reticent in a room of high testosterone 
surgical domination. I mean I’m now sufficiently old and weathered to 
not be in anyway bothered by that and indeed take delight in making 
fun of my surgical colleagues but they can’t.” Don Team 1 
 
At an organisational level both the CNSs and consultants acknowledged 
the fact that there was insufficient time within the CNSs’ working week to 
see all patients and this very much reflected the organisational problem 
that there was an insufficient CNS workforce to meet the demands of the 
increasing volume of patients.  
Two further factors, not identified by the CNSs, were reported by the 
consultants as inhibiting the CNSs from speaking in the meeting. These 
were poor leadership within the meeting (which the consultants proposed 
resulted in the CNSs not being included in the discussion), and issues 
related to professional status  - which some described as traditional 
patterns of hierarchy between male surgeons and female nurses which 
some felt led to CNS deference toward surgeons.  
 
“And also I mean I think you have, most of the nurses are surgical 
nurses and I would say that some sort of traditional patterns are still 
very existent there….Yes and it’s also all the nurses are female, the 
vast majority of surgeons are male etc. so I think some of it is, you 
know, quite traditional stuff.” Nora Team 4 
 
“I mean she’s so gorgeous but she’s quite deferential towards the 
senior surgeons so she would never speak out of turn. If they gave 
her a cue, if for instance they say Caroline what do you think then 
she’s amazing. Janice Team 2 
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Factors that enable CNS contribution  
Within Phase 2 study participants were also asked to reflect on and 
consider factors that they felt enabled, or could enable CNSs contributing 
to the meeting discussion. This was an important consideration as the 
results from this informed Phase 3 - the focus group with CNSs where 
they were asked to consider and prioritise proposed changes to practice 
that would further enable their contribution to the meeting. 
Within the semi-structured interviews respondents were asked to explore 
the factors that they felt either enabled or could enable the CNS to 
contribute more effectively to the meeting discussion. 
The findings from this are presented separately for the CNSs and the 
medical consultants. 
 
Clinical Nurse Specialist perspective 
Table 4.20 presents the factors thought to enable the CNS to contribute 
from a CNS perspective.  
 
Table 4.20: Factors that enable/could enable CNS contribution (CNS 
perspective) 
Factors that enable (or could) CNS contribution  
Systematic input 
Confidence to speak 
Role clarity 
Knowing the patient 
More surgical knowledge 
Learning from other MDTs 
Other professionals with a holistic focus in the MDT (palliative care or 
psychology) 
Presenting information more concisely  
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Most of the factors listed above had not been implemented and were 
strategies that the CNSs felt could help to improve their contribution to the 
meeting discussion. Many of the CNSs spoke of implementing a system 
where the opinion of the CNS was routinely given in the course of the 
meeting, in much the same way the other core team members 
contributed. This seemed the most popular and supported change to 
practice. 
 
“I suppose if our comments were routinely invited that would 
help….Well perhaps if after every, when each patient was, the 
discussion was finished maybe at the end someone might say would 
‘anyone like to add anything’ ..and then maybe if there were a couple 
of minutes that would be good, possibly.” Fran Team 3 
 
“I do think the start for us is by actually if there is something there 
then speaking up there and then don’t just think leave it and let 
everybody else have their say, just be able to say routinely I’ve seen, 
but also that needs to be reciprocated doesn’t it because people need 
to say to us what do you think and not a lot of that goes on all the 
time.” Ginny Team 3 
 
Medical consultant perspectives 
Table 4.21 presents the factors thought to enable the CNS contribution 
from a medical consultant perspective. 
 
Table 4.21: Factors that enable/could enable CNS contribution 
(consultant perspective) 
Factors that enable (or could) CNS contribution  
Senior nursing support (mentorship, support, training) 
Active encouragement to speak up 
Respectful behavior from colleagues 
Presenting concise information in the meeting  
A good relationship with them 
 163 
Many of the enabling factors identified above had not been implemented 
but were reflections and ideas put forward by the consultants that in their 
opinion would enable the CNS contribution. 
One factor identified by one of the consultants related to having good 
senior nursing leadership to support training and help the CNSs to 
develop resilience and ‘look after themselves’. This was not a factor 
identified by the CNSs but clearly supportive nursing leadership would 
play an important part in delivering some of the factors identified by the 
CNSs. 
 
“I think what the likes of Caroline have really lacked is good 
mentoring, good mentoring, good investment, almost permission to go 
on study leave and look after themselves and they haven’t had that, 
they’re just work horses, beautiful work horses and they are. Nothing 
is too much for them but actually they are completely put upon.” 
Janice Team 2 
 
One factor identified by both the CNSs and the consultants related to the 
manner in which an MDT member provided the verbal information within 
the discussion; 
 
“I just think a lot of people don’t understand what an MDT is and so 
they start telling a story like a medical student clerking a patient rather 
than the reason ‘I’ve put this case on the MDT is today I want an 
answer to this question’ and that’s what I always try to do and I’ve 
noticed a few more people do it because it’s quite hard to tune into 
every case and I think if up front you say what you want the answer to 
then the experts round the room say oh this is for me.” Janice Team 2 
 
Due to the perceived time pressures of the MDT meeting both the CNSs 
and doctors felt there was a particular way in which the discussion points 
and contributions should be made. The implication being that CNSs 
needed to be trained to deliver information concisely, 
  
“You know, it varies, there is an art to delivering the history of the 
patient and giving a feel for what the patient is like in two sentences 
which is what is needed.” Don Team 1 
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From a medical perspective there was also acknowledgement that the 
CNSs needed to be actively encouraged to contribute and this too aligned 
with the CNS view that they needed to routinely and systematically 
contribute to the discussion. This strategy appeared to be a primary 
enabler put forward by all interview participants. 
 
“I suppose as long as you involve them in the MDT and make sure 
they’re asked the questions regularly they will become more 
empowered and more confident and they’ll offer that, and after a 
course of time...then they will give their opinion regardless, they have 
to become more part and parcel of that MDT discussion so you go 
round the table and make sure they are people in that table.” Imran 
Team 3 
 
4.5.5 Research question 5:  
What changes to practice would enhance the clinical nurse specialist 
role at the multidisciplinary meeting and improve patient-centred 
decision-making? 
 
Within the semi-structured interviews all participants were asked to 
suggest any changes to practice that they felt could improve the 
contribution of the CNS within the MDT meeting. Analysis of the interviews 
revealed a range of proposals that could improve the CNS contribution 
and enable more patient-centred information to be part of the decision-
making process in the meeting.  
These proposals were summarised and for Phase 3 of the study all the 
CNSs from participating teams were invited to participate in a focus group 
at which these proposed changes to practice were presented, discussed 
and prioritised. 
Presented below are the findings from the semi-structured interviews in 





Semi structured interviews: proposed changes to practice 
Most interviewees (n =11) put forward a number of suggestions and 
proposals that they felt would enable the CNS to better contribute to the 
meeting discussion. These were thematically analysed and synthesized 
into four main categories as outlined in Table 4.22. 
 
Table 4.22: Proposed changes to practice to enable CNS contribution 
Category Change to practice 
Training CNS development programme 
Training on team dynamics 
Team training on presenting cases 
Role development Clarity and agreement of the role of the CNS in 
the meeting 
Systematising of the CNS opinion into the 
discussion 
Cultural issues Understanding medical cultures (oncologists and 
surgeons) 
Addressing hierarchical issues (professional 
status and gender issues) 
Team willingness to change 
Structural issues Person discussing the patient should know the 
patient 
One person running the meeting 
Core members on front row/appropriate seating 
to enhance team communication 
More preparation time prior to meeting 
 
 
Some of the CNSs proposed that on entry into the role they should be 
offered a development programme that allowed them to better understand 
the key roles and responsibilities of the CNS with appropriate training to 
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underpin some of these elements. This included training on how to deal 
with difficult team dynamics and also how to communicate confidently with 
team members. It was also felt that some training on how to present cases 
concisely would also be useful and enable contribution. 
 
“I think a proper development programme is completely missing 
from this Trust so that is about having time to go off and learn 
treatments, see how others work in their team because every team 
works so differently and we all do things differently and we’ve all 
developed our services depending on who we are and who our 
consultants are. I don’t think we really get enough time to step out 
of the box and think outside..” Alice Team 1 
 
Whilst many of the CNSs felt they had sufficient clarity in understanding 
their role they was a view that less was understood about their role in the 
MDM and that local and national work to delineate and agree the nature of 
their contribution would be a positive change to practice. What was 
evident was that both the CNSs and other core MDT members felt that the 
contribution of the CNS should be routine within the MDM and that they 
should be invited to contribute about a patient even if they had nothing to 
contribute. This systematising would, it was felt, make it common practice 
for them to input to the discussion rather than the impetus being on the 
CNS to initiate a contribution. 
 
“I suppose each patient we discuss that we always ask a nurse 
specialist, do you have any input towards this patient, and do it on 
a regular basis so every patient that comes with that agenda they 
get discussed and then at the end say right what do you think. 
That’s not unreasonable I don’t think.” Imran Team 3 
 
Some CNS participants wanted to have a better understanding of the 
issues between different medical specialisms, oncology and colorectal 
surgery. The manner in which oncologist and surgeons spoke to each 
other often gave rise to tension within the meeting. Some CNSs felt that 
by having an understanding of such issues this would facilitate better 
understanding in the team and perhaps improve communication.  
 
“I think that’s unfortunately or fortunately just the difference in the 
way people work and the surgeons go into surgery because they 
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like to do things, get it sorted and move on whereas the 
oncologists are used to dealing with people for years and years 
and years and trying things over and over again so it’s just a 
different way of, you know they’re bound to have different 
personalities I guess.” Belinda Team 1 
 
Some MDT members also recognised the particular dynamic between 
CNSs and surgeons, which was, at times, perceived as subservience and 
deference by other team members. Some felt it would be important to 
understand this better within the team and might help to distil and clarify 
the role of the CNS to surgical colleagues in the meeting rather than them 
holding onto traditional notions of CNSs as ‘handmaidens’. Reference to 
professional status and the hierarchy of professionals was frequently 
raised as an inhibiting factor but with the perception that these issues 
were  deep-rooted and not amendable to changes to practice. 
 
“And also I mean I think you have, most of the nurses are surgical 
nurses and I would say that some sort of traditional patterns are 
still very existent there….Yes and it’s also all the nurses are 
female, the vast majority of surgeons are male etc. so I think some 
of it is, you know, quite traditional stuff.” Nora Team 4 
 
Finally, there were some changes to practice that were of a structural 
nature. These included a range of issues from ensuring that the person 
presenting the patient had actually met the patient and so could ensure 
that the patient did have a ‘voice’ in the meeting; to ensuring that all core 
MDT members sat close to each other with good eye contact and not 
talking to the ‘back of someone’s head’.  
 
“I suppose more time really as I say to see patients and assess 
patients before the meeting and then you are more armed going to 
the meeting with information about that particular patient.” Nora 
Team 2 
“I mean it’s interesting we’re supposed to be a team and we never 
sit in a circle, nobody is ever sitting looking at their colleagues, 
everyone is sitting like at the cinema looking at either a 
mircroscope or image or head..” Peter Team 4 
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Summary of phase 1 and 2 
Looking back over Phases 1 and 2 of the mixed methods study a number 
of key themes emerged that appeared to account for the low participation 
and contribution of the CNS within the MDM. Phase 1 identified clearly 
that the contributions of the CNSs in the MDM were minimal and not 
patient-centred. Phase 2 raised issues related to a perception of low 
professional, which was accompanied, by issues of role conflict and 
ambiguity on the part of the CNSs. Some of these perceptions were also 
expressed by other MDT members as contributing to their low 
participation. Additionally, there was a real sense from MDT members and 
the CNSs in particular that the culture within the meeting was focussed 
around the ‘disease’ or ‘tumour’ and that there was little space for 
contributions that related to non-medical aspects of the patient. These 
findings form the basis of an explanatory model for the low participation 
and contribution of the CNSs to the MDMs and will be further discussed in 
Chapter 5. 
 
Table 4.23: Factors that potentially lead to low contribution 






Multiple roles No knowledge of the 
patient 
Intimidated by medical 
colleagues 
Taking notes Discussion medically 
driven 
Lack of confidence Uncertainly about 
role in meeting 
Insufficient time to 
prepare and review all 
aspects of care 
Subservience and 
deference toward medical 
colleagues 





The integration of the qualitative and quantitative data was illuminating 
and showed clearly that there was a difference between perception and 
practice. The use of the structured observational tool demonstrated little 
active participation from the CNSs within the meeting and the semi-
structured interviews appeared to contradict this finding. Interviewees 
were naturally more inclined to explore what they ‘should’ be doing and 
less able to articulate what they were not doing and why. What a mixed 
methods approach to data collection enabled me to do as a researcher 
was to explore this contradiction further. They knew I had seen them in 
the meetings and thus facilitated a degree of honest exploration with 
regard to the issue of contribution in the MDM. The interaction of the two 
data sets enabled a more informed exploration and understanding of the 
causative factors that underpinned their lack of contribution.  
 
4.6  Phase 3 focus group 
Changes to practice  
Phase 3 of the study consisted of a focus group to which all CNSs were 
invited (n=8). However, on the day only three (n=3) CNSs from two teams 
(one from Team1 and two from Team 4) participated.  
Participants were presented with the thematic findings to the research 
questions 2, 3, and 4. For each question the results were discussed and 
the group asked for their views and opinions on the themes. As the group 
was small this enabled a rich and in-depth discussion of the findings. (See 
Appendix 25 for the focus group presentation) 
The purpose of the focus group was primarily to present the changes to 
practice identified from the semi-structured interviews and for the CNSs to 
consider which they would prioritise in terms of its likelihood to effect 
change. There were thirteen proposals that had been identified and for 
each proposal there was a discussion of how it could enhance 
participation and contribution. From this initial list the CNSs were asked to 





Table 4.24: Top 5 prioritised proposals for changes to practice 
 Practice proposals 
1 Clarity of role in meeting 
2 Understanding medical culture 
3 Training in team dynamics 
4 Systematising of the CNS opinion 
5 Addressing hierarchical issues 
 
 
These were then further discussed with the CNSs and they were then 
asked to collectively agree and rank which they felt would be the most 
useful and feasible in improving the CNS contribution. Table 4.25 present 
the ranking of proposals. 
 
Table 4.25: Ranked practice proposals 
Ranked Practice proposals 
1 Clarity of role in meeting 
2 Systematising the CNS opinion  
3 Training in team dynamics 
4 Addressing hierarchical issues 





4.7  Summary  
This mixed method study set out to answer five research questions in 
relation to the CNS contribution to colorectal MDT meeting discussions. 
The study had three phases using structured observation and field notes, 
semi structured interviews and a focus group.  
Phase 1, structured observations and field notes from sixteen (n=16) 
MDMs showed that the CNSs contributed minimal patient-centred 
information to the meeting discussion. Team 1 was, however, different 
from the other three teams with results showing that the CNSs within this 
team contributed more patient-centred information due to their role in 
presenting cases. 
Phase 2, semi structured interviews of eighteen (n=18) core MDT member 
revealed a range of perceptions of the CNS role and contribution in the 
meeting. From the CNS perspective they recognised their multiple roles in 
the meeting but that their medical colleagues lacked understanding of 
their role in the meeting. Significantly, the CNSs acknowledged their 
inability to ‘speak up’ in the meeting and provided a number of 
explanations as to the underlying causes of their silence. Finally, the 
CNSs expressed a range of opinions in relation to their sense of feeling 
valued in the meeting. Some felt very highly valued but some intimated 
and undervalued by colleagues. 
The perceptions of other core MDT members (n=10) of the CNS role in 
the meeting revealed similar themes but with some variation. Other core 
MDT members, nine (n=9) of whom were doctors, also recognised the 
important advocacy role of the CNSs in the meeting but had little 
understanding of the other aspects of the role identified from the CNS 
interviews. Participants also acknowledged the ‘lack of voice’ exhibited by 
the CNSs within the meeting discussions and perceived this as passivity, 
combined with a view that the CNSs felt subservient to surgical colleagues 
resulting in a lack of confidence. From the semi-structured interviews 
other core MDT members were emphatic that they wanted the CNSs to 
contribute more in the meeting and that they highly valued their 
contribution both within and outside of the meetings. 
Finally, Phase 3 consisted of the focus group with three (n=3) CNSs. For 
this I presented the summarized data from the semi-structured interviews 
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relating to both enabling and inhibiting factors to CNS contribution within 
the meeting. These were discussed and validated by the CNSs. The 
CNSs were then asked to comment and rank proposed changes to 
practice identified from the semi structured interviews.  
This chapter has presented the results from the three phases of the study 
and used the data to address the key research questions. Chapter 5 will 
discuss the results and provide further exploration and possible 
explanations for the overall finding of low contribution and participation of 













Chapter Five: Discussion 
and implications of findings  
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5.1 Introduction  
The previous chapter presented the findings from this mixed methods 
study of CNS contribution in MDMs. This chapter will consider the study 
findings in the context of the wider evidence on the contribution of CNSs 
to MDT meetings and also highlight the study’s original contribution to the 
existing knowledge on the CNS role in the MDM. The findings are then 
interpreted in the context of relevant theoretical and empirical literature to 
provide an explanatory framework for the key findings. The strengths and 
limitations are then discussed together with implications for practice and 
future research. 
 
5.2  Summary of key findings  
In this study specialist colorectal cancer nurses contributed minimally to 
MDM discussions. The key barriers to their active participation included 
issues relating to low professional status, role conflict/ambiguity and a 
‘tumour centred’ culture in the MDM. Table 5.1 provide a summary of the 
key findings. 
 
5.3 Findings in relation to the literature review 
It is first important to explore and understand how these findings relate to 
the existing evidence on CNS contribution to MDT meetings. Do the study 
findings fit with the current evidence? Are there contradictions? How does 
this study extend and deepen the knowledge base on the nature and 
impact of CNS contribution to meeting discussions? 
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Table 5.1: Summary of key findings 
Lack of CNS contribution  Low professional status Role ambiguity Tumour centred culture 
- CNSs  provided no verbal 
contribution for 165/200 of the 
observed case discussions.  
- CNSs and other core MDT 
members recognised and 
acknowledged this lack of 
contribution on the part of the 
CNSs and both expressed a 
preference for the CNSs to 
contribute more actively and 
systematically. 
 
- A range of individual, team and 
organisational factors inhibited 
the contribution of the CNSs. 
These included feeling 
undermined by medical 
colleagues and that their opinion 
was not valued. 
- CNSs had mixed views as to 
whether they were valued by 
other MDT members but other 
core MDT members reported that 
they respected and valued the 
CNS contribution. 
 
- CNSs perceived they had multiple roles within 
the meeting and that this was not understood by 
core MDT members, in particular by the 
surgeons. 
- Both CNSs and other core MDT members 
recognised that the primary role of the CNS 
within the meeting was to advocate for the 
patient. There was no observational evidence to 
substantiate this. 
- Team 1 CNSs, who ‘presented’ cases and 
therefore had a more defined role in the MDM 
were more patient-centred in relation to “co-
ordination of care” and this appeared to be 
associated with them being more vocal in their 
contributions compared to CNSs in other teams. 
- The culture of the MDT 
meetings was focused 
on diagnosis and 
treatment decisions, 
predominantly based on 
the tumour 
characteristics resulting 
from investigative tests, 
with minimal patient-




The literature review for this study found a mix of both quantitative (four 
papers) and qualitative studies (ten papers). It revealed a number of key 
themes: 
x None of the studies directly addressed why the CNSs did not 
contribute 
x None exclusively focused on the role of the CNS within the MDT 
meeting 
x None exclusively focused on aspects of patient centredness and 
how this was enacted in practice 
x None explored the role and perceived role of the CNS from both 
the CNS and other team members’ perspectives. 
 
Nonetheless, the review of the evidence indicated CNSs rarely 
incorporated patient-centred information into the MDM and this important 
finding is substantiated within this study.  The observational data (Phase 
1) confirms that the verbal contribution of CNSs on patient related factors 
was minimal and that their interactions with other core MDT members 
were limited in the meeting. The semi-structured interviews (Phase 2) 
indicated a wide range of perspectives in relation to the role of the CNS in 
the meeting, demonstrating a problem with clarity of role. 
In terms of understanding the nature and content of the CNS contribution, 
this study corroborates the findings of earlier studies into MDT work. 
Whilst the quantitative studies within the literature review were concerned 
with constructing and testing the validity and reliability of observational 
tools to assess team performance across a range of professions (Lamb, 
Wong, Vincent, Green and Sevdalis, 2011d; Lamb, Sevdalis, Mostafid, 
Vincent and Green, 2011c; Taylor, Atkins, Richardson, Tarrant and 
Ramirez, 2012; Jalil, Akhter, Lamb, Taylor, Harris, Green and Sevdalis, 
2014), all reported that the CNSs contributed significantly less or the least 
when compared to surgeons and other medical colleagues. Furthermore 
they noted that the case presentations were largely driven by surgeons. 
Both of these findings were evident within my study. 
Most evident within the previous qualitative studies was the conclusion 
that CNS contribution was limited (Willard and Luker, 2007; Lanceley et 
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al., 2008; Kidger et al., 2009; Lamb et al., 2011b; and Rowlands and 
Callen, 2013). Some of these studies refer to the flexible boundaries of the 
CNS role in the meeting resulting in uncertainty within the team about the 
nature of the role (Willard and Luker, 2007) and also the perception from 
surgeons that CNSs contributed in a ‘silent way’ (Lanceley et al., 2008) 
meaning that they only spoke when they disagreed or when asked. 
In terms of the content of their interactions within the MDM previous work 
by Willard and Luker (2007) have referred to the idea of ‘service work’, 
that task focussed work rather than patient-centred work dominated. The 
observational work of my study also saw a tendency for the CNSs to 
provide content in the MDM relating to the transactional aspects of care 
rather than the relational. This indicated a range of issues but 
fundamentally they did not feel able or enabled to provide more patient 
centred content within the meeting. 
There is therefore consistency within and throughout my study and earlier 
studies in relation to the finding that CNSs have limited active involvement 
in the MDM discussion. What this study adds is an in-depth understanding 
of the content of their contribution, when it occurred, the type of interaction 
the CNSs had with MDT members within the meeting context and the 
barriers/facilitators from a range of perspectives. 
In terms of understanding the barriers to CNS participation, previous 
studies have indicated a number of key issues that resonate with these 
results. The thematic analysis of the ten qualitative studies within the 
literature review highlighted a number of themes. These included 1) 
dominance of the treatment agenda; 2) power dynamics within the team; 
3) role issues and 4) team issues. Within this study the findings showed 
that there were individual, team and organisational factors operating and 
these also related to issues of professional status, role ambiguity and a 
meeting culture that was centred on the ‘tumour’ rather than the ‘person’. 
There is therefore concordance with findings from this study and the ten 
studies reviewed as part of the initial literature review. However, compared 
to other studies exploring decision making or team work more generally, 
this study with its specific focus on the role of the CNS in the meeting has 
been able to substantiate and extend our understanding.  
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5.4 Original contribution to knowledge 
The review of the literature (Chapter 2) suggested that CNS participation 
within MDT meetings was minimal although there was no direct empirical 
evidence to specifically substantiate this observation. This study provides 
that evidence and verifies low participation and a lack of contribution 
within the meeting context. Using patient-centredness as a conceptual 
approach to define the core contribution of the CNS in MDT meetings this 
study provides an in depth understanding of which domains of patient-
centredness were considered, and which were not. Additionally, the use of 
an adapted form of the Bales IPA (Bales, 1950) demonstrated that the 
CNSs did not contribute to other aspects of patient discussions and were 
rarely given space within the meeting to provide their opinion or invited to 
give their opinion.  
This is the first study that has exclusively focused on the contribution of 
CNSs within the MDT meeting and therefore provides empirical insights 
into what has been a previously unexplored area of research. It is 
ultimately an important first step in our understanding of this aspect of 
practice and has several implications for practice. These will be discussed 
later in this chapter. 
 
5.5 Interpretation of findings 
The findings from this study indicate that a number of related factors 
explain the lack of CNS contribution to MDT meetings. These are 
presented diagrammatically in Figure 5.1. 
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Figure 5.1: Explanatory factors that lead to a lack of CNS 
contribution in MDT meetings 
 
These factors were identified from Phase 1 and 2 (see Table 4.23) and 
are key concepts underpinning the themes from these phases. Phase 1 
identified an evident lack of contribution and low participation and Phase 2 
identified a range of themes, which were grouped under the concepts of 
low professional status, role conflict and ambiguity and a 'tumour centred’ 
culture. These ideas form the basis for the explanatory model into the lack 
of contribution from the CNSs within the MDM. These concepts will now 
be reviewed with reference to both to the wider literature and the empirical 
findings from this study. 
 
5.5.1 Low professional status 
The extent to which professions share a similar status has implications for 
whether and how they work together and the implication for joint working 
may be more difficult where there are perceived status differentials 
between team members (Hudson, 2002). Furthermore, there is an 
argument that members of teams with higher status participate more 
actively in team decisions and are perceived to have a greater influence 
over decisions than those whose characteristics are considered lower 
status (Lichtenstein et al., 2004).  












Participation by the CNSs within team discussions was low and Status 
Characteristics theory, which includes the characteristic of professional 
status, offers important insights into explaining why this may have 
occurred. The central idea within Status Characteristic theory is that the 
same status characteristics that differentiate the power and prestige that 
individuals hold in broader social context (e.g. age, gender, ethnicity and 
profession) also differentiate status within task-orientated groups (Berger 
et al., 1972, Cohen and Zhou, 1991, Wagner and Berger, 1993). Groups 
therefore import societal valuations of different demographic categories, 
irrespective of the purpose of the group, as a basis for forming status 
hierarchies amongst members.  
Within health care the status hierarchy of different professions and 
disciplines is well defined (Freidson, 1970) with the medical profession 
holding the highest status. Some would argue that health care has 
changed significantly to alter this professional hierarchy  (Hoff, 2001), 
whilst others maintain a more pessimistic perspective that the concept of 
professional status remains sufficiently alive to undermine inter-
professional and team working with Jones Elwyn et al (1998) stating that: 
 
“ There are so many factors which mitigate against team working 
that the team is in danger of becoming an unmanageable area of 
professional conflicts struggling to provide an ever fragmented 
service” (Jones Elwyn et al., p191).  
 
Previous research (Bloom, 1980; Cott, 1997) has shown that status 
differences among members of teams negatively affect their functioning. 
The specific mechanisms that connect variations in status to poor team 
functioning remain unclear. However, Lichtenstein et al. (2004) 
hypothesize that it is the suppression of participation among low status 
team members that leads to poor team function. Nembhard and 
Edmondson (2006) argue that the belief that membership of a particular 
professional group bestows a level of status that creates a sense of 
superiority or inferiority is what consistently guides behaviour so as to 
maintain the hierarchy.  
Low status individuals therefore tend to experience low self-efficacy and 
underestimate their contribution (Berger et al., 1985), withhold information 
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(Argyris, 1995), and importantly, for this context, speak less (Pagliari and 
Grimshaw, 2002).  The persistence of an inadequate contribution to the 
work task continues because the social hierarchy allows the domination of 
high-status individuals and the continued self-censoring of low status 
individuals. The consequence of this self-censoring leads to a perception 
of risk to self, a fear of others’ disapproval and an inability to speak freely 
– or a risk to ones psychological safety (Nembhard and Edmondson, 
2006).  
Findings from the interview data within this study showed that CNSs had 
mixed views as to whether they were valued by medical colleagues and 
that they were very aware of the professional hierarchy that existed within 
their teams. They often reported that the ‘culture of medicine’ was a 
barrier to their participation and likely that what was really being referred 
to was their perceived risk of disapproval from their medical colleagues. 
Within the interviews CNSs also reported being called ‘just a nurse’ by 
medical colleagues and being ‘talked over’ when speaking. These 
behaviours served to reinforce their view of having a lower professional 
status and undermined the nursing contribution and the sense of 
professionalism they felt towards their patients. 
Research findings have indicated that high status members of teams 
generally tend to initiate communications more frequently and are given 
more opportunities to participate in team decisions than lower status 
members (Cott, 1997; Fried at al., 2000). As well as professional status 
other status characteristics such as being male, older and more educated 
have also been shown to impact on increased participation and influence 
(Bloom, 1980). Within this research the doctors, and in particular the 
surgeons dominated the discussion and with the exception of Team 1 all 
the other teams were chaired by a surgeon who was also the colorectal 
lead for the service.  
Whilst other studies have noted a lack of contribution by the CNS within 
the MDT meeting, no study has attempted to explore the nature of the 
contribution or confirm and understand their lack of participation. This 
study has confirmed, both through observations and the perspectives of 
MDT members, including the CNSs, that the professional role of the CNS 
in the meeting is relatively absent but that there is an expressed desire 
from all members to improve their contribution. Understanding these 
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issues has important consequences for practice as explanations of the 
underlying reasons for their lack of participation can better inform changes 
to practice.  
This study provides empirical evidence that CNSs do not actively 
participate within MDT meetings. Working on the proposition that higher 
status clinicians are more likely than individuals with low status to actively 
participate in team discussions and that relationships are defined in 
broader social contexts (in particular professional status), it is asserted 
that these factors are sufficiently salient to affect the purpose of the 
multidisciplinary team meeting, which, as discussed in Chapter one, is to 
harness the diversity of ideas from a range of disciplinary groups to secure 
better decision making and ultimately improved outcomes and patient 
experience (Flessig et al., 2006; Lamb et al., 2011a; Prades et al., 2014). 
A key consideration is to explore whether there are strategies that can 
mitigate the impact of professional status on participation. Kennedy (2006) 
emphasizes that professionals must be encouraged to redefine their 
professionalism in order to change power differentials and that the 
leadership currently vested in the medical profession must alter if joint 
interprofessional working is to become a reality. This equalizing of power 
did appear to be emerging in Team 1, albeit in some small but impactful 
way. Whilst all the teams within this research were ‘chaired’ by doctors 
there was a difference in terms of the patient-centred contributions within 
Team 1. This appeared to be related to the fact that the CNSs were given 
the formal role by the ‘chair’ of presenting all the cases at the start of the 
meeting and therefore they had a formalized position within the meeting 
discussion. This formalisation did appear to alter the power differential and 
enabled the CNSs to participate more actively and have a consistent 
‘voice’ within the meeting discussion. Whilst the focus of their contribution 
was limited to aspects of ‘co-ordination’ of the patients’ pathway and not 
all aspects of patient-centred care it did enable them to have a 
professional role within the discussion and this was accepted and 
embraced by the chair of the meeting and the rest of the team. 
There are complex processes at work in multidisciplinary collaboration and 
teamwork. Redefining professionalism and establishing a culture of 
equality between professionals calls for a rethinking of multidisciplinary 
team working that recognises that the professional knowledge that the 
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nurse can bring is of equal importance to the ‘tumour’ related knowledge 
that others bring.  Addressing low participation involves reviewing a range 
of complex and embedded processes involved in team working. However, 
in the context of cancer MDMs it appears to be fundamentally reflective of 
a culture that views the MDM discussion as a forum for ‘objective’ 
biomedical, pathological and radiological findings to be discussed and 
where ‘subjective’ information about patients is not viewed as a core part 
of the decision-making process. Defining the professional role of the CNS 
within the meeting will inevitably be difficult until there is an accepted view 
that the MDM discussion must explicitly incorporate the patient-centred 
knowledge that the CNS brings and that this has an impact on decision-
making. In particular their contributions have an impact on decision 
implementation where it is known that non-consideration of patient related 
factors can cause significant delay to the patients’ treatment as decisions 
have to be reconsidered (Blazeby et al., 2009; Stalfors et al., 2007; Wood 
et al., 2008). 
 
5.5.2 Role conflict and role ambiguity  
Role conflict and role ambiguity have a strong influence on performance. 
Role conflict occurs when the individual is required to play a role which 
conflicts with their value system or multiple roles, which conflict with each 
other (Van Sell et al., 1981). It differs from role ambiguity, which occurs 
when the roles expected of the individual are not clearly articulated in 
terms of behaviours or expected performance (Kahn, Wolfe, Quinn, Snoek 
and Rosenthal, 1964) or when role incumbents lack adequate role 
relevant information (Lyons, 1971). 
Interviews with the CNSs revealed that there was an internal sense of 
discomfort in terms of the role they should be performing within the 
meeting versus that which they undertook. Whilst they believed that 
patient-centred issues were important to the discussion and that it was 
their primary role to be the patient’s advocate within the meeting they did 
not feel that the culture of the meeting allowed them opportunities to 
engage in a dialogue about the holistic concerns of their patients. Their 
values, as a nurse, were rooted in seeking to input the holistic concerns 
and representing the patient’s perspectives but in reality they expressed a 
view that they did not believe that this was critical to the outcome of the 
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decision or valued by some team members. At times this advocacy role 
was also compromised by the fact the CNSs would not have had the 
opportunity to meet all patients prior to the meeting due to the pressures 
of maintaining the national cancer waiting times targets and having too 
many patients to see within a specified time. This also served to conflict 
with their value of advocating for the patients. The consequence of this 
appeared to result in a level of role conflict with CNSs focusing on roles 
that enabled the smooth running of the meeting and the co-ordination of 
the patient’s pathway. Whilst important roles they were not reflective of the 
advocacy function the CNSs felt they should fulfil.  
An issue that resonated with many of the CNSs was the view that the 
surgeons in the team saw the CNS role as flexible and could alter and 
respond to gaps in the team. This was particularly the case for one team 
where the junior medical staff had been withdrawn and the CNS was left 
to undertake those roles normally carried out by the junior medical team in 
the meeting. This perceived flexibility of the CNS role caused significant 
tensions and typified the issue of role conflict experienced by the CNSs. 
Being required to undertake some of the roles undertaken by junior 
medical staff undervalued their role as a nurse, conflicted with their values 
of being a nurse and they were also conflicted by their inability to refuse to 
undertake these additional roles. 
Role ambiguity has been identified as a potential source working against 
team collaboration (Jenkins et al., 2001). To achieve collaboration each 
professional group must acknowledge that each discipline has an 
important contribution to make in the process of decision-making and 
providing care. Yeager (2005) maintains that multidisciplinary 
collaboration requires a commitment from team members to work together 
across traditional boundaries and involves mutual valuing, recognition of 
separate and combined areas of responsibility, mutual safeguarding of 
each disciplines interest, and a focus on shared goals (Yeager, 2005). 
Lack of awareness of the roles of other team members is likely, therefore, 
to lead to uncertainty and breakdowns in communication.  
Unlike the diverse and multiple specialisms of medicine that tended to 
have clear and unambiguous contributions to bring to the discussion with 
regard to diagnosis and clinical treatment the role of the CNS within the 
context of the MDT meeting remains ill-defined. Whilst the language of 
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‘supportive care’, ‘holistic care’ and ‘patient-centred care’ has framed their 
role as members of the MDT there has been insufficient definition to 
determine the nature of this within the context of the MDT meetings.   
Within this study it was evident from observations and interviews that 
there were multiple perspectives on the role of the CNS within meeting 
discussions and thus role ambiguity emerged as a key feature impacting 
on the participation of the CNSs. The specialist nurses tended to have an 
all-encompassing perspective of their role in the meeting, from advocate, 
navigator, and coordinator of the pathway and key translator of information 
from the patient to the team. However, in practice they had few openings 
to deliver this information and enact these roles in the MDM and this led to 
ambiguity and uncertainty as to the actual role they fulfilled within the 
meeting context.  
The CNSs and other team members agreed that the role of the CNS was 
to primarily advocate for the patient but the reality was that there was little 
overt seeking of the CNS opinion on such issues. CNSs had a very long 
list of roles they felt they should fulfil and surgeons and oncologists also 
had differing emphases in terms of the CNS role. These varying views 
appeared to lead to some confusion and consequent uncertainty within the 
members of the team as to the precise contribution CNSs should make. 
Across the four teams the CNSs perceived that oncologists had a more 
holistic approach to patients and recognised the psychological aspects of 
care provided by the CNSs whereas they perceived the surgeons as less 
psychologically oriented and hence appreciated more the logistical 
support provided by the CNSs.  
The consequence of this ambiguity between and within team members 
contributed to a marginalizing of the role of the CNS in the meeting. None 
of the key players (CNS, oncologist and surgeon) had a common or 
shared understanding of the core contribution the CNS could and should 
make to the decision-making process. Whilst the CNSs had 
preconceptions of their potential contribution in terms of their list of roles, 
this was not always shared or understood by their medical colleagues. 
The consequence of these multiple and diverse perspectives from 
different members of the team led to uncertainty and a lack of 
understanding of the purpose of the CNS role in the meeting.  
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5.5.3 Tumour centred culture 
As has been discussed in Chapter 1 the evolution of cancer MDTs grew 
out of a concern for responding to the increasing complexities of treatment 
and the necessity of a multidisciplinary approach for optimising outcome in 
patients with cancer (Van Laethem et al., 2001; Blumberg and 
Ramanathan, 2002).  
In relation to cancer services Prades et al 2015 argue that;  
 
“As health systems increasingly pursue patient-centred approaches to 
treat people rather than diseases new dimensions of care have 
emerged that are critical, including psychosocial aspects of care, 
quality of life, comorbidities and survivorship”.  (Prades et al., 2015 
p472) 
 
Additionally, the most recent policy statement on multidisciplinary care by 
the European Partnership Action Against Cancer (EPAAC, 2014) 
acknowledges the importance of a patient-centred approach within MDT 
care stating that, 
 
“Cancer care is undergoing an important paradigm shift from a 
disease-focused management to a patient-centred approach in which 
increasingly more attention is paid to psychosocial aspects, quality of 
life, patients’ rights and empowerment, co-morbidities and 
survivorship” (EPAAC, 2014 p 479) 
 
There is, therefore, a growing global recognition and acceptance of the 
need to embrace patient-centred approaches to the delivery of health care 
(Kitson et al., 2012). However, unpacking the conceptual components of 
patient-centred care and providing definitions is still evolving. The 
terminology in relation to patient-centred care has altered even within the 
life span of this study moving from terms such as such as ‘whole person 
care’, ‘patient centric’, ‘individualised care’, ‘family-centred care’ and now 
the commonly used ‘person-centred care’. 
At the onset of this study operational definitions of patient-centred care 
were still emerging and in the context of cancer care there were no 
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instruments designed to assess the observable indicators of patient-
centred care within the cancer MDT meeting setting. There were, 
however, two frameworks, the Institute of Medicine (Institute of Medicine, 
2001) and Picker frameworks that were both viewed as useful in defining 
the domains of patient-centred care (Robert et al., 2011). Both had their 
origins in the same research by Gerteis et al. (1993) and so were 
comparable. The IOM framework had six dimensions and although not 
conceived as an instrument to assess patient-centredness, the 
dimensions could be adapted easily for observational assessment as they 
were non-ambigious aspects of care that were either mentioned or not. 
Whilst there were challenges in defining and assessing the patient-
centredness of the CNS contribution the evidence from both the 
quantitative and qualitative data showed that the CNSs did not exhibit a 
patient-centred approach, as defined by the IOM categories, during the 
MDMs. CNSs also reported within the interviews a perception that they 
had little remit in this decision-making process and felt that decisions 
about treatment were not perceived by members of the MDT as involving 
nurses. 
Field notes taken throughout the observation period and across all four 
teams also showed that there was little discourse within the meeting about 
aspects other than diagnosis and clinical treatment options. At times 
decisions about treatment and management would be made on objective 
radiological and histopathological information only as no clinician had met 
the patient prior to MDT review. In sum, the meeting remained medically 
dominated with a predominant focus on the disease and tumour and little 
consideration of the ‘psychosocial aspects, quality of life, patients’ rights 
and empowerment, co-morbidities and survivorship’ issues as outlined 
within the European Partnership Action Against Cancer (EPAAC, 2014) 
consensus policy statement on multidisciplinary cancer care. 
Data from field notes and interviews indicated that there was an absence 
of a patient-centred discourse within the meeting with MDT members 
reporting that they recognised this as an issue but also expressed that 
they were uncertain, indifferent and, at times, reluctant to acknowledge the 
relevance this information had to the primary purpose of deciding 
treatment. This indifference and reluctance to consistently incorporate 
patient preferences and other patient related information into the decision-
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making process has more recently been identified as a key issue by 
others (Taylor et al., 2014; Hahlweg et al., 2015; Eigenmann, 2015) 
concluding that there is either an inconsistent approach to the inclusion of 
patient-centred issues or an absence of the patient perspectives with MDT 
meetings and that teams often base their decision-making on medical 
information only.  
Field note observations within the study revealed a range of issues that 
appeared to mitigate against enabling a more patient-centred approach to 
decision making. The structure and pattern of the discussion was similar 
across all four teams with medical information being exchanged between 
radiologists, histopathologists, surgeons and oncologists. With the 
exception of Team 1 where the CNSs presented each case, the 
responsible consultant or medical trainee presented most patients. At 
times, no one present at the MDM had met the patient prior to the MDT 
discussion and initial decisions were made on the basis of the available 
medical information. In such cases there was a recognition that the 
decision may have to be altered once the patient had been properly 
reviewed.  
Despite national guidance on some of the key elements that characterise 
effective MDTs in cancer (National Cancer Action Team, 2010) there were 
basic features still in place across the four teams that mitigated against 
good communication across all disciplines. The layout of the room did not 
facilitate good team discussion. Three out of four teams had a lecture style 
room layout where on the front row would be sat the consultants and on 
the side or at the back of the room would be the CNSs. Effective eye 
contact with team members was limited as members would often have to 
talk to the back of a colleagues’ head or a screen and thus the ability to 
engage in an interactive discussion often appeared limited. The MDT 
rooms were often darkened to enable better viewing of the imaging and 
pathology data and once again this minimised the opportunity for team 
interaction.  
Team members appeared rushed and at times distracted. There was a 
sense of ‘time pressure’ and urgency and although only one meeting out 
of the sixteen observations in Phase 1 ran over its allotted time (most 
completed earlier) there was always a constant reminder from the chair or 
other team members to reach a decision and move onto the next case. All 
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these factors conspired to create a very time pressured environment in 
which the CNSs reported feeling unable to contribute information that they 
often felt was perceived by the team, in particular the medical staff, as 
being secondary or not critical to the treatment and management 
decisions.  
In essence, across all teams, there was a ‘tumour centred’ approach to 
care, which was dominated by a medical discourse, and a team culture 
that did not enable a ‘patient-centred’ approach to care within the context 
of the decision-making process within the meeting. 
 
5.6 Strengths 
A major strength of this study related to the use of a sequential mixed 
method design (Creswell and Clark, 2007). The findings from the 
observational assessment of the MDMs indicated low participation of the 
CNSs within the meeting. The CNSs’ perceptions of their own role within 
the MDT meeting was explored in subsequent qualitative interviews and 
although there was some acknowledgement they could improve their 
meeting contribution they did not realise the extent of their low 
participation. However what the interviews did reveal, through use of 
framework analysis, were the reasons why they did not contribute, and 
also other team members’ views and perceptions of CNS contribution in 
meetings. Without a mixed methods approach the stark reality of their 
poor participation would not have been so evident and the reasons for 
their lack of contribution may have been falsely assumed. This highlights 
the inadequacy of using a single approach when researching phenomena 
related to complex processes of clinical practice.  
Throughout all phases of the study due attention was paid to ensuring that 
all methods were conducted with rigour. This was important to ensure and 
enhance the trustworthiness of the data and reduce any potential bias. 
Whilst there were potential limitations to using a bespoke approach to 
assessing patient-centredness (see below), in practice its strength was 
that the assessment criteria was based on a well-known and respected 
framework for conceptualizing patient-centredness (IOM, 2001). As 
previously noted very little research on cancer MDTs has been conducted 
to rigorously assess the patient-centred approach of MDTs and with 
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further development, this offers a useful approach to assessing how 
patient-centred MDT discussion are in practice.  
There has often been reported a lack of transparency in the reporting of 
mixed methods studies within health care research (O’Cathain et al., 
2008) and this is important to the quality assessment of any study. To 
assist in overcoming such criticism I used the guidelines for Good 
Reporting of a Mixed Methods Study (GRAMMS) developed by O’Cathain 
and colleagues (2008) as a checklist to ensure that I made explicit all the 
key elements required for quality assessment of a mixed methods study 
(Appendix 26). 
 
5.7 Limitations of the study  
The sample of MDTs was all taken from one geographical region and 
whilst the teams were selected randomly they were selected from a small 
population of thirteen MDTs from the same area and may not have been 
representative of colorectal MDTs nationally. However, whilst the sample 
of MDTs was small it did cover a relatively diverse population and findings 
did resonate with the wider literature across other regions, countries and 
tumour types. 
As the focus of the study was on the CNS within the MDM patient-
centredness was not measured more generally. I did not observe what 
happened outside of the meetings and so can only limit my findings to the 
MDM context.  
A limitation within the study related to the observational tool used within 
the quantitative phase to assess and measure the patient-centred 
contributions of the CNSs. Given that the quantitative instrument used to 
measure patient-centredness was developed specifically for the study, 
and the resources available for the study were restrained by its doctoral 
nature, its validity and reliability has yet to be determined. Whilst there 
were survey instruments available to measure certain components of 
patient-centred care, observational measures were less developed and 
tended to be ‘one off’ instruments used in research studies aimed at 
measuring professionals’ clinical interactions with patients. There were no 
measurement tools available to assess patient-centredness in team 
decision-making. There was consequently no ‘silver bullet’ or best 
 191 
measure that covered all aspects and this in part reflected the lack of a 
common definition of patient-centredness (Health Foundation 2014). This 
measure if further validated could contribute significantly to taking 
research forward in this field.  
A modified version of the Bales Interaction Process Analysis tool (IPA) 
was used to measure the interactions of the CNSs within the meeting. 
This was potentially a limitation, as the measure was not validated to be 
used in this way. Traditionally the tool is used to measure group 
behaviour. For the purposes of this study only the interactions with and by 
the CNSs were the focus and the tool was therefore modified for 
simplicity. The application of this measure across the whole team would 
have required videotaping the meetings as the numbers in attendance 
ranged from 16-37 persons. This was not feasible within the study and so 
a pragmatic approach was taken to modify and apply the tool to the CNS 
interactions as it provided a systematic and consistent method of 
capturing their verbal and non-verbal interactions.  
It was hoped that the focus group conducted in Phase 3 would include all 
the CNSs who participated in the interview phase. Despite several 
invitations and two attempts to bring this group together only three of the 
CNSs were able to attend the focus group. This was a limitation as it 
narrowed the discussion with regard to exploring the potential strategies to 
improving the CNS contribution, as there was not a wide breadth of 
perspectives from differing CNSs.  Further work should be undertaken to 
disseminate and discuss the focus group findings to gain wider consensus 
on the priorities for action. 
From a personal perspective I had had considerable experience as a 
cancer nurse working with specialist nurses over a career span of thirty 
years. Having worked as a cancer CNS in the past and been involved in 
the development of the CNS role from a number of professional nursing 
roles it was likely that my own preconceived ideas and assumptions 
impacted on the study. To manage the tension between being a 
researcher and nurse I put a number of strategies in place to allow for a 
reflexive approach to the research process. These included keeping and 
reflecting on fieldwork notes, explicitly considering this issue when 
collecting and analysing data and maintaining a personal research diary. 
Additionally, a major role of supervision was to ensure that data were 
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collected and analysed without undue influence from my personal views 
and this was helped by the fact that two of my supervisors were not 
cancer nurses.  
Coming to the research as an ‘insider’ undoubtedly had its challenges but 
was also advantageous. I was able to identify this as an important issue to 
be researched and therefore bring to the fore a problem that potentially 
impacted on patient outcomes and experience whilst providing rich 
insights into the underlying issues relating to the professional role of the 
CNS within the MDM. Additionally, my interpretation of the data and 
suggestions for future recommendations are grounded in the reality of 
cancer care and this will have been due to my knowledge and expertise of 
the field. 
 
5.8 Recommendations  
5.8.1 Implications for clinical practice 
It is evident from the literature that bringing patient-centred issues to the 
MDT discussion has an important impact on the treatment and 
management decisions for patients with cancer. This study has 
demonstrated that the perceptions and views of both the CNSs and other 
MDT members are that the CNS is the professional who should bring 
those issues and concerns to the discussion and be the primary advocate 
for the patient. The principal finding from this research was that this did 
not occur in practice and that there were a number of barriers to CNSs 
inputting patient-centred information to the decision-making process. 
These centred on issues of low professional status, role conflict and 
ambiguity and a meeting culture that was ‘tumour’ centred. 
This section on implications for practice starts with exploring 
recommendations that could impact on the ‘culture’ of the MDT meeting, 
as this seems fundamental to ensuring a more patient-centred approach 
to decision making in MDMs.  
In recognition of the call from the European Partnership Action Against 
Cancer (EPAAC) for a paradigmatic shift in cancer from disease-focused 
management to a patient-centred approach there is an argument that the 
current guidelines on MDT working and the MDM decision-making 
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process should be nationally reviewed and aligned to the EPPAC policy 
statement.  
A specific recommendation of this research would be to consider the 
design and development of a national MDT training program which factors 
in not only the desired behaviours of team leaders to maximize 
contribution but also offers an opportunity to reaffirm the purpose of the 
MDT in the context of the current policy agenda on patient and person-
centred care. It has now been ten years since the development of any 
national training program for MDTs and during this period cancer care has 
become more pressurised with increasingly more complex pathways. The 
landscape of cancer MDTs and MDMs has probably changed significantly 
and so would be opportune to develop a new programme that 
acknowledges these changes. 
As the prevalence of cancer increases due to an ageing population, 
cancer MDTs will have increasing numbers of patients to review and if 
teams are to be enabled to incorporate information beyond that which is 
medical there has to be guidance and agreement at a national level as to 
how and when issues beyond diagnosis and treatment are factored into 
the MDM discussion. There also needs to be acknowledgement of the 
significant impact that the national targets on ‘waiting times’ have on 
teams and that the pressure to ensure that patients are diagnosed and 
treated quickly may be another obstacle to creating a more patient-centred 
approach within the MDM. 
The issue of professional status had a significant impact on the low 
participation of the CNSs. As has been discussed the extent to which 
professionals share a similar status has implications for whether and how 
they work together. With the medical profession as the most established 
and dominant of the healthcare professions nursing faces significant 
challenges in establishing an equal status within the context of team 
working. Whilst there are no simple recommendations to address this 
complex phenomenon the behaviours of team leaders have been shown 
to impact on the internal dynamics of a team and team members are 
known to be highly attuned to the behaviours of leaders (Yukl, 1994; Lind 
and Tyler, 1992).  
The construct of ‘leader inclusiveness’, defined as words and deeds by a 
leader that indicate ‘invitation’ and appreciation’ for others’ contributions 
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as a mechanism for moderating the relationship between status and 
psychological safety in health care teams is a potential approach to 
overcoming the issues associated with the professional hierarchy with 
health care teams (Nembhard and Edmondson, 2006). Applying this 
approach to the training of MDT chairs and clinical leads to understand the 
leaders’ role in fostering inclusivity and the impact this has on the 
contribution of other team members would be beneficial not only to 
improving team working but would also help to improve MDTs to make 
better decisions.  
Role conflict and role ambiguity within the meeting was a dominant theme 
with the CNSs perceiving that they had multiple roles which they felt 
unable to fulfil; and the oncologists and surgeons had different views on 
the core role of the CNS within the meeting. National guidance does exist 
that outlines the key roles of MDT members for colorectal teams 
(Improving Outcomes Guidance for Colorectal Cancer, 2004a). However, 
the guidance is vague and non-specific in relation to the contribution of 
CNSs. Consideration should be given to the production of national 
guidance and guidelines in relation to the specific role and professional 
requirements of the CNS within the MDT meeting context. This would 
enable a shared understanding across the specialist cancer nursing 
community about their core role and contribution within the meeting and 
also a shared understanding amongst MDT members.  
Developing clarity with regard to the role of the CNS within the meeting 
was also a clear recommendation from the Phase 3 focus groups and 
these proposed changes to practice could inform the production of 
national guidance. 
 
5.8.2 Implications for further research 
This is the first study that has attempted to define the components of 
patient-centeredness within the role of the cancer CNS and explored 
perceptions of role and contribution. This has only been done in colorectal 
cancer teams and replicating this study with other cancer MDMs, caring 
for different cancer types, would help to understand if the findings are 
generalizable and the issues common within the cancer CNS community.  
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This study was also conducted within a predominantly urban population 
and replicating the study with MDMs within a rural setting would help to 
understand if the findings are setting specific. 
The IOM component of the structured observational tool was a useful tool 
for exploring the complex concept of patient-centred care. Further 
research to validate this as a tool should be undertaken.  
Further work should be undertaken to develop and test a structured 
approach to MDM discussion to systematise the CNS opinion.  
 
5.9 Summary 
This chapter has presented the findings of the study and attempted to 
interpret these in the context of the literature review and wider literature. 
An explanatory model has been hypothesised to explain the reasons for a 
lack of CNS contribution in the MDM and this has been drawn from the 
findings of the study. The strengths and limitations of the study have been 
outlined together with some recommendation for practice and future 
research. The final chapter of this thesis will provide some final reflections 




















As it has unfolded this thesis has encompassed a wide range of issues 
and concepts each of which would merit a study of their own: the nature of 
multidisciplinary teams and team working; professional identity; barriers 
and enablers of knowledge mobilisation within organisations; the rhetoric 
and reality of the supposed shift from focusing on a disease to a person; 
and many more. 
Fundamentally, however, I believe this research has identified some very 
real issues with the functioning and effectiveness of cancer MDTs in the 
contemporary NHS, in terms not only of team working but also wider 
contextual factors such as an ever increasing workload, static resources 
and the requirement to meet national guidance on MDM working and 
waiting times targets. The combination of these was to make MDMs 
excessively rushed and pressurised and not a forum within which the 
notion of ‘patient-centredness’ could be easily enacted.  
Critically rethinking the current model and functioning of the MDM is a 
major issue for the future. This has been recognised and acknowledged in 
the recently published Independent Cancer Taskforce (2015) ‘Achieving 
world-class cancer outcomes: A strategy for England 2015-2020’, which 
calls for MDTs to streamline MDM discussions and to prioritise more 
complex cases against those which are more straightforward. The 
rationale being that decisions about ‘complex’ cases in terms of disease 
requires information on a range of factors and not that, which is solely 
biomedical. This will entail a major shift in practice but does offer the 
potential for nurses to play a greater part in meetings and for team 
discussions to move beyond purely presenting biomedical information to 
consider all aspects of patient-centred care. To realise this opportunity, 
nurses will need strong leadership, training to build confidence, clarity of 
role and the facility to both speak freely and have their contribution heard. 
Strategies that have been identified within my study. 
The findings from my study show that the traditional model of medical 
dominance persisted with limited communication between CNSs and other 
members during the MDM. CNSs did not actively participate and had 
limited involvement in the development of patient management plans 
within the MDM. This diminished their impact on multidisciplinary decision-
making and impacted on the effectiveness of the MDT model. 
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My findings contrast with ideas on effective team working where the roles 
of all health care professionals are known and respected. They also raise 
the important issue that strategies are needed to ensure that 
multidisciplinary working avoids falling into professional silos and 
traditional hierarchies.  
However, in keeping with the national strategy, I hope this research will 
help to focus attention on some important issues in cancer care and 
provide a new narrative and fresh thinking with regard to reframing the 
professional role of the cancer CNS within the MDM, particularly with 
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Appendix 1: Search strategies 
Concepts and key words 




























Psych Info 2000 – March 2014 week 3 (search date 25/03/2014) 
1. exp Neoplasms/ 
2. exp Teams/or exp Work Teams/ exp Interdisciplinary Treatment 
approach/or exp Decision making  
3. 1 and 2 
4. exp nurses /or exp oncology/ 
5. 3 and 4 
6. “cancer.” mp 
7. “multidisciplinary team.” mp 
8. 6 and 7 
9. “cancer nurse.” mp 
10. “clinical nurse specialist.” mp 
11. “colorectal nurse.” mp 
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12. 9 or 10 or 11 
13.  8 or 12 
14. 5 or 13 
 
CINAHL (EBSCO Host) 2000 – 2014 (search date 25/03/2014) 
S13. S7 or S12 
S12. S10 AND S11 
S11. “nurses” 
S10. S8 AND S9 
S9. “multidisciplinary team*” 
S8.  Cancer 
S7. S3 AND S6 
S6. S4 or S5 
S5. (MH “oncologic nursing*”) 
S4. (MH “clinical nurse specialists”) 
S3. S1 AND S2 
S2. (MH “Multidisciplinary Care Teams*”) or (MH “Multidisciplinary Care 
Conference (IOWA NIC)”) 
S1. (MH “Neoplasms*”) 
 
British Nursing Index 2000 to 28 March 2014  (searched on 
28/03/2014) 
S1. Su. exact (‘cancer”) 
S2. Su. exact (‘multidisciplinary teams”) 
S3. Su. exact (“cancer”) AND su exact (“multidisciplinary teams”) 
S4. Su. exact (“nurse specialist”) 
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S5. Su. exact (“multidisciplinary teams) AND su exact (“nurse specialist) 
S6.  (su. Exact (“cancer”) AND (“multidisciplinary teams”)) OR (su. exact 
(“multidisciplinary teams”) AND su.exact (“nurse specialist”) 
S7. Cancer 
S8. Oncology 
S9. Multidisciplinary team 
S10. Clinical nurse specialist 
S11. Cancer clinical nurse specialist 
S12. Colorectal nurse specialist 
S13. Cancer OR oncology 
S14. (multidisciplinary team) AND (cancer OR oncology) 
S15. (clinical nurse specialist OR (cancer clinical nurse specialist) 
S16. ((multidisciplinary team) AND (cancer OR oncology)) AND (( clinical 
nurse specialist) OR (cancer clinical nurse specialist)  
S17. ((su. exact (“multidisciplinary teams”)) OR ((su.exact 
(‘multidisciplinary teams”)AND su. exact (“nurse specialist”)) OR 
((multidisciplinary team ) AND (cancer OR oncology)) AND ((clinical nurse 
specialist) OR (cancer clinical nurse specialist)) 
S18. (colorectal nurse specialist OR S17) 
 
EMBASE 2000-2014 week 12 (Search date 22/04/2014) 
1. exp neoplasm/ 
2. exp teamwork/ 
3. exp clinical nurse specialist 
4. 1 or 2 
5. 3 and 4 
6. cancer or oncology 
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7. multidisciplinary team 
8. clinical nurse specialist 
9. colorectal nurse specialist 
10. 6 or 7 
11. 8 or 9 
12. 4 or 10 
13. 3 or 11 
14. 12 and 13 
 
Medline (Ovid sp) 2000 to March 2014 week 2 (search date 
22/04/2014) 
1. exp neoplasms/ 
2. limit 1 to English language 
3. adult/or Patient Care Team/ or Medical oncology/ or Decision Making 
4. exp Nurse Clinicians/ 
5. 1 or 3 
6. 4 or 5 
7. “cancer.” mp 
8. “oncology.” mp 
9. 7 or 8 
10. “multidisciplinary team.” mp 
11.  “clinical nurse specialist.” mp 
12.  “colorectal nurse specialist.” mp 
13.  “cancer nurse specialist. mp 
14.  9 or 10 
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15.  11 or 12 or 13 
16.  5 or 14 
17. 4 or 15 







Appendix 2: Data eligibility form 
 
Eligibility Form: Clinical Nurse Specialist MDM study  
Author (s)  
 















A (first sift) Is the paper relevant to the research question and 
worthy of further consideration? 
1 Relevance Is the paper about the contribution of the 
clinical nurse specialist to cancer MDT 
meetings? 
(a) If Yes, is it: 
- In the UK 
- Other health care system (state) 
(b) If No, reason (s) for exclusion 
- Not an empirical study 
- Not in the English language 
YES       
NO 
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2 Worth Does the paper go beyond superficial 
description or commentary – i.e. is it a 
broadly competent attempt at research 
enquiry, investigation or study? (If a 
confident ‘no’ to ether of these, reject) 
 





Does the paper explore: 
x How clinical nurse specialists contribute 
to the clinical decision making process in 
cancer multidisciplinary meetings? 
x The barriers and facilitators to clinical 
nurse specialists contributing to decision 
discussions on the context of cancer 
MDT meetings? 
x  The consequences/impact of clinical 
nurse specialists contributing to decision 
discussions in the context of cancer 
MDT meetings? 
x In relation to the 3 sub questions above 
does the paper relate specifically to 
colorectal cancer MDT meetings? 
 
Y          N 
 
 




Y          N 
 
 
Y          N 
Include   







Appendix 3:  Data extraction form  
Data Extraction Form: Clinical Nurse Specialist MDM study 
B Data Extraction Form 
STUDY DESIGN  
Aim (s) of study  




Sampling procedure  
Participants  
Number of eligible participants  
 
Number of participants recruited  
Number of surveys and/or participants 
included in the analysis 
 
Sample characteristics  
Other relevant demographic details (inc 
data from tables/figures) 
 
 
Data collection methods  
Analysis methods  




Measurement scales/units used: 
Were they: investigator designed/tools 
already established 
 
Timing of outcomes measured. When 
were measures taken?  
 
 
Key conclusions as reported by 
authors: 
 




Appendix 4: Quantitative Studies Critical Appraisal Form 
C Critical appraisal form – Quantitative Studies 
© Law M, Stewart D, Pollock N, Letts L, 
Bosch J, and Westmorland M, 1998 
McMaster University 
Study purpose: 




Outline the purpose of the study. How does the 












Single case design 




Describe the study design. Was the design 
appropriate for the study question? (eg., for 
knowledge level about the issue, outcomes, 
ethical issues etc) 
 
 
Specify any biases that may have been 






Was the sample 
described in detail: 
Sampling (who; characteristics; how many; 
how was sampling done?) If more than one 





















Specify the frequency of outcome 
measurement (ie pre, post, follow-up) 
 




































Results were reported in 






What were the results? Were they statistically 
significant (ie p<0.05)? If not statistically 
significant, was the study big enough to show 
an important difference if it should occur? 











What was the clinical importance of the 
results? Were differences between groups 
clinically meaningful? 
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Dropouts were reported? 
Y 
N 
Did any participants drop out from the study? 
(Were reasons given and were drop outs 
handled appropriately) 




appropriate given study 
methods and results 
Y 
N 
What did the study conclude? What are the 













Appendix 5: Critical Appraisal Skills Programme: Qualitative 

















Appendix 6: Excluded Studies 
Author/year Title Reason for exclusion 
1. Arora S, Sevdalis N, Tam C, 
Kelley C and Babu E (2012) 
Systematic evaluation of decision-making in multidisciplinary 
breast cancer Team: A prospective, cross sectional study 
Conference abstract – study not formally 
published 
2. Jenkins V, Fallowfield J and 
Poole K (2001) 
Are members of multidisciplinary teams in breast cancer 
aware of each other’s roles? 
Paper not does address any of the research 
questions 
3. Sharma A, Sharp D, Walker L, 
and Monson J (2006) 
Colorectal MDTs: the teams’ perspective Paper does not address any of the research 
questions 
4. Harrison J, Choy E, Spillane A, 
Butow P, Young J and Evans A 
(2008) 
Australian breast cancer specialists’ involvement in 
multidisciplinary treatment planning meetings 
Paper does not address any of the research 
questions 
5. Barthow C, Moss C, McKinlay 
E, McCullough L and Wise D 
(2009) 
To be involved or not: factors that influence nurses’ 
involvement in providing treatment decisional support in 
advanced cancer 
Paper does not address any of the research 
questions 
6. Taylor C and Whayman (2009) Raising the profile of the national colorectal cancer nurses 
network; and email survey 
Paper does not address any of research 




Author/year Title Reason for exclusion 
7. Ream E, Wilson-Barnett J, 
Faithfull S, Fincham L, Khoo V 
and Richardson A (2009) 
Working patterns and perceived contribution of prostate 
cancer clinical nurse specialists: A mixed method 
investigation 
Paper addresses only one of the four research 
questions (Q1 but not evident in results) 
8. Robertson T, Li J, O’Hara K 
and Hansen S (2010) 
Collaboration within different settings: a study of co-located 
and distributes multidisciplinary medical team meetings 
Paper does not address any of the research 
questions 
9. McCullough L, McKinlay E, 
Barthow, Moss C and Wise D 
(2010) 
A model of treatment decision making when patients have 
advanced cancer: how do cancer treatment doctors and 
nurses contribute to the process? 
Paper does not address any of the research 
questions 
10. Lamb B, Sevdalis N, Taylor 
C, Vincent C and Green J (2011) 
Multidisciplinary team working across different tumour types: 
analysis of a national survey 
Paper did not address any of the research 
questions (*paper shows consensus that 
patient-centred issues should always be 
considered) 
11. Lamb B, Sevdalis N, Benn J, 
Vincent C and Green J (2012) 
Multidisciplinary cancer team meeting structure and treatment 
decisions: a prospective correlational study 





Author/year Title Reason for exclusion 
12. Regan M, Mills J and 
Restevski E (2012) 
Cancer care coordinators’ relationship with the 
multidisciplinary team and patients: Everything to everyone 
Paper did not address any of the research 
questions (cancer care coordinators not 
nurses) 
13. Lamb B, Green J, Benn J, 
Brown K, Vincent C and Sevdalis 
N (2013) 
Improving decision making in multidisciplinary tumour boards: 
prospective longitudinal evaluation of a multicomponent 
intervention for 1,421 patients 
Paper did not address any of the research 
questions 
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Appendix 7: Methodological review of qualitative studies using CASP  
Studies Was there 
a clear 
statement 































































out of 10 
Amir Z, Scully J, 
Borrill C  (2004) 
yes yes yes yes yes yes yes yes yes yes 10 
Willard C and 
Luker K (2005) 
yes yes yes yes yes no yes no can’t tell yes 7 
Willard and 
Luker (2007) 
yes yes yes yes yes yes yes yes yes yes 10 
Lanceley A, 
Savage J, 
Menon U, and 
Jacobs I (2008) 




Studies Was there 
a clear 
statement 





































































yes yes yes yes yes no yes can’t tell yes yes 8 
Lamb B, 
Sevdalis N, 
Arora S, Pinto 
A, Vincent C 
and Green J 
(2011b) 




Studies Was there 
a clear 
statement 































































out of 10 
Lamb B, Taylor 
C, Lamb J, 
Strickland M, 
Vincent C, 
Green J, and 
Sevdalis N 
(2013) 
yes yes can’t tell yes yes can’t tell can’t tell yes yes yes 7 
Rowlands S 
and Callen J 
(2013) 




Studies Was there 
a clear 
statement 































































out of 10 
Jalil R, Ahmed 
M, Green J, and 
Sevdalis 
N(2013) 
yes yes yes yes yes yes yes yes yes yes 10 
Lamb B, Jalil R, 
Shah S, Brown 
K, Allchorne P, 
Vincent C, 
Green J, and 
Sevdalis N 
(2014)  
yes yes yes yes yes yes yes yes yes yes 10 
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Appendix 8: Methodological appraisal of quantitative studies using key items from Law et al 1998 critical appraisal form  





























test a team 
performance 
assessment 


















Yes Yes NA Yes Interobserver 
agreement - 
potential bias 

























































Yes First study 
to test this 
approach 



























Appendix 9: Summary of studies’ responses to research questions 
Quantitative 
Studies 
How do CNSs 
contribute to the 
MDT meeting? 












What is the 
















1. Lamb B, 
Wong H, 
Vincent C, 
Green J, and 
Sevdalis N 
(2011d) 
- Contributions of 
histopathologists 















- Many patients 
referred with 
suspected 
cancer are not 
seen by the 
CNS before the 
initial MDT 
discussion, 
which limits the 
potential for 
involvement of 
the CNS at the 
team discussion.  




- Once patients 
are given their 
diagnosis, the 
CNS is usually 
very involved 
None N/A (urology) - The two observers 
statistically agreed on ratings 
of quality of information 
presentation and team 
members’ contribution, with 
the exception of the rating of 
the performance of the MDT 
chair 
- Additional limitation of all 
observational research is the 
interpretation of silence. It is 
difficult for observers to rate 
whether a lack of input is 
constructive or not. For 
clarity, in this study a low 
mark was recorded for 
silence. However, in reality 
- Good 
performance of 
the team should 
take account of 
both the process 










of one or more 
treatments that 
are both clinically 
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4.05, SD= 1.26) 
and CNS lowest 
(observers’ 
mean=1.6, SD= 
1.07), with other 
team members in 
between (p<0.05) 
- CNS contribution 













the course of 
















of the CNS – 
which was 
typically low. 
such silence during an MDT 
may be necessary to permit 










metrics can be 




asses a range of 
aspects of MDT 
performance. 
- The importance 
of developing a 
systematic 
approach to case 
discussion to 
enable all to have 
the opportunity to 
contribute. 









building) in a 
staged approach 




2. Lamb B, 
Sevdalis N, 
Mostafid H, 
Vincent C and 
Green J 
(2011c) 
- Regarding the 
contribution of 












methods found that 
the contributions of 
nurse and MDT 
coordinators to 
case discussions 
were least frequent 








can lead to 
inappropriate 
clinical decisions, 
which may not be 
implemented. 
NA (urology) - Ratings from the 
observation and self-
assessments concurred that 
patients’ views and 
comorbidities/psychosocial 
issues were least well 
covered (in other words they 
were aware the team were 
aware that these issues were 
not discussed in the meeting) 
- The tendency of 
participants to overate 
aspects of their performance 
compared with an external 
assessor needs to be 
investigated further. The 
difference was pronounced in 
relation to patient-centred 
information (comorbidities, 
psychosocial issues and 





were adequate to 
strong across all 
MDTs, with the 
pattern of self-
reported results 
mirroring those of 
the observer. 
- The peripheral 






self-report data, is 
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- Another pattern 
that emerges 
(reflected in 
previous studies) is 
that biomedical 





that nursing MDT 
members often 






patient’s views); in other 
words, teams thought they 
were significantly more 
patient-centred that the 
observer found 
- Furthermore, the increased 
variability seen in patient-
centred categories of self-
assessment may suggest 
that there is disagreement 
within the team about what 
constitutes good and poor 
performance in these areas. 
- Re-education of MDT 
members may be required 
into the nature and 
importance of patient-centred 
information when making 







central to high 
quality clinical 
decision-making, 
with evidence to 
show that, in 
MDTs where such 
information is not 
considered, there 
is less chance of 
reaching clinically 
appropriate 
decisions that are 
acceptable to 
patients  
- Outside of 
cancer care, the 
current trend in 
healthcare is for 
patients to play 
an active, 



















- Data from the 
present study 
replicate previous 
findings  - that the 
case reviews were 
largely driven by 







- Cancer nurses’ 
low scores may 
be partly due to 
the fact that 
some cases are 
discussed at the 
meeting before 
the nurses have 
had the 
opportunity to 
see the patients 
– hence their 
contribution will 
likely be limited. 
None None NA (Urology) - If MTBs are to offer the 
intended benefits that arise 
from truly multidisciplinary 
care then better balance 
between the different 
specialties should be 
established during the 
meetings.  
 
- Proposing that 
there are clear 
instances of lack 








chairs of those 
meetings, should 
show leadership 




the benefit of the 
patient. 
4. Taylor C, 
Atkins L, 
Richardson A, 
Tarrant R and 
Ramirez AJ 
(2012)  
- Wide diversity in 
ratings between 
teams across all 
characteristics. 
 





in all patient 
discussions; 
- Teams that 
demonstrated 
optimal chaiing 














- Few nurses 
contributed 
to case 
- Proof of concept study 
which has shown possible to 
measure complex aspects of 
team behavior. 
 










less that half of 
cases 
and not allow 
discussions to 
be dominated 
by one or two 
members. 




How do CNSs 
contribute to the 
MDT meeting? 












What is the 

















5. Amir Z, 
Scully J, Borrill 
C  (2004) 
- Informal leaders 
of the team 




- role in 
coordinating other 
core members 










- confident to 
challenge the 










NA Breast - no evidence to show they 
had been promoted as 
official team leader 
- never invited to important 
Trust meetings despite 
holding the team together 
 
- Difficult to 
distinguish 
between role in 
team and 
contribution in 




- planning and 
documenting team 
meetings 
- found innovative 




- use a network of 
contacts 
- expert advice and 
support to other 
team members in 
the meeting 
- conduits of 
medical 
management as 
well as the patients 
advocate 
- pivot lynchpin of 
the treatment team 
 
6. Willard C 
and Luker K 
None - Dominance of 
the treatment 
None None NA - Treatment agenda 
relegated support to a 










- Doctors did not 
always agree 
about the role of 
the CNS – often 




- vulnerable to 




subordinate position  support in cancer 
care is reliant on 
effective 
organizational 
support – this is 
difficult in an 
environment 
where centrally 
driven outputs are 
not aligned with 
providing 
supportive care 
7. Willard and 
Luker K 
(2007) 
“service work”  - Role ambiguity 
- Conflict 






doctors and not 




service work – 
collecting notes, 
x-rays and scans 
for the meeting, 
making informal 
notes about 
NA - Medical staff had little 
understanding of the role of 
the CNS thus limiting their 
contribution 
- In their desire to be 
accepted some CNS were 
flexible about their role 
- Detrimental to 
establishing the 
nature and 
purpose of the 
CNs role in the 
meeting 






























their status in 
the meeting and 






















boundaries and undertook 
“service work” – this only 
served to create more 
uncertainty about the role.  
- provision of supportive care 
impaired 
- concept of “patronage” (an 
accepted means to improve 
social status) to explain why 
CNSs are compelled to find 
ways of making change 
without jeopardizing their 
‘hard won” relationships with 
doctors 
about the purpose 
and boundaries of 
their role and 
conveyed to other 
team members 
- Service work 







8. Lanceley A, 
savage J, 






- It was difficult for 
the nurse to make 
- Structural 











None  NA 
Gynaecolo
gy 
- To realize the alleged 
benefits of multidisciplinary 
working teams need to 
consider how different forms 
of knowledge coexist during 













prevail and the 
individuality of the 
patient to be 
downplayed 
- “their participation 
is in a silent way. If 
they do not agree 
with something, 
they let us know”. 
knowledge. team members 
had personal 
knowledge of 
the patient, the 
different forms 
of contribution 













commonly if they 
were asked a 
question 




questions and also 
- “there are 
some times 
when you feel 
hesitant to say, 
you know we’re 
running late, you 
feel there’s 
something 
important to say 
and you know 
others are 
pushing to move 
things forward 
- The meeting 
concluded with 
a ‘round the 
table’ process in 
which each 
member was 
asked for any 
other business – 
the nurses in 
particular used 
this time to ask 
about patients 
not on the list or 
- “the specialist 
nurses are the 
people that know 
the patient best, 
so it is very 
important that 
they can say no, 








- A repeat of the Lanceley 
study 
- The unsystematic 
consideration of patient 
related factors such as co-
morbidity, psychosocial 
situation and wishes 
compared with disease 
related information 
- The observed lack of a 









-It is likely that 
patient-centred 




given less weight 
(e.g. outlined in a 
box) where the 
nurses comment 
about the patient 
wanting surgery is 
not responded to 
therefore you 

















to report back 
on patients who 
had received 
treatment 
- Patient views 





were less clear 
cut 













need to take a 
more central 
role in the 
patient’ views appeared at 
odds with a consensus 
among interviewee that this 
is an extremely important 
factor in decision making 
Reflects Lanceley’s “silent 
way” 
- This study has found that 
teams need to ensure patient 
preferences and co-
morbidities are consistently 
considered for all patients 
and that the decision-making 
process results in final 
outcomes that are clear and 













may well change 
over time. The 
key issue is to 
ensure it is taken 
into account for al 
women, not just 
those who are 
unusual in some 
way i.e. complex 
- checklist for 
each patient that 
included the 
areas that nurses 









done 7 years ago 
and yet no 
evidence of check 
lists in any of my 
study MDTs) 
10. Lamb B, 
Sevdalis N, 
Arora S, Pinto 
A, Vincent C 
and Green J 
(2011b) 
Participation 
unequal – most 
participants thought 
the case discussion 





- It was recognized 
that different 
members of the 
MCC contribute to 
the discussion in 





surgeon said “the 
nurses are 






- Even when 
others were 
present at The 









mostly related to 
surgeons but 









case discussion  
-The role of the 
chair is really to 
ensure that all 
voices are heard 
- Working in a 
more structured 





there should be 
more set riles” 
(? Coordinator – 
not clear what M 
is) 




- Contribution ignored – a 
consistent finding with other 
studies which have found 
that traditional professional 
hierarchies lead to the 
exclusion of nurses and a 
bias toward biomedical 
information (Kidger et al 
2009; Lanceley et al 2008) 
- Without addressing 
systems and behaviours at a 
micro level, the quality of a 
health care system is difficult 
to optimize. 
- Improving MCC processes 
from the “bottom-up” can 
lead to smoother team-
working, clinically appropriate 
decision-making and thus 
improved patient care 
- effective team 
performance 
relies on having a 
diverse team with 
good attendance 
(Haward et al 
(2003) Borrill et al 
(2000) 
- Some research 
has shown 
(Haward et al 
2003; Kidger et al 
2009) that the 












they know a 
patient’s 
wishes…and they 
often know about 
home 
circumstances”. 
- “I never get an 
opportunity to 
speak at that 
meeting, if I have, 
or in the past when 
I have tried to 
speak at that 
meeting you’re 
more or less told its 
not my place to 
question a 
consultant’s 
opinion, and really 
then you just think 
well what’s the 
point in me coming” 
(CNS) 
- “I think the 
patient’s views 
need to be 
represented a bit 
more (CNS)” 
was not one of 
equality.  









ignored – a view 




















- This builds on 
previous work on 
Breast MCCs , 
which has shown 
that nurses play a 





aspects of care 




(Haward et al 
2003) 
- Highlights the 
importance of 
good leadership 
and that that the 
chair does not 








- The potential of 
a more 
standardized 
approach to case 
discussion should 
be explored 





Green J, and 
Sevdalis N 
(2013) 





within the team 
decision-making 
process 
- Q4 main 
reasons for 
recommendatio





lack of personal 
contact with the 
patient (i.e. they 
had not seen 
the patient 
before the 
- Q1 What 













(e.g. of theme 
quotes) 
- Q 2 What 








- The role of professional 
status in team decision-
making – risk that those with 
lower professional status will 
not have their say 
- Q5 Who is the best person 
to represent the patients 
views in an MDT meeting > 
All highly agreed that this 
should be the CNS. 
Interestingly the CNS thought 
less so than the doctors 
- The results 
suggest that the 




patient in the 
meeting 
- The question of 
how to bring 
patient 
preferences and 
values into the 
MDT is a complex 
one. 
- Psychological 
research on team 
decision making 
shows that it can 
be improved by 




- Only 4% of 
nurse/AHPs 
reported lack of 
knowledge of 
comorbidities as 












did impact on 
non-
implementation 
job plan to 








by other team 
members (not 





(done as a 
team) 
- from a team 
psychology 
perspective 
dissent is not 
detrimental to a 
team; in contrast 
teams where no 
one ever 
dissents are at 
risk of “group 
think” where 
dissent exists 





safe within the 
team, the impact 
of hierarchy is 
controlled and a 
shared view of the 
tasks and each 
others roles are 
held within the 
team (ref 22/23 in 
article) 
Christensen et al 
(200); Orasanu et 
al 2000) 
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but never openly 
expressed (see 
ref 23/47 in 
article) 
12. Rowlands 
S and Callen J 
(2013) 
- Nurses and AHPs 
are present at the 
meeting but their 
involvement 
limited..”we have a 
presence but not 
much interactions” 
- On rare occasions 
AHPs and nurses 
may be asked for 
an opinion or if they 
thought it was of 
crucial importance 











with each other 
and this gives 





are taught to 
‘paint the big 
picture’ whereas 
doctors are 
taught to be 
concise and get 
to the 
‘headlines’ 
(Leonard et al 
2004) Nurses 
are taught that 












role and the 








the Chair” (care 
coordinator) 
- The seniority 
- Professional 
silos and not 
multidisciplinarity 
NA Lung - There isn’t a forum for 
multidisciplinary care 
planning, particularly on 
issues of a non-medical 
nature 
- Only contribute either when 
asked or if absolutely critical 
- Implication here 
that there is no 
forum for planning 
care – where then 
does this take 
place?  
- The meeting 
while deemed 
multidisciplinary 
was primarily a 
decision-making 
forum for doctors 
- Communication 
strongly 
influenced by the 
role of the health 
care professional 
- The findings are 
consistent with 
the research of 
Flessig et al 
(2006) who could 
find no empirical 
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they do not 
make diagnoses 









based on role 
were further 
reinforced by 








that “there are a 
lot of territorial 
attitudes based 
on ownership of 
patients…and 
people not 
feeling that they 
of some health 
professionals on 
the team 














- Influence of 
hierarchy a 
hidden pitfall to 
the success of 
multidisciplinary 
care (Gupta 2007) 
- implication is 
that the team is 
operating not as 
an effective 
multidisciplinary 
unit but within 
professional silos 
- This contrasts 
with a true 
multidisciplinary 
model of care 
which requires an 
integrated team 
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want to hand 
patients over 





some ways it 
kind of has to be 
to get the 
medical 
decisions made 
that need to 
be..but I think 
this is potentially 
an issue as to 
whether there is 
enough 
openness for 
other people to 
contribute to the 
discussion..” 
(medical onc) 
















and AHPs to 
develop a mgmt. 
plan for the 
patient covering 
the clinical and 
social aspects of 
care 
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the meeting was 
seen as an 
inhibitor by the 
registrar – who 
felt that if 
everyone’s 
opinions were 






13. Jalil R, 
Ahmed M, 
Green J, and 
Sevdalis N 
(2013) 




expressed as to 
whether the 
MDT could ever 






this related to 
patient factors; 
lack of 
- Suggested for 
all participants 














MDMs and; v) 







- Overlap in reasons for not 
reaching a decision and non-
implementation: that ignoring 
patient related factors and 
psychosocial factors might 
affect decision 
implementation.  








and needs to be 
factored into the 
MDM discussion 
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consideration of  not discussing 
all patients. 
14. Lamb B, 
Jalil R, Shah 
S, Brown K, 
Allchorne P, 
Vincent C, 




- Participants felt 
that the nurse was 
the easiest person 
to talk to would be 
the best person to 
gather information 
to input into the 
team meeting 
- participants 
adamant that the 
nurse was the 
member of the 
MDT whom they 
had the best 
relationship and 
who would be best 
placed to ascertain 





was the team 
member best 






the MDT – 
concerning to 
patients 
- The advocacy 





work load (Leary 






delayed if no 
MDT member 
knew the patient 
(“if they don’t 
know me how 













et al 2012) 
- Restructuring 






- Patients felt they could 
contribute indirectly via the 
CNS who by virtue of their 
close relationship with 
patients had a special role in 
gathering information and 
could act as an advocate 
- Implication that 
CNS should see 
all patients before 
they can be 
discussed at MDT 
even if this meant 
a delay 
- Currently no 
tools to asses the 
“patient 
centredness” of 




aim to inform 









proceed without a 
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- One participant 
thought the CNS 
should have a 
formal role as 
patient advocate 
- Patients value 
nurses as the team 
member with whom 
they can relate and 
who can act as an 
interface between 
the patient and 
healthcare system 























Appendix 10: Study information pack  
 
SUMMARY INFORMATION SHEET FOR 
PARTICIPANTS: Phase 1 
REC Reference Number: PNM/12/13-26 
Multidisciplinary clinical decision 
making in colorectal cancer teams 
Invitation to participate in the study 
We would like to invite you to take part in this doctoral research study. Before you 
decide we would like you to understand why the research is being done and what 
it would involve for you. Please take time to read the following information 
carefully and discuss it with others if you wish. 
What is the purpose of this study? 
Multidisciplinary cancer teams have become central to the delivery of quality 
cancer care and decision making about the treatment and management of cancer 
patients is their key function. It is now standard practice that any decision relating 
to the treatment and management of a cancer patient is made by clinical 
consensus and that all newly diagnosed patients have the benefit of their 
individual case being assessed by a cancer multidisciplinary team. Little is known 
about the process of multidisciplinary team decision making and we need to 
better understand this clinical process so that we can inform future development. 
This study aims to explore the nature of this process. To do this requires an 
exploration of team decision making from a number of perspectives. This study 
proposes to explore this process by (1) observation of the team meetings (2) 
interviews with team members and (3) a focus group with selected team 
members. 
The study will, therefore, be conducted in three phases and will include: 
x Observation of up to five colorectal multidisciplinary team 
meetings from four randomly selected colorectal teams. 
x Face to face interviews with a sample of multidisciplinary team 
members. 
x A focus group with a sample of multidisciplinary team members. 
 
Why have I been invited? 
You have been invited to take part in this study because you are a member of one 
the colorectal multidisciplinary cancer teams that have been randomly selected to 
participate. We would like to recruit all multidisciplinary team members to (1) be 
observed in their meetings (up to about five meetings); (2) recruit some members 
to participate in a face to face interview with the researcher and (3) and recruit 
some members to be part of a focus group. This information sheet relates to 
taking part in the observations of the MDT meeting. 
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Do I have to take part? 
You do not have to take part in the study; it is up to you to decide. If you decide to 
take part you are free to change your mind at any time without giving a reason. 
Your decision will not affect you in any way.  
What will happen to me if I take part? 
If you are interested in taking part in the study you can call the researcher directly 
on the number provided. The researcher will contact you by email and if you are 
happy to take part you will be asked to provide consent to be observed in (up to 
five) multidisciplinary meetings. The researcher will wish to take notes of what 
they observe during the meetings and will need the consent of all attendees in 
order to do this. 
The researcher will also invite a number of those observed to take part in an 
interview and some to take part in a focus group to explore the multidisciplinary 
team decision-making process. The researcher will seek samples for interviews 
and the focus group that provide wide representation across professional groups. 
If you are selected to take part in an interview or focus group you will be provided 
with additional information about these stages of the research and be asked to 
provide written consent confirming your willingness to participate in them. 
What are the possible benefits of taking part? 
There will be no direct benefit to you from participating but the findings from this 
study will be disseminated widely alongside recommendations for improving 
practice. This research will contribute to an accumulating evidence base about 
the effectiveness of multidisciplinary working within cancer care. Participants may 
find the opportunity to discuss the way they work and potential solutions to 
improvements a positive process. All participants will receive a copy of the final 
research report and findings. 
What are the possible disadvantages and risks of taking part? 
We do not anticipate that there will be any risks to you in taking part in the study, 
but if you have any concerns please do discuss with the researcher (contact 
details below). 
What arrangements are in place for ensuring anonymity and confidentiality? 
Your participation in any part of this study will remain anonymous in any reports 
or papers generated by the study. All personal information will remain confidential 
and all data will be anonymised and confidential. The researcher will follow ethical 
and legal practice and all information about you will be handled in confidence. 
The information you give will be stored and processed on secure computers 
which are password protected.  
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the research at any time, up to the point of analysis 
(September2014), without giving a reason. A decision not to take part, or to 
withdraw at any time, will not affect you in any way. 
However, should you wish to withdraw from the research during the MDT 
observations, the meeting will continue and it may not be possible for you to 
withdraw your data due to the interdependent nature of observational research. 
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What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
the Principal Investigator; Ms. Lallita Carballo, or the local Principal Investigator 
(contact details at the bottom of this form).  
What happens to the results of the research study? 
This study is part of a postgraduate doctoral programme sponsored by King’s 
College London. The results of this study will be part of a thesis report. The 
results will also be published in health care journals and presented at national and 
international conferences. At the end of the study, a summary of the findings will 
be sent to all participants for their interest. 
Who is organising and funding the research? 
This research is being sponsored by King’s College London as part of a doctoral 
programme. 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 
approved by King’s College London, Psychiatry, Nursing and Midwifery Research 
Ethics Subcommittee. 
Further information and contact details 
If you have any questions or require more information about this study, please 
contact the researcher using the following contact details: If you decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form.  
 
Ms. Lallita Carballo (Principal Investigator) 
University College London Hospitals NHS Foundation Trust  
UCH Macmillan Cancer Centre, Huntley St, London, WC1E 6AG 
Tel: 020 3447 8663  
Email: lallita.carballo@kcl.ac.uk 
 
If this study has harmed you in any way, you can contact King's College London 
using the details below for further advice and information: SUPERVISOR: 
Professor Glenn Robert (glenn.robert@kcl.ac.uk)  
Florence Nightingale School of Nursing & Midwifery 
King’s College London, James Clark Maxwell Building, Waterloo Road 
London, SE1 8WA:  
Tel: 020 7848 3011 
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 FM FOR PARTICIPANTS IN RESEARCH 
STUDIES: Phase 1 
CONSENT FORM FOR PARTICIPANTS IN 
RESEARCH STUDIES: Phase 1 
 
Please complete this form after you have read the 
Information Sheet and/or listened to an explanation about the research. 
 
King’s College Research Ethics Committee Ref: PNM/12/13-26 
Title of Study: Multidisciplinary clinical decision making in colorectal 
cancer teams 
 
Thank you for considering taking part in this research. The person 
organising the research must explain the project to you before you agree to 
take part.  If you have any questions arising from the Information Sheet or 
explanation already given to you, please ask the researcher before you 
decide whether to join in. You will be given a copy of this Consent Form to 
keep and refer to at any time. 
x I consent to being observed by the researcher during the 
multidisciplinary team meeting (up to five meetings) and I 
understand that all information will be handled in accordance with 
the terms of the UK Data Protection Act 1998. 
 
x I understand that if I decide at any time during the research that I no 
longer wish to participate in this project, I can notify the researchers 
involved and withdraw from it immediately without giving any 
reason. Furthermore, I understand that it may not be possible to 
withdraw my data due to the interdependent nature of observational 
research. 
 
- I understand that the researcher will only breach confidentiality if 
there is concern over the safety of an individual staff member or 
patient. In the event of these extreme circumstances the Principal 
Investigator, Lallita Carballo (a clinician with extensive experience of 
delivering cancer care) will make an informed decision and act upon 
it accordingly ensuring that the participant is informed about any 
potential breach of confidentiality. 
 
-The information you have submitted will be published as a report; 







agree that the research project named above has been explained to me to 
my satisfaction and I agree to take part in the study. I have read both the 
notes written above and the Information Sheet about the project, and 
understand what the research study involves. 
 





Confirm that I have carefully explained the nature, demands and any 
foreseeable risks (where applicable) of the proposed research to the 
participant. 
 













































































































































Ethics approval & access
Sample & conduct MDM observations (s1) (s2) (s3) (s4)
Observation analysis
Sample and conduct interview s (s1) (s2) (s3) (s4)
Transcribe & Analyse interview s
Conduct & analyse focus group data
Write up findings, and results
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Appendix 12: Bales IPA categories (Bales 1950) 











Appendix 13: Field notes template 
Pre meeting (15 mins  
prior) 












Appendix 14: Structured observational tool 
MDT IOM/Bales Observation Schedule (09/05/13) No. In attendance: 
Observation session:   Any missing core mem: 
Date:  Site number: 












































C Gives  
info 
5 CNS 
A asks for 
info 
B asks for 
opinion 
C asks for 
suggestion 
6 CNS 
A is asked 
for info 
B is asked 
for opinion 














Impact of CNS 
contribution 
0 = None 
1 = Some 
other observations 
1                  
2                  
3                  
4                  
5                  
6                  
7                  
8                  
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Appendix 15: Codebook 





Coding Instructions Comment 
    
Identification 
number 
ID Ist number: site (123 or 
4) 
2nd number: observation 
(1,2,3 or 4) 
3rd number: Case 
number of each patient 
discussion observed  
Should end 
up with 111 
(ist site,ist 
observation












1= observed  
0= not observed  
 
Frequency of IOM 
dimension 

































Frequency of BIPA 
dimension 


















Number of times i.e. 
0,1,2,3,4,5 
 
Impact of CNS 
contribution 
cnsi 0= none 
1= some 
 







obsnum 1= first observation 
2= second observation 
3= third observation 
4= fourth observation 
Meeting 
level 
Date of meeting Date of 
meeting 
Add date and year Meeting 
level 
Length of meeting Meeting 
time 
Add in minutes Meeting  
level 
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Core team present Core team  1= none absent 
2= 1 absent 
3= 2 or more absent 
Meeting 
level 














10,11,12,13 etc Meeting 
level 





Appendix 16: Information sheet for participants (phase 2) 
 
SUMMARY INFORMATION SHEET FOR 
PARTICIPANTS: Phase 2 
 
REC Reference Number PNM/12/13-26 
Multidisciplinary clinical decision making in colorectal 
cancer teams 
Invitation to participate in the study 
We would like to invite you to take part in this doctoral research study. Before you 
decide we would like you to understand why the research is being done and what 
it would involve for you. Please take time to read the following information 
carefully and discuss it with others if you wish. 
What is the purpose of this study? 
Multidisciplinary cancer teams have become central to the delivery of quality 
cancer care and decision making about the treatment and management of cancer 
patients is their key function. It is now standard practice that any decision relating 
to the treatment and management of a cancer patient is made by clinical 
consensus and that all newly diagnosed patients have the benefit of their 
individual case being assessed by a cancer multidisciplinary team. Little is known 
about the process of multidisciplinary team decision making and we need to 
better understand this clinical process so that we can inform future development. 
This study aims to explore the nature of this process. To do this requires an 
exploration of team decision making from a number of perspectives. This study 
proposes to explore this process by (1) observation of the team meetings (2) 
interviews with team members and (3) a focus group with selected team 
members. 
The study will, therefore, be conducted in three phases and will include: 
x Observation of up to five colorectal multidisciplinary team 
meetings from four randomly selected colorectal teams. 
x Face to face interviews with a sample of multidisciplinary team 
members. 
x A focus group with a sample of multidisciplinary team members. 
 
Why have I been invited? 
You have been invited to take part in this study because you are a member of one 
of the colorectal multidisciplinary cancer teams that have been randomly selected 
to participate. We would like to recruit all multidisciplinary team members to (1) 
be observed in their meetings (up to about five meetings); (2) recruit some 
members to participate in a  face to face interview with the researcher and (3) and 
recruit some members to be part of a focus group. This information sheet 
relates to taking part in a face to face interview with the researcher. 
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Do I have to take part? 
You do not have to take part in the study; it is up to you to decide. If you decide to 
take part you are free to change your mind at any time, up to the point of analysis, 
without giving a reason. Your decision will not affect you in any way.  
What will happen to me if I take part? 
If you are interested in taking part in the study you can call the researcher directly 
on the number provided. The researcher will also contact you by email and if you 
are happy to take part you will be asked to provide consent to be interviewed by 
the researcher. If you consent the researcher will contact you to arrange the 
interview at a time and location of your choosing and at your convenience. 
How will the interview be conducted? 
This will be a face to face interview with the researcher lasting from 30 – 45 
minutes. During the interview the researcher will ask you to talk about your 
experience of team decision making and being in a multidisciplinary team 
meeting. This interview will be audio recorded to provide an accurate record of 
the conversation and to allow the researcher to focus on the discussion. You may 
request that the recording is stopped at any time, without having to give any 
reason. You may also request to clarify or withdraw any statements made during 
the course of the interview. The researcher will not use quotations that can be 
attributed to you in any way. 
An electronic and hard copy record of the interview will be kept in a secure 
environment and only the research team will have access to your interview 
record. These will be destroyed some time after the study has been completed. 
What are the possible benefits of taking part? 
There will be no direct benefit to you from participating but the findings from this 
study will be disseminated widely alongside recommendations for improving 
practice. This research will contribute to an accumulating evidence base about 
the effectiveness of multidisciplinary working within cancer care. Participants may 
find the opportunity to discuss the way they work and potential solutions to 
improvements a positive process. All participants will receive a copy of the final 
research report and findings. 
What are the possible disadvantages and risks of taking part? 
We do not anticipate that there will be any risks to you in taking part in the study, 
but if you have any concerns please do discuss with the researcher (contact 
details below). 
What arrangements are in place for ensuring anonymity and confidentiality? 
Your participation in any part of this study will remain anonymous in any reports 
or papers generated by the study. Any personal information will remain 
confidential and all data will be anonymised and confidential. The researcher will 
follow ethical and legal practice and all information about you will be handled in 
confidence. The information you give will be stored and processed on secure 
computers which are password protected.  
What will happen if I don’t want to carry on with the study? 
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You are free to withdraw from the research at any time, up to the point of analysis 
(September 2014), without giving a reason. A decision not to take part, or to 
withdraw at any time, will not affect you in any way. 
If you are unable to continue, at any point, we will continue to use your 
information in our research unless you tell us that you would prefer us not to.  
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
the Principal Investigator; Ms. Lallita Carballo, or the local Principal Investigator 
(contact details at the bottom of this form).  
What happens to the results of the research study? 
This study is part of a postgraduate doctoral programme sponsored by King’s 
College London. The results of this study will be part of a thesis report. The 
results will also be published in health care journals and presented at national and 
international conferences. At the end of the study, a summary of the findings will 
be sent to all participants for their interest. 
Who is organising and funding the research? 
This research is being sponsored by King’s College London as part of a doctoral 
programme. 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 
approved by King’s College London, Psychiatry, Nursing and Midwifery Research 
Ethics Subcommittee. 
Further information and contact details 
If you have any questions or require more information about this study, please 
contact the researcher using the following contact details: If you decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form.  
 
Ms. Lallita Carballo (Principal Investigator) 
Tel: 020 3447 8667  
Email: lallita.carballo@kcl.ac.uk 
 
If this study has harmed you in any way, you can contact King's College London 
using the details below for further advice and information: SUPERVISOR: 
Professor Glenn Robert 
Florence Nightingale School of Nursing & Midwifery, King’s College London, 
James Clark Maxwell Building Waterloo Road, London, SE1 8WA 
Tel: 020 7848 3011 Email: glenn.robert@kcl.ac.uk 
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CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES: Phase 2 
 
Please complete this form after you have read the 
Information Sheet and/or listened to an explanation 
about the research. 
 
King’s College Research Ethics Committee Ref: PNM/12/13-26 
 
Title of Study: Multidisciplinary clinical decision making in colorectal 
cancer teams 
 
Thank you for considering taking part in this research. The person 
organising the research must explain the project to you before you agree to 
take part.  If you have any questions arising from the Information Sheet or 
explanation already given to you, please ask the researcher before you 
decide whether to join in. You will be given a copy of this Consent Form to 
keep and refer to at any time. 
x I consent to being interviewed and I understand that all information 
will be handled in accordance with the terms of the UK Data 
Protection Act 1998. 
 
x I understand that if I decide, at any time, during the research that I 
no longer wish to participate in this project, I can notify the 
researchers involved and withdraw from it immediately without 
giving any reason. Furthermore, I understand that I will be able to 
withdraw my data up to the point of analysis  
 
- I understand that the researcher will only breach confidentiality if 
there is concern over the safety of an individual staff member or 
patient. In the event of these extreme circumstances the Principal 
Investigator (a clinician with extensive experience of delivering 
cancer care) will make an informed decision and act upon it 
accordingly ensuring that the participant is informed about any 
potential breach of confidentiality. 
 
x I consent to my interview being audio recorded 
 
-The information you have submitted will be published as a report; 












agree that the research project named above has been explained to me to 
my satisfaction and I agree to take part in the study. I have read both the 
notes written above and the Information Sheet about the project, and 
understand what the research study involves. 
 






Confirm that I have carefully explained the nature, demands and any 
foreseeable risks (where applicable) of the proposed research to the 
participant. 
 
Signed                                            Date
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Appendix 17: Interview protocol used for the semi-structured 
interviews 
Interview Protocol/Topic Guide: Face-to-face interview 
Multidisciplinary clinical decision making in colorectal cancer teams 
  Introduce study  
  Clarify the purpose of the interview: To explore their experience of 
the MDT meeting and the clinical decision-making process. 
  Explain that there will be 3 sections to the interview: firstly to look 
at their role, secondly explore others’ role in the MDT team 
meeting and in particular how they contribute to decision-making 
processes and thirdly to explore how these might influence patient-
centred care 
  Obtain/ verify consent 
Sections Key Questions and prompts 
About you Explain that you ask these questions to understand 
a bit about them to provide some context to the 
interview: 
 What is your professional background?  
 How long have you been working as a *** ? 
 How long have you been working in this MDT 
team?  




What do you see as the main purpose of the CRC 
MDT? 
 Can you tell me about your role in the CRC MDT 
team? 
 Can you tell me your views on how well the MDT 
meeting is working?  
 Do you always feel able to speak up when you have 
something to contribute?  
 Do you feel your contribution is always valued 
appropriately?  
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 How do you think your contribution impacts on the 
decision-making process in the MDT meeting? 
 Please could you give an example of this? 
Section 2  
About others’ 
contribution 
Are there any things that you think help or hinder 
others’ contributing in the MDT meeting? 
 Can you tell me what you think of the role of the 
CNS within the MDT meeting and specifically within 
the clinical decision-making process? 
 Any particular issues for the CNSs in the meeting? 
Section 3  
Patient-
centred care 
in the MDM 
Patient-centred care, may need to offer your 
definition of the term patient centred  
 What do you understand by term patient-centred 
care? 
 Which member of the team is responsible for 
bringing patient-centred care issues to the attention 
of the meeting? 
 Do you think discussing patient-centred issues 
within the meeting makes a difference to decision 
outcome? (Added October 2013) 
 
 How does it manifest itself (or not) in the MDT 
meeting? 
 
 Could this be improved? If so, how? 
 
Many thanks for your time in answering theses questions.  Your 
information is very valuable to me.  Before we finish is there anything else 
you would like to add?  Anything that I’ve not asked but you think I should 
have? 
Again thank you very much… 
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Appendix 18: Elements, dimensions and classification of perception 
of CNS role 
Chart 3: Perceptions of the CNS Role 
Column 3.2 – Role and contribution in the meeting 
Phase 1Detection of elements 
Participant Detected elements 
Alice S1 Not very vocal 
CNS makes it easier for patients 
Unofficial chair of the meeting 
To streamline the meeting and pt. pathway 
Be the pts. advocate 
Joy of being a CNS is knowing the pt. well 
Consultants do not understand the CNS role 
Would speak if there was something specific 
Belinda S1 Presenting prevents her opinion being sought on 
nursing issues 
Team stuck in a rut 
Stressful to prepare and present cases 
Feels disempowered to change things 
Role of CNS not used to full potential 
Feels unable to change her role – resistance from 
colleagues 
Thinks she takes off her nursing hat by presenting 
the case 
CNS role to communicate decision to pt. after 
meeting 
Lack of self confidence in presenting cases 
Key role is to present cases in the meeting 
Would be better to do the CNS role differently (in 
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meeting) 
Team do respect the CNS input 
Would speak up if she had to 
Takes time for the team to realize she has a voice 
Don S1 (med 
onc) 
The worst case is when the nurses do not speak 
CNS reticent to speak in meeting 
CNS best person to bring knowledge of pt. 
Brilliant when the CNS runs the meeting 
CNS role in meeting varies 
CNS may not have met the pt. so not able to present 
pt. issues 
The patient’s champion (new) 
CNS dumped on by surgeons (new) 
Makes the doctor’s job unbelievably easy if they are 
able to put fwd. the problems (new) 
Rachel S1 CNS should not spend time checking proformas or 
writing all the background 
CNS should be in the crowd more (being the nurse) 
CNS should take more of a backseat 
Consultants expect them to do everything – unfair 
and tough 
Consultants not helpful – make presenting difficult for 
CNSs 
Doctors are “baby fed” by CNSs 
Harry S1 
(Clin Onc) 
CNS understands pt. and makes clear to team pt. 
wishes/concerns 
CNS role pivotal 
Doctor and CNS know the pt. differently 





Would speak out if she felt decision not right for 
patients 
Feels able to raise issues about pt. wishes and co-
morbidities 
Feels her opinion is valued but not relevant to 
decision outcome 
CNS role to ensure pts. are discussed in the meeting 
(put the list together) 
CNs there to advocate and co-ordinate care 
Janice S2 
(Med Onc) 
Surgeons are dependent on CNS 
CNSs deferential to surgeons 
CNS gives the surgeons confidence 
Surgeons have tremendous respect for the CNS 
CNS hides her light under a bushel 
CNS is the lynchpin but the quietest 
Thinks the CNS would speak up if she disagreed with 
a decision 
CNSs are very gifted (diagnostic work) 
CNS role not about filling in information gaps 
CNS contribution could be more forthcoming 
Would like the CNs to have more of an opinion in the 
meeting 
CNS does not interject 
CNS subservient 
Only speaks when asked her opinion 




Feels CNS totally passive 
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Takes on a lot of work and completely overstretched 
Feels frustrated that CNS does not give her opinion 
Thinks how the CNS works depends on their 
personality 
Would like CNS to summaries chairs decisions 
Emma S3 
(CNS) 
Difficult to contribute if she has not seen the pt. 
Primary role to contribute on pts. She knows 
Opportunities for the CNS to raise points are rare 
CNS role about navigating the system for the pt. 
To listen to and hold the story around the decision 
CNS duty lies mostly in coordinating care 
Speaks about treatment and performance status in 
meeting 
To bring pt. concerns but rarely happens 
Fran S3 
(CNS) 
Difficult to contribute due to time constraints 
Writes a lot down as helps when speaking to the pt. 
To give the CNS opinion where relevant to decision 
Thinks team do not understand the role 
Ginny S3 
(CNS) 
A resource and the pt. advocate 
To marry medical care with holistic needs 
Primary role as pt. advocate 
To speak up and give CNS opinion 
The voice for the pt. 
Wants to be more vocal in meeting 
Role is about being informed and informing others 
Thinks team respects role 
Thinks she is listened to 
Team seems role as practical 
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Thinks she needs to have more confidence to speak 
in meeting 
Admits she does not speak in meeting 
Often speaking does not come 
Imran S3 
(surgeon) 
To advocate for the pt. 
To temper the enthusiasm of the surgeon 
CNS contribution makes a difference to the decision 
They add value 
Doctors still do not ask them enough about the pt. 
Kevin S3 
(med onc) 
No one asks the CNS anything 
Hopes CNSs do not feel intimated as do not speak 
CNs never says anything 
Olivia S4 
(CNS) 
Key worker – main link for pts. 
Sometimes there is nothing to contribute 
Team would always take opinion on board 
More impact on decisions with pts. With recurrent 
disease 
Will know two thirds of pts. at meeting 
Writes in meeting to give feedback to pt. 
Spend a lot of time preparing for meeting 
Doctors always try to bend CNS role 
Doctors take the role for granted 
CNs often speaks after the meeting – “chats” 
Queenie S4 
(CNS) 
CNS there to speak up for the pt. 
Good at getting the jobs done but Not the voice for 
the pt. 
Pt. advocate to tailor care plans 
Contribution undermined by consultant – “you are 
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only a nurse” 
Thinks twice about speaking in meeting 
Contribution not always valued 
NS role not understood by consultants 
Does not feel clear about the role herself 
Finds meetings challenging  
Much of the work done after the meeting 
Michael S4 
(surgeon) 
CNS provides the specific social dynamic 
CNs tells the team if decision not right 




Close longstanding relationship with CNS 
Understands her expressions 
Coordination function role relevant only in the 
meeting 
CNS acts in a subtle way 
CNS could be more present in the meeting 
CNS attentive but quiet in meeting 
Communicates by eye contact rather than verbally – 
“they have an understanding” 
Peter S4 
(radiologist) 
They know what the pt. really wants 
CNs is the mental prompt for the clinician 
The CNSs do occasionally speak 
No MDM without them  






Phase 2: categorisation (CNS perception) 
Element Dimension 
Role of cns not used to full potential (bs1) 
Would be beneficial to do the CNS role differently 
(bs1) 
Feels unable to change her role – resistance from 
colleagues (bs1) 
Presenting in meeting prevents her opinion being 
sought on nursing issues (bs1)] 
Feels disempowered to change things (bs1) 
Does not feel clear about the role herself (qs4) 
Does not think the team understand the role (fs3) 
Team see the role as practical (gs3) 
Ill defined 
  
Doctors take the role for granted (os4) 
Doctors always try to bend the CNs role (os4) 
Consultants do not understand the CNS role (as1) 




Would speak if there was something specific (as1) 
Sometimes there is nothing for her to contribute 
(os4) 
Not very vocal in the meeting (as1) 
Would speak up if she had to (bs1) 
Admits she does not speak in meeting (gs3) 
Opportunities for CNs to raise any points are rare 
(es3) 






Thinks twice about speaking in the meeting (qs4) 
Thinks she needs to have more confidence to 
speak in meeting (gs3) 
Good at getting the jobs done but not being the 
voice for the pt. (qs4) 
Often speaking up doesn't come 
Lack of self confidence (bs1) 
Finds meetings challenging (qs4) 
Would speak up if she felt decision not right (cs2) 
Give CNS opinion when asked and say something 
if relevant to decision (fs3) 
Bringing pt. concerns important but rarely happens 
(es3) 
Difficult to contribute if the CNS has not seen the 
pt. (es3) 
Will only know 2/3rds of the pts. discussed at 
meeting (os4) 
Difficult to contribute due to time constraints (fs3) 
External 
factors 
CNS often speaks after the meeting “chats” (os4) 
Much of the CNS work done after the meeting (qs4) 
Compensating 
factors 
Thinks team would always take on board her 
opinion (os4) 
Team do respect the CNS input (bs1) 
Took time for the team to recognize she had a 
voice (bs1) 
Contribution not always valued (qs4) 
Says her opinion valued (cs2) 
Contribution undermined by consultant – “you are 
only a nurse” (qs4) 
Thinks team respects role (gs3) 
Team view 
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Thinks she is listened to (gs3) 
Spends a lot of time preparing for the meeting (os4) 
Role to streamline the meeting (as1) 
Takes off her nursing hat by presenting the cases 
(bs1) 
Stressful to prepare and present the cases (bs1) 
Unofficial chair of the meeting (as1) 
CNS role to ensure pts. are on list and discussed 
(cs2) 
Role to present the cases (bs1) 
Organisational 
role 
Primary role as pts. Advocate, to speak up and give 
CNS opinion (gs3) 
To marry medical care with pts. Holistic needs 
(gs3) 
CNS role is a resource and the pts. advocate (gs3) 
Be the pts. advocate (as1) 
Make it easier for the pt. (as1) 
Lie mostly in coordinating care (es3) 
There to speak up for the pt. (qs4) 
To advocate and co-ordinate care (cs2) 
To raise issues about pt. wishes and comorbidities 
(cs2) 
Joy of being a CNS is knowing the pt. well (as1) 
Primary role to contribute about pts. she knows 
(es3) 
Voice for the pt. (gs3) 
To tailor care plans (qs4) 
To talk about their treatment and performance 
status (es3) 
Key worker - Main link for pts. (os4) 
Advocacy role 
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Writes in meeting to give feedback to pt. (os4) 
Writes a lot down as helps when speaking to pt. 
(fs3) 
Role is about being informed and informing others 
(gs3) 
To listen and hold the story around the decision 
(es3) 
To communicate the decision to the pt. (bs1) 
Navigating the system on behalf of the pt. (es3) 
Translator 
 
Phase 3: Classification  
Perception of CNS role in the Meeting: CNS view 
1. Ill defined 
2. Misunderstood 
3. Difficulties speaking in the meeting: 
a. Internal factors 
b. External factors 
c. Compensating factors 
4. Key roles: 
a. Organizational role  
b. Advocacy role 
c. Translator role 
 
Phase 2: Catergoraisation 
Elements Dimensions 
Believes the CNS contribution makes a difference 
to the decision (is3)  
They add value (is3) 
Valued 
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CNS are very gifted (js2) 
CNS role of pivotal importance to the outcomes in 
the meeting (hs1)  
Surgeons have a tremendous respect for the CNS 
(js2) 
CNS is the lynchpin (js2) 
No MDM without them (ps4) 
Glue that holds it all together (ps4 new) 
CNS is the mental prompt for the clinician (ps4) 
Fills in information gaps for docs (js2) 
CNS gives the surgeon confidence (js2) 
CNS deferential toward surgeons (js2) 
CNS role to temper the enthusiasm of the surgeon 
(is3) 
Surgeons are dependent on CNS (js2) 
CNS dumped on by surgeons (ds1 new) 
Makes the doctor’s job unbelievably easy if they 
are able to put fwd. the problems (ds1 new) 










CNS attentive but quiet in meeting (ns4) 
Communicates by eye contact rather than verbally 
(ns4) 
The CNSs do occasionally speak (ps4) 
Hopes CNSs do not feel intimidated as do not 
speak (ks3) 
CNS never says anything (ks3) 
CNS reticent to speak (ds1) 





Never interjects with opinion (js2)  
CNS hides her light under a bushel (js2) 
CNS totally passive (ls2) 
Acts in a subtle way (ns4) 
The lynchpins are the quietest (js1 new) 
Only speak if spoken to or asked opinion (js1 new) 
Frustration that CNS does not give her opinion 
(ls2) 
Would like CNS to have more of an opinion in 
meeting (js2) 
Contribution could be more forthcoming (js2) 
Could be more present in the meeting (ns4)  
Would like CNS to summaries chairs decision, type 
proformas in real time (ls2) 
Brilliant when the CNS runs the meeting (ds1) 
Contribution  
wanted 
How CNS works in meetings depends on 
personality of CNS (ls2) 
CNS role in meeting varies (ds1) 
Contribution 
variable 
Would speak up is she disagreed with a decision 
(js2) 
Expresses view on appropriateness of treatment 
(ms4)  
Tells the team if decision not right (ms4) 
Provides the specific social dynamics (ms4) 
Know what the pt. really wants (ps4) 
Best person to bring the knowledge of the pt. (ds1) 
Advocate for the pt. (is3) 
Very holistic, look after pts. well being and do this 























Perception of CNS role in the meeting: Medical view 
 
Phase 3: Classification  
 










Doctors and CNSs know the pts. differently (hs1) 
Makes clear to team pts. wishes/concerns (hs1) 
The patients champion (ds1 new) 
 





lack of clarity 
about role 
No one asks her anything (ks3) 







Appendix 19: Thematic Index 
The Framework Index v1 21 December 2014  
Categories and sub categories 
1. Participant background 
a. Professional background 
b. Previous experience 
2. Experience of MDT 
a. Purpose of the MDT 
b. Views on the meeting 
3. Perception of the CNS role  
a. General views on role 
b. Role in the meeting 
4. Contribution in the meeting 
a. Factors that enable CNS contribution 
b. Factors that inhibit CNS contribution 
c. Factors that enable others’ contribution 
d. Factors that inhibit others’ contribution 
e. Changes to practice to improve contribution 
f. Contribution valued ??? 
5. Patient-centred care 
a. Definitions of patient-centred care 
b. Views on relevance within the MDT meeting 
c. Barriers to incorporating into the meeting 
d. Improving the patient centredness of the MDT meeting
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Appendix 20:  Example of a sample of a Thematic Chart  
Chart 3: 
Perceptions 
of the CNS 
role 
3.1 General views of the role 3.2 Role in the meeting 3.3 
Other 
3.4  Analysis 
thoughts 
Alice s1 The CNS role was brand new and the 
team was deciding how best to run the 
MDT.// Referral through the CNS:  The 
CNS is emailed or called about any patient 
with CT or specimen that looks like a likely 
cancer. The patient is then tracked by the 
MDT coordinator to ensure their scans are 
booked, patient is aware they are being 
referred, that they go onto the MDT list 
and have an appointment to be told they 
have cancer in the nurse lead clinic. The 
consultant spends 10/15 mins with the pat 
and the CNS does the rest.// Just a nurse 
In the beginning there were less patients being discussed in 
the meeting and she would always have spoken up if a 
patient had said "something specific". She did not start 
presenting the  patients history in the meeting till later.//  
Preparation for the meeting: The CNS presents the 
clinical history and does the preparatory work for that 
including chasing things they are not sure about. If it a 
follow patient that she knows well she would be able to give 
an opinion as to whether they would agree to certain 
treatments. //Knowing your patients well: The joy of being 
a CNSs is you know the patients so well and can bring 
additional knowledge to the meeting which surgeons and 
oncologists rarely pick up as they spend so little time with 
  Thinks the 
consultants not 








attitude: Surgeons still think that "we're 
just a nurse". She feels that they are her 
patients as much as the consultants and 
she too has her own caseload and work. 
The consultants do not seem to recognise 
this and often belittle the CNS contribution 
and do not reognise their experience.// 
Supporting patients at diagnosis: The 
surgeons cant deal with patients crying so 
she has the nurse led clinic so that the 
consultant can give the news and then 
leave the patient with the CNS where they 
have an hour to sit down and go through 
issues. She feels the consultants do a 
"very quick" discussion, not in the "patients 
language" and she does not feel that is 
enough 
their patients.// Unofficial chair: Because she presents the 
patients and gets agreements about treatment "outcomes" 
describes this as chairing the meeting. The team have 
always been happy for the CNS to undertake this role and 
says the lead does not really chair the meeting as such.// In 
the meeting specifically: Role of the CNS is to be the 
patients advocate if they know them. Ensure there is a plan, 
and take specific questions that the patient may wish to be 
discussed at the meeting and then feedback. Part of role is 
to "streamline" the meeting and the patients pathway so 
they do not have long waits or too many "hurdles" - 
hopefully making it easier for patients.// Role in decision-
making process: The CNS is there to Ensure there is a 
plan, that the patient knows their treatment options and that 
she can understand those options sufficiently to be able to 
convey it to the patient as often it is her telling the patient 
and not the consultant. // What the consultants think: She 
thinks the consultants think the CNSs do the profomas and 
have some knowledge of the patient but does not know if 
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they think they contribute more than that.// She admits that 
she thinks she may not be doing things she thinks she is 
doing and that she may not be as vocal as she thinks. 
Belinda s1 Role in team: To link and coordinate 
between the surgical and oncology teams. 
As the CNS have equal exposure to both 
they need to ensure that there is 
communication between them to ensure 
that the transition for the patient form 
surgery to oncology is comfortable should 
they need it. She believes her role to be 
more patient centred than administrative 
but not convinced that all CNSs would 
agree. Thinks that this is because CNSs 
tend to get caught up in logistics rather 
than being on "the front line". Thinks her 
role is to coordinate care and ensure it is 
holistic.// Holistic role: Means meeting 
the needs of the patient from every 
Presents the cases: Presenting the case in the meeting is 
sometimes done by the MDT coordinator in other MDTs but 
as her CNS colleague is keen to continue to do it this way it 
is the way it is done.// Communicating the decision: She 
always comes out of the meeting knowing what the next 
step is for the patient and it is usually herself and her 
colleague who have to communicate that decision to the 
patient. Not necessarily to disclose important information 
like scan results but to organize further scans. The meetings 
always generate clear decisions.// Self confidence and 
exposure: Definitely difficult at first due to a lack of self 
confidence and exposure in presenting cases. Needed time 
to develop a rapport and taken time for the "them" to realize 
she has a "voice". Their respect for her has grown over 
time. They do not tend to ask for a "nurse opinion" but ask a 
question about someone's fitness for treatment. They would 
  CNS tend to 
get caught up 
in logistics 
rather than 
being on the 
front line.// 











perspective. This is different from being a 
ward sister - where you would sort them 
out and pass on. As a CNS every different 
avenue is explored. The important thing is 
to ensure the physicians recognise those 
needs as well.// Oncologists and 
surgeons: Has a better relationship with 
the oncologists as they have a better 
understanding of the psychological 
support and contribution provided by the 
CNS. Surgeons do not really recognise 
any psychological needs and therefore 
only see the CNS role as there to sort out 
the logistics. Compounded by the fact that 
often surgical patients will come in and out 
quickly and so tend to have less of a 
relationship with those patients. With 
oncology patients you have more of a 
relationship and maybe why the 
turn around and ask "have you met this patient, how are 
they?"// Speaking up: If she really felt something nurse 
related needed to be brought up she would feel comfortable 
to say "hang on a sec I don't think this is the way fwd.". She 
gives an example of a discussion she had with a patient 
where she knew the patient would not go with the MDT 
decision and expressed as such. As a result the MDT 
outcome was changed. She thinks the team do respect their 
input.//Impact on decision making (r8pocnsr): Thinks the 
team do not look to the CNSs for a clinical decision which 
she believes is reasonable as they are the doctors and she 
the nurse. But does think they "take our decisions on and 
respects" their input. Gives an example of an elderly frail 
gentleman who would have gone on to have radiotherapy 
but her discussions with the patients son revealed that this 
was not wanted by the patient. She conveyed this in the 
meeting and the decision was reversed. // Role in the 
meeting (r9 pocnsr): Her role at the moment is to present 
the patient's history. She would like to approach her input 
limited 
exposure in 
speaking in the 
meeting. Do 
not ask for a 
nurses opinion 
generally.// 
The impact of 
presenting the 
case on the 
CNS role: can 
improve self 
confidence to 
speak; air time 






contribution by the CNSs is better 
understood by the oncologists. 
differently and take more of a "back seat or different seat" 
as she thinks in presenting she takes her "nurses hat off" 
and would find it interesting to go their as a nurse rather 
than as a chair or presenter. In her current role she is rarely 
asked what she thinks about a patient and feels presenting 
prevents her opinion being sought on nursing issues//. 
Problems with presenting in the meeting (r10pocnsr): 
Thinks that she spends too much time ensuring that she 
presents all the information correctly as needs to be right to 
ensure the right decision is made. This in itself is quite 
stressful and she would like to change her role in the 
meeting to put her nurse perspective in more. (r11pocnsr) 
Chairing stops her from taking on an active CNS role. Does 
not feel confident to do that at the moment and feels unable 
to say to her colleagues she would like it to change. Feels 
that the current approach does not work and that the role of 
the CNS is not used to its full potential in the MDT meeting. 
(r12pocnsr) Agrees that this explains why the team do not 




the role of the 





not presenting their role in that way. Feels disempowered to 
change things.  Stuck in a rut: (r13pocnsr) She says the 
team has got stuck in a rut . It has been useful for her to 
start to question processes in the meeting. Some elements 
of her role she does not even know why she does them but 
its always been that way but she thinks they could save a lot 
of time and make a lot of difference if they did it differently. 
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Appendix 21: Focus Group participant information sheet  
SUMMARY INFORMATION SHEET 
FOR PARTICIPANTS: Phase 3 
REC Reference Number: PNM/12/13-26 
Multidisciplinary clinical decision making in 
colorectal cancer teams 
Invitation to participate in the study 
We would like to invite you to take part in this doctoral research study. Before you 
decide we would like you to understand why the research is being done and what 
it would involve for you. Please take time to read the following information 
carefully and discuss it with others if you wish. 
What is the purpose of this study? 
Multidisciplinary cancer teams have become central to the delivery of quality 
cancer care and decision making about the treatment and management of cancer 
patients is their key function. It is now standard practice that any decision relating 
to the treatment and management of a cancer patient is made by clinical 
consensus and that all newly diagnosed patients have the benefit of their 
individual case being assessed by a cancer multidisciplinary team. Little is known 
about the process of multidisciplinary team decision making and we need to 
better understand this clinical process so that we can inform future development. 
This study aims to explore the nature of this process. To do this requires an 
exploration of team decision making from a number of perspectives. This study 
proposes to explore this process by (1) observation of the team meetings (2) 
interviews with team members and (3) a focus group with selected team 
members. 
The study will, therefore, be conducted in three phases and will include: 
x Observation of up to five colorectal multidisciplinary team 
meetings from four randomly selected colorectal teams. 
x Face to face interviews with a sample of multidisciplinary team 
members. 
x A focus group with a sample of multidisciplinary team members. 
Why have I been invited? 
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You have been invited to take part in this study because you are a member of one 
the colorectal multidisciplinary cancer teams that have been randomly selected to 
participate. We would like to recruit all multidisciplinary team members to (1) be 
observed in their meetings (up to about five meetings);  (2) recruit some members 
to participate in a face to face interview with the researcher and (3) and recruit 
some members to be part of a focus group. This information sheet relates to 
taking part in a focus group. 
Do I have to take part? 
You do not have to take part in the study; it is up to you to decide. If you decide to 
take part you are free to change your mind at any time, up to the point of analysis, 
without giving a reason. Your decision will not affect you in any way.  
What will happen to me if I take part? 
If you are interested in taking part in the study you can call the researcher directly 
on the number provided. The researcher will also contact you by email and if you 
are happy to take part you will be asked to provide consent to participate in a 
focus group discussion about multidisciplinary team decision making with 
approximately six to eight professional colleagues from other colorectal cancer 
teams participating in the study. The focus group will be held in a central London 
location and will last approximately one and a half hours. The focus group will be 
audio recorded to provide an accurate record of the discussion and to allow the 
researcher’s facilitating the focus group to follow the discussion. 
The researchers will be available to debrief with any participant(s) after the focus 
group should any participant wish to do this.  
What are the possible benefits of taking part? 
There will be no direct benefit to you from participating but the findings from this 
study will be disseminated widely alongside recommendations for improving 
practice. This research will contribute to an accumulating evidence base about 
the effectiveness of multidisciplinary working within cancer care. Participants may 
find the opportunity to discuss the way they work and potential solutions to 
improvements a positive process. All participants will receive a copy of the final 
research report and findings. 
What are the possible disadvantages and risks of taking part? 
We do not anticipate that there will be any risks to you in taking part in the study, 
but if you have any concerns please do discuss with the researcher (contact 
details below). 
What arrangements are in place for ensuring anonymity and confidentiality? 
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Your participation in any part of this study will remain anonymous in any reports 
or papers generated by the study. All personal information will remain confidential 
and all data will be anonymised and confidential. The researcher will follow ethical 
and legal practice and all information about you will be handled in confidence. 
The information you give will be stored and processed on a secure computer 
which is password protected.  
Due to the collective nature of focus groups it is not possible to guarantee that 
participation will remain confidential. Participants will, therefore, be requested to 
consent that discussions in the focus group should remain confidential between 
participants and not discussed outside the group. 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the research at any time, up to the point of analysis 
(July 2015), without giving a reason. A decision not to take part, or to withdraw at 
any time, will not affect you in any way. If you are unable to continue, at any point, 
we will continue to use your information in our research unless you tell us that you 
would prefer us not to.  
Participants need to be aware that due to the nature of the focus group it may be 
difficult to withdraw an individual participant’s data from the project (as doing so 
would make it difficult to retain the context of other participant data). However, 
should this be the case the researcher will not use any of the participant’s quotes 
in any of the reports. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
the Principal Investigator; Ms. Lallita Carballo, or the local Principal Investigator 
(contact details at the bottom of this form).  
What happens to the results of the research study? 
This study is part of a postgraduate doctoral programme sponsored by King’s 
College London. The results of this study will be part of a thesis report. The 
results will also be published in health care journals and presented at national and 
international conferences. At the end of the study, a summary of the findings will 
be sent to all participants for their interest. 
Who is organising and funding the research? 
This research is being sponsored by King’s College London as part of a doctoral 
programme. 
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Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 
approved by King’s College London, Psychiatry, Nursing and Midwifery Research 
Ethics Subcommittee. 
Further information and contact details 
If you have any questions or require more information about this study, please 
contact the researcher using the following contact details: If you decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form.  
Ms. Lallita Carballo (Principal Investigator) 
University College London Hospitals NHS Foundation Trust  
Cancer Division, 3rd floor West 
250 Euston Road 
London 
NW1 2PG 
Tel: 020 3447 8667  
Email: lallita.carballo@kcl.ac.uk 
 
If this study has harmed you in any way, you can contact King's College London 
using the details below for further advice and information: SUPERVISOR: 
Glenn Robert 
Professor  
Florence Nightingale School of Nursing & Midwifery 
King’s College London 




Tel: 020 7848 3011 
Email: glenn.robert@kcl.ac.uk  
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CONSENT FORM FOR PARTICIPANTS IN RESEARCH 
STUDIES: Phase 3 
 
Please complete this form after you have read the Information Sheet and/or 
listened to an explanation about the research. 
King’s College Research Ethics Committee Ref: PNM/12/13-26 
Title of Study: Multidisciplinary clinical decision making in colorectal 
cancer teams 
Thank you for considering taking part in this research. The person organising the 
research must explain the project to you before you agree to take part.  If you 
have any questions arising from the Information Sheet or explanation already 
given to you, please ask the researcher before you decide whether to join in. You 
will be given a copy of this Consent Form to keep and refer to at any time. 
x I consent to participating in the focus group and being audio recorded 
and I understand that all information will be handled in accordance 
with the terms of the UK Data Protection Act 1998. 
x I understand that if I decide, at any time, during the research that I no 
longer wish to participate in this project, I can notify the researchers 
involved and withdraw from it immediately without giving any reason. 
x I understand that I can withdraw from the study at any time, but due to 
the interdependent nature of focus groups it may not be possible to 
remove my ideas and views expressed in the discussion from the 
study. 
x I understand and agree that discussions in the focus group should 
remain confidential between participants. 
x I understand that the researcher will only breach confidentiality if there 
is concern over the safety of an individual staff member or patient. In 
the event of these extreme circumstances the Principal Investigator (a 
clinician with extensive experience of delivering cancer care) will make 
an informed decision and act upon it accordingly ensuring that the 
participant is informed about any potential breach of confidentiality. 
x The information you have submitted will be published as a report; 















agree that the research project named above has been explained to me to my 
satisfaction and I agree to take part in the study. I have read both the notes 
written above and the Information Sheet about the project, and understand what 
the research study involves. 
 





Confirm that I have carefully explained the nature, demands and any foreseeable 
risks (where applicable) of the proposed research to the participant. 
 






Appendix 22: Focus group protocol 
 
Protocol for Clinical Nurse Specialist Focus Group  
Date: 
Attendees:  
Name of Moderator:  
(When receiving participants, hand out consent form and ask to sign (if not 
previously completed). Give copy 
 
Introduction 
Good morning/afternoon. First of all, thank you very much to you all for 
coming today and taking part.   
 
My name is _______________ and this is my colleague __________.  
This study is about exploring the clinical decision-making process 
within colorectal cancer teams. The aim is to understand this process 
and develop recommendations that could improve decision making. 
The study is sponsored by King’s College London and part of a 
doctoral programme of study. 
 
A little bit about focus groups for those who may not know: A focus 
group is meant to be a relaxed discussion where people share their 
views and experiences, but also hear from other people. You do not 
have to wait to be invited into the discussion, but I would appreciate it if 
you try to let each other finish talking before you start, as it can be 
difficult to understand the recording and take notes if several people 
speak at the same time. All perspectives and comments are valid, as 
long as they are related to the study. In order for people to feel happy 
with speaking openly and freely, it is important that we keep each 
other’s identities private and their remarks confidential.  The discussion 
will last approximately one and a half hours. You have all consented to 
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being recorded. ______ (colleague) will be taking notes and recording 
the discussion. The focus group is recorded to ensure we have an 
accurate account of the discussion. The recording will be typed up but 
each person will be given an ID number - in this way no identifiable 
information will be associated with a named individual. In this way your 
responses will be anonymous.  
The recording will be typed up and destroyed once the analysis is over. 
If you wish, I can send you a copy of the final report once it is finished. 
Does anyone have any questions about confidentiality that I haven’t 
covered? 
 
Present the purpose of the focus group 
We are here today to talk about two topics.  
 
First the themes I have identified from the work I have been doing in 
observing team decision making and the interviews that many of you 
participated in. With particular reference to the clinical nurse specialist 
role I would like to present these theme to you and then get your views. 
The second topic for discussion is to get your views on the ideas and 
recommendations that were suggested during the interviews that could 
help improve the contribution of the clinical nurse specialist to the team 
decision-making process within the meeting. 
 
I am not here to give you my opinions. Your views are what matter. 
There are no right or wrong answers. You can disagree with each 
other, and you can change your mind. I would like you to feel 
comfortable saying what you really think and how you really feel. 
Participant introduction 
I would like us to start with a brief introduction, so if you could each 
state your name and tell us a little about your experience of working in 
a colorectal cancer multidisciplinary team.  
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Main content of focus group 
1. Summary of findings from interviews on themes. 
2. What are your thoughts on these findings? 
a. Are they surprising? 
b. Is anything missing? 
3. Summary of proposals that may improve the contribution of the 
clinical nurse specialist to the team decision-making process. 
a. What are your views on these? 
b. Are there any that you think more 
appropriate/possible/unworkable? 
c. Could we rank these in terms of priority? 
 
Closure 
[Summary of ranked recommendations which have been suggested]. 
Just to reaffirm, your responses are confidential and you will not be 
identifiable in the final report. Thank you very much for coming this 
morning/afternoon. Your time is very much appreciated and your 
comments have been very helpful.   
  
 304 
Appendix 23: Enablers to CNS contribution  
 
Enablers identified from the semi-structured interviews and used for 
Phase 3 Focus group 
 
1. CNS development programme 
2. Training on team dynamics 
3. Understanding medical cultures 
4. Team willingness to change 
5. Clarity on role in the meeting 
6. Person discussing the patient should know the patient 
7. Appropriate seating to enhance team communication 
8. Team training on presenting cases 
9. One person running the meeting 
10. Addressing medical hierarchical issues 
11. Core members on front row 
12. More preparation time 
13. Systematising of CNS opinion into discussion  
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Appendix 24: Summary of modified Bales IPA data across the four 
teams 










14 (23.7%) 7 (18.4%) 7 (11.1%) 5 (12.5%) 33 (16.5%) 
(BIPA2) 
CNS dramatizes 




















22 (37.3%) 4 (10.5%) 6 (9,5%) 3 (7.5%) 35 (17.5%) 
(BIPA5a) 
CNS asks for 
information 
12 (20.3%) 1 (2.6%) 2 (3.2%) 3 (7.5%) 18 (9.0%) 
(BIPA5b) 
CNS asks for 
opinion 
5 (8.5%) 0 (0%) 0 (0%) 1 (2.5%) 6 (3.0%) 
BIPA5c 
CNS asks for 
suggestions 
2 (3.4%) 0 (0%) 0 (0%) 0 (0%) 2 (1.0%) 
(BIPA6a) 
CNS is asked for 
information 









Site 1 Site 2 Site 3 Site 4 Total 
(BIPA6b) 
CNS is asked for 
opinion 
3 (5.1%) 0 (0%) 4 (6.3%) 1 (2.5%) 8 (4.0%) 
(BIPA6c) 
CNS is asked for 
suggestion 









































Appendix 26: Good Reporting of A Mixed Methods Study (GRAMMS) 
 
Item Guidelines Application to 
MDM study 
1 Describe the justification for using a mixed 
methods approach to the research question 
Chapter 1 and 
Chapter 3 
2 Describe the design in terms of the purpose, 
priority and sequence of methods 
Chapter 3 
3 Describe each method in terms of sampling, 
data collection and analysis 
Chapter 3 
4 Describe where integration has occurred, how 
it has occurred and who has participated in it. 
Chapter 3 and 
Chapter 4 
5 Describe any limitations of one method 
associated with the present of the other 
method 
Chapter 3 and 
Chapter 4 
6 Describe any insights gained from mixing or 
integrating methods 
Chapter 4 
 
 
